Computer Programs and Systems Annual Report 2012

FY2012 Annual Report · Computer Programs and Systems

Loading PDF…

2012 annual report

Company profile

CPSI is a leading provider of healthcare information solutions for rural and community hospitals with over 650 client
hospitals in 45 states and the District of Columbia. Founded in 1979, the Company is a single-source vendor providing
comprehensive software and hardware products, complemented by complete installation services and extensive support.
Its fully integrated, enterprise-wide system automates clinical and financial data management in each of the primary
functional areas of a hospital. CPSI’s wholly owned subsidiary, TruBridge, LLC, focuses exclusively on providing business
management, consulting and managed IT services to rural and community healthcare organizations, regardless of their
primary information technology vendor. CPSI’s staff of over 1,400 technical, healthcare, medical and business professionals
provides system implementation and continuing support services as part of a comprehensive program designed to
respond to clients’ information needs in a constantly changing healthcare environment. For more information, visit
www.cpsinet.com or www.trubridge.net.

annual Meeting

The annual meeting of stockholders will be held on May 9, 2013, at 9:00 a.m., Central Time, at the Mobile Convention
Center, One South Water Street, Mobile, Alabama.

Financial Highlights

(In thousands, except per share data)

Total sales revenues

Total cost of sales

Gross profit

Total operating expenses

Operating income

Other income, net

Income before taxes

Provision for income taxes

Net income

Basic earnings per share

Diluted earnings per share

Weighted average shares outstanding:

Basic

Diluted

Years Ended December 31,
2012

2011

$ 183,309

102,648

80,661

39,384

41,277

721

41,998

12,025

$ 29,973

2.71

11,066

$ 173,476

94,065

79,411

38,116

41,295

667

41,962

16,129

$ 25,833

2.34

11,034

left inside panel

to our Shareholders:

The American Recovery and Reinvestment Act of 2009 (ARRA) created a watershed moment in healthcare
information technology by offering direct financial incentives for hospitals to adopt electronic health records (EHRs).
Nowhere was the impact felt more strongly than on rural and community hospitals – the market segment served by
CPSI. Until that time, insufficient financial resources had long been the biggest obstacle to the adoption of EHRs.
The funds available under ARRA removed that barrier. To receive payments for EHR adoption, hospitals must
successfully attest to meeting certain objectives specified as “Meaningful Use” criteria. As expected, attaining that
standard in order to receive those funds, which are substantial, has been a primary focus for many hospitals since
2009. At CPSI, we made it our primary mission to ensure that our clients successfully achieved that goal.

Fast forward to late 2012, Modern Healthcare magazine analyzed a federal database reporting successful attestation of
meaningful use among U.S. hospitals that had adopted electronic health record systems. The data revealed that CPSI
“had attained the No. 1 position among vendors whose hospital clients have achieved meaningful use with systems
certified as ‘complete EHRs.’” At that point, nearly half of CPSI’s client hospitals had achieved meaningful use,
which accounted for 19.3% of the total number of hospitals that had implemented complete EHR systems. Among
companies that primarily serve small community hospitals, we achieved more meaningful use attestations than the
next three competitors combined. In fact, CPSI ranked first among all providers of EHR systems – including those
who focus on large urban facilities.

Through the first quarter of 2013, that success has translated into payments of more than $280 million to our
customers for EHR adoption. For these hospitals, those funds not only represent a return on their EHR investment, it
helps finance long-term strategies aimed toward completely integrating information technology into their operations.
The end result is that physicians and other caregivers will continue to see the growing positive impact on delivering
quality patient care as a result of the availability of real time clinical data provided by EHR systems.

While a number of hospitals in our market segment have successfully achieved Stage One of EHR adoption, many
more hospitals are just now moving toward implementing EHR systems. This means that our pipeline of potential
clients remains very strong. To these facilities, our company’s success sends a clear message: CPSI is not merely a
vendor, but a partner with a proven track record for helping clients reach their goals. Rest assured that we intend to
make the most of our leadership position to capitalize on the tremendous opportunities our marketplace offers.

While we are understandably proud of what we have accomplished to date with this success, it is far from the only
significant benchmark by which we measured our company’s performance last year. From increased revenues to
earnings per share of $2.77 to a special dividend payment in December of $1 per share, 2012 was the third consecutive
year of strong performance for CPSI. But in many ways, what we’ve accomplished in the EHR adoption effort
epitomizes the kind of success we can accomplish as an organization – and the reasons why we are even more excited
about what lies ahead in 2013 and beyond.

We also continue to build on excellent relationships with our existing clients. Our add-on sales remain strong as clients
still moving toward EHR certification continue to implement our Nursing Point of Care, Computerized Physician
Order Entry, and Physician Documentation applications. Meanwhile, in addition to development related to Stage Two
of EHR adoption, we are steadily developing new products, new applications and new tools, with a particular focus on

physicians. Our Emergency Department module will be released in 2013 and our new ambulatory
product for physicians, Medical Practice EMR-5, will be available later this year as well. With the
completion of our new technology platform, we are enhancing the experience of our end-users
as well as their capabilities to manage information effectively – capabilities that are becoming
increasingly important as hospitals progress towards Stage Two and Stage Three meaningful use
requirements for EHR adoption.

In looking beyond our EHR product to our services business, we have made a key strategic
move to broaden our market for this important segment of our business. Early in 2013, we
formed a wholly owned subsidiary, TruBridge, LLC, to provide business management as well as
consulting and managed information technology services to all rural and community healthcare
organizations. Previously, we had offered those services only to users of our EHR system and had
been extremely successful in doing so. Through those efforts, we identified unmet needs that we
believe are consistent across our entire market. We are very confident we can have the same success
in delivering those services to any rural or community hospital, regardless of their primary IT
vendor.

The drive towards electronic health records presents us with great opportunity. As we have
demonstrated without question, it is an opportunity for which our company is well prepared. Our
approach to providing systems and services has proven to foster long-term partnerships with our
clients. Unlike most of our competitors, our company’s growth has always been organic, with a
workforce consisting entirely of US-based, full-time employees, fostering a shared culture focused
on consistent excellence. We seek to make ourselves exceptionally valuable to our clients, and our
record in helping them achieve meaningful use status over the past two years has made that value
especially apparent. We are not resting on our laurels, but are excited about the future and the
prospect of building on the advantageous position we have worked hard to earn. As always, we
deeply appreciate your support and your investment.

Sincerely,

J. Boyd Douglas
Chief Executive Officer and President

9
0
3

3
8
1
$

6
7
4

3
7
1
$

7
4
2

3
5
1
$

2
4
7

7
2
1
$

4
6
6
9
1
1
$

08 09

3
7
9

9
2
$

3
3
8

5
2
$

8
3
7

8
1
$

8
3
4

5
1
$

3
8
1
,

5
1
$

08 09

1
7

2
$

4
3

2
$

1
7

.
1
$

2
4

.
1
$

9
3

.
1
$

08 09

)
s
d
n
a
s
u
o
h
t
n

$
(

s
e
u
n
e
v
e
r

)
s
d
n
a
s
u
o
h
t

$
(

e
m
o
c
n
I

t
e
n

e
r
a
h
S
r
e
p
s
g
n

n
r
a
e
d
e
t
u

l
i

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 10-K

È ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES

EXCHANGE ACT OF 1934
FOR THE FISCAL YEAR ENDED DECEMBER 31, 2012

‘ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES

EXCHANGE ACT OF 1934
FOR THE TRANSITION PERIOD FROM

TO
Commission file number: 000-49796

COMPUTER PROGRAMS AND SYSTEMS, INC.

(Exact Name of Registrant as Specified in Its Charter)

Delaware
(State or Other Jurisdiction of
Incorporation or Organization)

6600 Wall Street, Mobile, Alabama
(Address of Principal Executive Offices)

74-3032373
(I.R.S. Employer
Identification No.)

36695
(Zip Code)

(251) 639-8100
(Registrant’s telephone number, including area code)
Securities registered pursuant to Section 12(b) of the Act:

Title of Each Class
Common Stock, par value $.001 per share

Name of Each Exchange on Which Registered
The NASDAQ Stock Market LLC

Securities registered pursuant to Section 12(g) of the Act:
None

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities

Act. Yes ‘ No È

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the

Act. Yes ‘ No È

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the
Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required
to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes È No ‘

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any,

every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this
chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such
files). Yes È No ‘

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein,
and will not be contained, to the best of registrant’s knowledge, in definitive proxy or information statements incorporated by
reference in Part III of this Form 10-K or any amendment to this Form 10-K. È

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or

a smaller reporting company. See the definitions of “large accelerated filer,” accelerated filer” and “smaller reporting
company” in Rule 12b-2 of the Exchange Act. (check one):

Large accelerated filer ‘
Non-accelerated filer ‘
(Do not check if smaller reporting company)

Accelerated filer È
Smaller reporting company ‘

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the

Act). Yes ‘ No È

The aggregate market value of common stock held by non-affiliates of the registrant at June 30, 2012 was $592,741,351.
As of March 8, 2013 the registrant had outstanding 11,080,062 shares of its common stock.

DOCUMENTS INCORPORATED BY REFERENCE IN THIS FORM 10-K:
Portions of the definitive Proxy Statement for the Annual Meeting of Stockholders to be held on May 9, 2013 are

incorporated by reference into Part III of this report.

TABLE OF CONTENTS

Item No.

Page No.

SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS . . . . . . . . . . . . . . . . . . .

1A.
1B.
2.
3.
4.

6.
7.

7A.
8.
9.

9A.
9B.

10.
11.
12.

13.
14.

PART I

Business . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Overview . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Industry Dynamics . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Our Solution . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Strategy . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Our Products and Services . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
System Implementation and Training . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Technology . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Product Development and Enhancement
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Customers, Sales and Marketing . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Competition . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Health Information Security and Privacy Practices . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Internal Management Control System . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Intellectual Property . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Employees . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Executive Officers . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Company Web Site . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Risk Factors . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Unresolved Staff Comments . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Properties . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Legal Proceedings . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Mine Safety Disclosures . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

PART II

Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer

Purchases of Equity Securities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Selected Financial Data . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Management’s Discussion and Analysis of Financial Condition and Results of

Operations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Quantitative and Qualitative Disclosures about Market Risk . . . . . . . . . . . . . . . . . . . . . . . . .
Financial Statements and Supplementary Data . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Changes in and Disagreements with Accountants on Accounting and Financial

Disclosure . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Controls and Procedures . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Other Information . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

PART III

Directors, Executive Officers and Corporate Governance . . . . . . . . . . . . . . . . . . . . . . . . . . .
Executive Compensation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Security Ownership of Certain Beneficial Owners and Management and Related

Stockholder Matters . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Certain Relationships and Related Transactions, and Director Independence . . . . . . . . . . . .
Principal Accountant Fees and Services . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

PART IV

15.

Exhibits and Financial Statement Schedules . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
SIGNATURES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

1
1
1
3
4
5
15
16
16
17
17
18
18
19
19
19
22
23
34
34
35
35

36
37

38
53
54

80
80
81

82
82

82
82
82

83
84

* Portions of the definitive Proxy Statement for the Annual Meeting of Stockholders to be held on May 9, 2013

are incorporated by reference into Part III of this Form 10-K.

SPECIAL NOTE REGARDING FORWARD LOOKING STATEMENTS

This Annual Report on Form 10-K contains forward-looking statements within the meaning of the “safe
harbor” provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements
can be identified generally by the use of forward-looking terminology and words such as “expects,”
“anticipates,” “estimates,” “believes,” “predicts,” “intends,” “plans,” “potential,” “may,” “continue,” “should,”
“will” and words of comparable meaning. Without limiting the generality of the preceding statement, all
statements in this Annual Report relating to estimated and projected earnings, margins, costs, expenditures, cash
flows, growth rates and future financial results are forward-looking statements. We caution investors that any
such forward-looking statements are only predictions and are not guarantees of future performance. Certain risks,
uncertainties and other factors may cause actual results to differ materially from those projected in the forward-
looking statements. Such factors may include:

•

overall business and economic conditions affecting the healthcare industry;

government regulation of the healthcare and health insurance industries;

government regulation of our products and customers, including changes in healthcare policy affecting
Medicare reimbursement rates;

the potential effects of the federal healthcare reform legislation enacted in 2010, and implementing
regulations, on the businesses of our hospital customers;

the funding uncertainties associated with and potential expenditures required by the American
Recovery and Reinvestment Act of 2009 in connection with the adoption of electronic health records;

saturation of our target market and hospital consolidations;

changes in customer purchasing priorities, capital expenditures and demand for information technology
systems;

competition with companies that have greater financial, technical and marketing resources than we
have;

failure to develop new technology and products in response to market demands;

failure of our products to function properly resulting in claims for medical losses;

changes in accounting principles generally accepted in the United States of America;

breaches of security and viruses in our systems resulting in customer claims against us and harm to our
reputation;

potential intellectual property claims against us;

general economic conditions, including changes in the financial markets that may affect the availability
and cost of credit to us or our customers; and

interruptions in our power supply and/or telecommunications capabilities.

For more information about the risks described above and other risks affecting us, see “Risk Factors”

beginning on page 23 of this Annual Report. We also caution investors that the forward-looking information
described herein represents our outlook only as of this date, and we undertake no obligation to update or revise
any forward-looking statements to reflect events or developments after the date of this Annual Report.

ITEM 1.

BUSINESS

Overview

PART I

We are a leading provider of healthcare information solutions for rural (including critical access) and
community hospitals, with over 650 client hospitals in 45 states and the District of Columbia. Founded in 1979,
we are a single-source vendor providing comprehensive software and hardware products, complemented by
complete installation services and extensive support. Our fully integrated, enterprise-wide system automates
clinical and financial data management in each of the functional areas of a hospital. Our software and hardware
products and installation and support services are further complemented by business management, consulting and
managed IT services offered by our wholly-owned subsidiary, TruBridge, LLC (“TruBridge”). We believe our
products and services enhance hospital performance in the critical areas of clinical care, revenue cycle
management, cost control and regulatory compliance.

Our target market includes acute care community hospitals with 300 or fewer acute care beds. Our primary

focus within this defined target market is on hospitals with 100 or fewer acute care beds, which comprise
approximately 94% of our hospital customer base. In addition to our target market, we provide information
technology services to other related entities in the healthcare industry, such as nursing homes, home health
agencies and physician clinics. During 2012, we generated revenues of $183.3 million from the sale of our
products and services.

Industry Dynamics

The healthcare industry is the largest industry in the United States economy, comprising approximately
17.9% of the U.S. gross domestic product in 2011 according to the Centers for Medicare and Medicaid Services,
or “CMS”. The CMS estimates that by fiscal 2021 total U.S. healthcare spending will reach $4.8 trillion, or
19.6% of the estimated U.S. gross domestic product.

Hospital services represents one of the largest categories of total healthcare expenditures, comprising
approximately 31.5% of total healthcare expenditures in 2011 according to the CMS. According to the American
Hospital Association’s AHA Hospital Statistics, 2012 Edition, there are approximately 4,200 community
hospitals in the United States that are in our target market of hospitals with 300 or fewer acute care beds, with
approximately 2,600 of those in our primary area of focus of 100 or fewer acute care beds. In addition, there is a
market of small specialty hospitals that focus on discrete medical areas such as surgery, rehabilitation and
psychiatry.

Notwithstanding the size and importance of the healthcare industry within the United States economy, the

industry is constantly challenged by changing economic dynamics, increased regulation and pressure to improve
the quality of healthcare. These challenges are particularly significant for the hospitals in our target market due to
their more limited financial and human resources and their dependency on Medicare and Medicaid populations
for a substantial portion of their revenue. However, we believe healthcare providers can successfully address
these issues with the help of advanced medical information systems. Specific examples of the challenges and
opportunities facing healthcare providers include the following.

Changing Economic Dynamics. Rural and community hospitals typically generate a significant portion of

their revenues from beneficiaries of the Medicare program. Consequently, even small changes in this federal
program have a disproportionately larger impact on rural and community hospitals as compared to larger
facilities where greater portions of their revenues are typically generated from beneficiaries of private insurance
programs. Medicare funding and reimbursements fluctuate year to year and, with the growth in healthcare costs,
will continue to be scrutinized as the federal government attempts to control the costs and growth of the program.
The Medicaid program, which is a federal/state program managed by the individual states and dependent in part
on funding from the states, also continues to struggle due to the increasing cost of healthcare and limited state
revenues.

Mandatory cuts in federal spending resulting from the Budget Control Act of 2011 became effective on

March 1, 2013. Although Medicaid is specifically exempted from the cuts mandated by the legislation, it
includes a reduction of up to 2% in federal Medicare spending. As the federal government seeks in the future to
further limit deficit spending due to fiscal restraints, it will likely continue to cut entitlement spending programs
such as Medicare and Medicaid matching grants which will place further cost pressures on hospitals and other
healthcare providers. Furthermore, federal and state budget shortfalls could lead to potential reductions in
funding for Medicare and Medicaid. Reductions in reimbursements from Medicare and Medicaid could lead to
hospitals postponing expenditures on information technology.

We expect that the demand for Medicare and Medicaid services will increase as a result of the current
challenging economic environment and high level of unemployment, and increasing age of the U.S. population.
According to the 2009 and 2010 National Health Interview Survey conducted by the U.S. Department of Health
and Human Services, less than one third of unemployed individuals subscribe to private health insurance,
whereas nearly three quarters of employed individuals have private health insurance. With national
unemployment hovering near 8 percent, significant pressure is being put on America’s hospitals as they struggle
to serve the growing numbers of uninsured patients. Additionally, tightened lending standards since 2007 have
increased the costs to hospitals of borrowing money and made it more difficult to find the financing for necessary
facility and technology improvements.

To compete in the continually changing healthcare environment, providers are increasingly using technology

in order to help maximize the efficiency of their business practices, to assist in enhancing patient care, and to
maintain the privacy of patient information. Healthcare providers are placing increased demands on their
information systems to accomplish these tasks. We believe that information systems must facilitate management of
patient information across administrative, financial and clinical tasks. Information systems must also effectively
interface with a variety of payor organizations within the increasingly complex reimbursement environment.

The American Recovery and Reinvestment Act of 2009. In February 2009, President Barack Obama signed

into law the American Recovery and Reinvestment Act (the “ARRA”). This $787 billion economic stimulus
package includes a number of healthcare policy provisions, including approximately $19 billion in funding over a
ten-year period for health information technology infrastructure and Medicare and Medicaid incentives to
encourage doctors, hospitals, and other providers to use health information technology to electronically exchange
patients’ health information, through the development of health information exchanges (“HIE”) and the adoption
of electronic health records (“EHR”). Approximately $2 billion of the total funding amount is in appropriated
funds for discretionary grants, loans and technical assistance programs designed to aid providers with the
adoption of EHR and the development of HIE. These funds are being disbursed by various agencies within the
Department of Health and Human Services, either directly to providers – including private physician offices – or
to other entities like states or non-profit organizations. The remaining allocated amounts take the form of
Medicare and Medicaid payment incentives. The ARRA identifies four priority areas for spending with respect to
health information technology: (1) establishing HIE; (2) EHR adoption; (3) workforce training; and (4) new
technology research and development. In order to qualify for EHR funding, providers are required to adopt an
EHR system and connect to an HIE, which means funding is dependent on state action to establish HIEs. The
payment incentives started to become available to our customers in 2011, and, as of March 8, 2013,
approximately 273 of our hospital customers had received payments under the ARRA totaling more than $277
million for EHR adoption.

The ARRA includes payment incentives for rural and community hospitals that are meaningful users of

certified EHR technology. During December 2010, both our hospital and medical practice EHR solutions were
certified as a complete EHR by the Certification Commission for Health Information Technology (CCHIT®).
Receiving this certification for both our hospital and medical practice EHR products ensures that hospitals and
other healthcare providers using our EHR systems can be considered “meaningful users” of EHR and qualify for
ARRA reimbursements. We believe that the ARRA and this certification of our EHR system will continue to
have a positive impact during the next few years on our business and the businesses of the rural and community
hospitals that comprise our target market.

Continued Push for Improved Patient Care. With pressure mounting to reduce medical errors and improve
patient safety, hospitals are actively seeking information technology solutions for clinical decision support. This
migration toward clinical decision support solutions is further supported by the ARRA. The provisions of the
ARRA offer incentives for hospitals to become meaningful users of EHRs through September 2015, and we
already have many hospital customers who have received these incentive payments as of February 2013.
However, the ARRA incentive program is set to expire as of October 1, 2015, and hospitals and healthcare
providers which have not implemented EHRs with HIE connectivity will be penalized with lower Medicare
payment levels after that date.

While economic, regulatory and consumer pressures such as those described above have increased rapidly

over the last several years, we believe healthcare organizations have historically underinvested in information
technology and services compared to other industries. This historical underinvestment has caused healthcare
providers to rely on non-integrated, complex and inefficient information systems. A hospital’s failure to
adequately invest in modern medical information systems could result in fewer patient referrals, cost
inefficiencies, lower than expected reimbursement, increased malpractice risk and possible regulatory infractions.

In the face of decreasing revenue and increasing pressure to improve patient care, healthcare providers are

in need of management tools that (1) increase efficiency in the delivery of healthcare services, (2) reduce medical
errors, (3) effectively track the cost of delivering services so those costs can be properly managed and
(4) increase the speed and rate of reimbursement. Despite challenging economic conditions, we believe the
industry will increase its adoption of information technology as a management tool, particularly as a result of the
ARRA. We further believe these dynamics should allow for future revenue growth.

Our Solution

We have tailored an information technology solution that effectively addresses the specific needs of small

and midsize hospitals. Due to their smaller operating budgets, rural and community hospitals have limited
financial and human resources to operate manual or inefficient information systems. However, these hospitals are
expected to achieve the same quality of care and regulatory compliance as larger hospitals, placing them in a
particularly difficult operating environment. These pressures on the operating environments of rural and
community hospitals were increased with the passage of the ARRA in 2009 which, in addition to providing for
incentives for healthcare providers to achieve meaningful use of EHR, will result in lowered Medicare payment
levels after 2015 for healthcare providers that have yet to achieve meaningful use of EHR.

We believe that the CPSI solution meets these challenges facing rural and community hospitals by

providing fully integrated, enterprise-wide and ARRA certified medical information systems and services that are
compliant with the Health Insurance Portability and Accountability Act of 1996 (“HIPAA”) and that collect,
process, retain and report data in the primary functional areas of a hospital, from patient care to clinical
processing to administration and accounting. As a key component of our complete solution, we provide ongoing
customer service through regular interaction with customers, customer user groups and extensive customer
support. Further, through our wholly-owned subsidiary, TruBridge, we offer business management, consulting
and managed IT services that allow customers to avoid some of the fixed costs of a business office and leverage
our expertise and resources in helping them identify their IT objectives, define the best way to meet those
requirements and manage the resulting projects and associated technologies. As a result, we are capable of
providing a single-source solution for small and midsize hospitals, making us a partner in their initiatives to
improve operations and medical care.

Our customers continually communicate with us through our support teams and through organized user

groups, allowing us to continue to provide a state-of-the-art solution that meets their specific needs. By
remaining sensitive and responsive to the ever-changing demands of our customers and regularly updating our
products, we believe that we provide an information technology solution that meets the needs of rural and
community hospitals. Our business has continued to grow because we have successfully addressed the needs of

rural and community hospitals for fully integrated, enterprise-wide information systems that allow them to
improve operating effectiveness, reduce costs and improve the quality of patient care.

On January 28, 2013, we formed TruBridge as a wholly-owned subsidiary focusing exclusively on
providing business management, consulting and managed IT services to rural and community healthcare
organizations. While our traditional customer base for these services has been those rural and community
healthcare organizations who have selected CPSI as their single-source healthcare information solutions
provider, we believe that the formation of TruBridge will allow for an improved focus of our marketing and
service delivery resources and assist us in expanding the customer base for these service offerings to all rural and
community healthcare organizations, regardless of their primary healthcare information solutions provider.

Strategy

Our objective is to continue to grow as a leading provider of healthcare information technology systems and

services to rural and community hospitals by expanding on the strategy that we have successfully pursued for
over thirty years, the key elements of which are described below.

Deliver a Single-Source Solution. When a customer purchases the CPSI system, we provide everything
necessary for the customer to implement and use our system. We deliver the application software, computer
hardware, peripherals, forms and supplies used in the comprehensive information network. Our installation teams
work extensively with each customer to convert existing data to the new system, to install all of the necessary
equipment and to train hospital personnel to use our system. After installation, our support teams answer and
address customer questions and issues related to any aspect of the system. Through TruBridge, LLC
(“TruBridge”), our wholly-owned subsidiary, we also offer our customers additional services such as business
management, consulting and managed IT services. We believe our single-source approach to delivering a
complete information system makes our system easier and more convenient for customers to understand and
manage, which results in greater customer satisfaction and retention.

Provide Enterprise-Wide, Fully Integrated Software Applications. We have developed all of our software
products internally as part of our fully integrated system architecture. Our experience has taught us that using a
fully integrated system in the primary functional areas of a hospital ensures compatibility among applications and
avoids pitfalls associated with interfacing disparate systems. Our system utilizes one central database where
information is stored and used by all of our software applications. With our single database model, our systems
provide secure, real-time access to all information across multiple applications for all those needing such access,
including physicians, nurses, laboratory technicians, pharmacists, clinicians and other users. The enterprise-wide,
fully integrated nature of our system also allows customers to monitor user access to information for purposes of
compliance with federal and state privacy regulations.

Maintain Commitment to Customer Oriented Operating Philosophy. A key factor in our success has been

our focus on customer service and support. We make available to our customers experienced support teams that
can assist with any question or problem. We currently have close to a one-to-one support staff to customer ratio.
Our support teams are extensively trained, and our employees are generally promoted from within so that they
have a thorough knowledge of our system and a commitment to our culture. Because all of our customers use the
same version of our system, our support teams can be more effective by maintaining a complete understanding of
a single system. As part of our commitment to system support, we actively solicit customer feedback regarding
ways in which we can improve the effectiveness and efficiency of our systems. To further this goal, we have
organized our customers into a national user group to promote the exchange of information regarding our system
and to identify product enhancements based on our customers’ operational experiences. We believe our user
group concept is a key component of our success by positively impacting customer satisfaction and retention and
by enhancing product development and system functionality. We will continue to focus on our national user
group as a key component to our goal of maintaining and growing our customer base and market share.

Expand Presence in Target Market for our Software and Hardware Products. We will continue to target small

domestic hospitals of 100 or fewer acute care beds, as well as expand our presence in midsize hospitals of 300 or
fewer acute care beds. In addition, a number of our customers are small specialty hospitals that focus on discrete
medical areas such as surgery, rehabilitation and psychiatry. According to the most recent data available from the
U.S. Department of Health and Human Services, there are approximately 1,200 specialty care hospitals in the
United States (excluding critical access and children’s hospitals). We intend to continue gaining customers from this
market segment. Our system can help these smaller hospitals reduce costs and increase their operating efficiencies.
We believe our personalized marketing approach and emphasis on customer relationships are attractive to the
management of these hospitals. We also believe our system is well-suited to hospitals of this size because they
typically demonstrate a greater commitment than larger hospitals to the concept of an enterprise-wide, fully
integrated system. In addition, we will continue to sell additional services and software and hardware products to
our existing customers who have not purchased our complete package of services and software applications.

Expand Presence in Target Market for our Suite of Additional Services. On January 28, 2013, we formed
TruBridge as a wholly-owned subsidiary focusing exclusively on providing business management, consulting, and
managed IT services to rural and community healthcare organizations. While we will continue our previous strategy
of continuing to sell additional services to those rural and community healthcare organizations that have selected
CPSI as their single-source healthcare information solutions provider, we believe that the formation of TruBridge
will enable us to more effectively market and further expand our target market for these service offerings to all such
healthcare providers, regardless of their primary healthcare information solutions provider. There are approximately
4,200 community hospitals in the United States that are in our target market of hospitals with 300 or fewer acute
care beds, with approximately 2,600 of those in our primary area of focus of 100 or fewer acute care beds. Given the
magnitude of the marketplace for TruBridge’s services, the ability to expand the customer base for our suite of
services beyond the more than 650 hospitals who have selected CPSI as their primary healthcare information
solutions provider has the potential to drive significant revenue growth.

Emphasize Other Recurring Revenue Opportunities. In addition to revenues from new system installations, we

have developed and will continue to develop sources of recurring revenues. Our current principal source of
recurring revenues is our support and maintenance fees paid by existing customers. As our customer base grows, our
recurring revenues from support and maintenance fees should also grow. We believe recurring revenues will also
continue to increase from the business management, consulting and managed IT services provided by TruBridge,
which we market to all rural and community healthcare organizations, regardless of their primary healthcare
information solutions provider. Our business management services include electronic billing, patient statement
processing, accounts receivable management, payroll processing, ISP services and web site hosting. Our consulting
services include IT staffing, IT infrastructure assessment and project management for clinical point of entry
(“CPOE”) implementation and meaningful use attestation. Our managed IT services include managed network
services, server and storage management, and desktop support, as well as communications, connectivity, security
and data center services.

Our Products and Services

New Products

Much of our software programming efforts in 2012 and continuing into 2013 have been focused on helping our

customers to achieve stage two of meaningful use of EHR, as the volume and complexity of changes required to
reach stage two are considerable. The final rules regarding stage two of meaningful use of EHR were released in
2012, and hospitals may begin reporting for stage two requirements as early as October 1, 2013. Stage two increases
data capture requirements and use of medical vocabularies, expands stage one functionality requirements, increases
interoperability requirements and emphasizes greater patient engagement. To meet these new requirements, new
data elements and functionalities must be created and tied to the existing data structure and system functionalities in
a manner that is consistent with healthcare provider workflows. Updates associated with stage two of meaningful
use of EHR will be provided to our customers with the release of version 19 of the CPSI system in July 2013.

During 2012, our development efforts also focused on our emergency department application. This new
application is in the final stages of development and is scheduled to be generally available with the release of
version 19 the CPSI system in July 2013. The emergency department application is specifically designed for the
care environment and workflow of a hospital emergency department. The application will provide
comprehensive and customizable patient tracking boards; real time displays of patient locations, statuses and
order/results alerts; computerized physician order entry specific to emergency care and workflow; evaluation and
management coding specific to emergency department patients; and department-contained order routing and
resulting. We feel that our emergency department application will allow customers to apply information system
efficiencies to the most costly care environment in the hospital.

Software Systems

We offer a full array of software applications designed to streamline the flow of information to the primary

functional areas of rural and community hospitals in one fully integrated system. We intend to continue to
enhance our existing software applications and develop new applications as required by evolving industry
standards and the changing needs of our customers. Pursuant to our customer support agreements, we provide our
customers with software enhancements and upgrades periodically on a when-and-if-available basis. See “Support
and Maintenance Services.” These enhancements enable each customer, regardless of its original installation
date, to have the benefit of the most advanced CPSI products available. Our software applications:

•

provide automated processes that improve clinical workflow and support clinical decision-making;

allow healthcare providers to efficiently input and easily access the most current patient medical data in
order to improve the quality of care and patient safety;

integrate clinical, financial and patient information to promote efficient use of time and resources,
while eliminating dependence on paper medical records;

provide tools that permit healthcare organizations to analyze past performance, model new plans for
the future and measure and monitor the effectiveness of those plans;

provide for rapid and cost-effective implementation, whether through the installation of an in-house
system or through our Software as a Service (SaaS) services; and

increase the flow of information by replacing centralized data over which there is limited control with
broad-based, secure access by clinical and administrative personnel to data relevant to their functional
areas.

Our software applications are grouped for support purposes according to the following functional categories:

•

Patient Management

Financial Accounting

• Clinical

•

Patient Care

• Enterprise Applications

Due to the integrated nature of the CPSI system, our software applications are not marketed as distinct

products, and our sales force attempts to sell all applications to each customer as a single product. New
customers must purchase from us and have installed the core applications of patient management and financial
accounting and all hardware necessary to run these applications. In addition to the core applications, customers
may also purchase one or more of our clinical, patient care and enterprise applications. Over two-thirds of our
customers have purchased a combination of applications that meet their enterprise-wide information technology
needs.

The general functional categories, as well as the software applications in each of these categories, are

described below.

Patient Management. Our patient management software enables a hospital to identify a patient at any point
in the healthcare delivery system and to collect and maintain patient information throughout the entire process of
patient care on an enterprise-wide basis. The single database structure of our software permits authorized hospital
personnel to simultaneously access appropriate portions of a patient’s record from any point on the system. The
patient management software performs the following functions:

Registration

•

records patient admissions, discharges and transfers

Patient Accounting

Health Information
Management

• manages patient status, room assignments and recurring charges

•

keeps information available to all hospital personnel in formats
designed for their particular requirements

records patient charges and maintains accounts receivable
information including aging, service charges and cash receipts

generates and processes insurance claims

supports the operational needs of the modern medical records
department including transcription, case indexing/abstracting and
statistical reporting

tracks deficiencies in a patient’s chart and provides chart location
information

Patient Index

• maintains a master index of hospital patients and provides

Electronic Claims
Processing

Medical Practice
Management

immediate online access to patient financial and medical data
associated with a patient stay

provides a computer-to-computer link with intermediaries for
Medicare and other payors for the submission of claims

supports patient account management and insurance processing
for single and multiple practices/clinics

supports both hospital-based and remote practices/clinics

•

We also offer the following optional products that may be purchased as part of our core patient management

suite:

Enterprise Wide
Scheduling

Contract Management

Quality Improvement

• maintains all patient scheduling information

•

tracks patients enrolled in managed care plans and conforms
billing functions to such plans

automates hospital-wide total quality management and reporting
requirements for utilization activity, risk management, infection
surveillance and all accreditation review functions

Financial Accounting. Our financial accounting software provides a variety of business office applications
designed to efficiently track and coordinate information needed for managerial decision-making. Our financial
accounting software:

Executive Information
System

General Ledger

Accounts Payable

Payroll/Personnel

Time and Attendance

Electronic Direct
Deposits

Human Resources

Budgeting

Fixed Assets

Materials Management

•

summarizes daily financial transactions regarding patient
revenues, receipts, census statistics and billing information for
ready access by hospital administrators

provides timely, accurate financial information generated from
daily hospital operations

formats financial statements to the specifications of each user and
is able to generate up to 999 different user-defined reports

processes vendor invoices and payments and their related general
ledger entries

calculates all employee wages and benefits for an unlimited
number of salaried and hourly employees

allocates employee time to user-defined cost centers

uses touch screen time clocks to eliminate manual time entry

reduces effort of gathering employee time data and increases
access of managers to such data

• makes time records more accurate by identifying employees

through bar-coding and optional biometric fingerprint technology

•

provides for computerized bank deposits to meet payroll and
accounts payable needs

provides for computerized employee files through document/
image scanning and data entry

allows for complete tracking of benefits and other employee data
through a variety of user-defined reports

tracks job applicant information to assist in the employee
recruiting and hiring process

allows for complete online budget preparation through
computerized access to historical data

allows access to information regarding hospital assets including
locations and depreciation scheduling

tracks the flow of materials throughout the hospital

automates the process of inventory control, materials purchasing,
stock requisitions and patient charging

Clinical. Our clinical software automates record keeping and reporting for many clinical functions including

laboratory, radiology, physical therapy, respiratory care, and pharmacy. These products eliminate tedious
paperwork, calculations and written documentation while allowing for easy retrieval of patient data and statistics.
Our clinical software:

Laboratory Information
Systems

Laboratory Instrument
Interfaces

Radiology Information
Systems

ImageLink®

Physical Therapy and
Respiratory Care

Pharmacy

•

provides an interface to laboratory analytical instruments in order
to transfer results to nurse stations, mobile point-of-care systems
and remote physician offices

allows users to receive orders from any designated location,
process orders and report results, and maintain technical,
statistical and account information

provides an automated solution for reviewing test results and
completing patient orders

reduces the amount of required manual data entry thereby
reducing the likelihood of human error

reduces time to process laboratory specimens

includes flash card printing, patient scheduling, transcription,
patient indexing by X-Ray film number, film tracking and
location

receives patient data, patient locations and other
interdepartmental communications support

provides a complete picture archiving and communications
system (PACS) with comprehensive functionality designed to fit
seamlessly with our other applications

allows the realization of an electronic health record complete with
diagnostic images

provides physicians real-time access to diagnostic images via the
internet through ChartLink®.

communicates to nursing the appropriate procedures and patient
preparation instructions from orders entered into the CPSI system

keeps a journal of the orders received and processed

handles a variety of processing tasks after a patient order is
reviewed

allows a department to customize its results to be sent back to
nursing

allows the hospital pharmacist to enter and fill physician orders

performs all of the functions related to patient charging, general
ledger upgrading, re-supply scheduling and inventory reduction/
statistics maintenance

improves patient care by monitoring drug/drug and food/drug
interactions, allergy contraindications, dosage ranges and
duplicate therapy

produces drug education information for each patient in an easy-
to-read format

Patient Care. Our patient care applications allow hospitals to create computerized “patient files” in place of
the traditional paper file systems. This software enables physicians, nurses and other hospital staff to improve the
quality of patient care through increased access to patient information, assistance with projected care
requirements and feedback regarding patient needs. Our software also addresses current safety initiatives in the
healthcare industry such as the transition from written prescriptions and physician orders to computerized
physician order entry. Our patient care software:

Order Entry / Results
Reporting

Point-of-Care System

Patient Acuity

ChartLink®

Medication Verification

Resident Assessment
Instruments

Medical Practice EMR

•

provides efficient order and result communication

automates the entry of patient charges

reduces “lost” charges and mistakes due to legibility

increases efficiency of nursing stations

provides interactive, real time status reports for orders

allows nurses to enter patient data into the network at the patient’s
bedside thereby eliminating the duplicate entry of information

utilizes touch-screen and wireless technology

• makes patient information instantly available throughout the

entire hospital system

•

categorizes patients according to an assessment of the acuity of
the illness, severity of the symptoms, and projected nursing
dependency

allows nurses to project the total character and amount of care
that should be provided to each patient

provides physicians with a secure and interactive portal to patient
information through a hospital’s web site

optional computerized physician order entry, including the ability
to enter medication, ancillary test and treatment orders

verifies the accuracy of patient medication orders at a patient’s
bedside by comparing scans of patient and medication bar codes
against the medication orders and history for that patient

screens medication orders for possible patient allergies and/or
drug interactions

allows nursing staff to complete time consuming resident
reporting requirements in an expeditious and efficient manner

generates nursing care plans based on deficiencies in the resident
reports

provides medical practices and clinics with a complete CCHITSM
certified electronic medical record

supports patient account management and insurance processing
for single and multiple practices/clinics

automates medical practice workflow with an interactive white
board, template driven documentation, image capture/document
scanning, and an integrated superbill

integrated with CPSI’s ChartLink® EMR portal, the module
provides immediate and secure access to the patient’s complete
ambulatory and inpatient history

Outreach Client Access

Electronic Forms

Physician
Documentation

•

supports both hospital-based and remote practices/clinics

supports patient account management and insurance processing
for home health agencies

provides complete, regulatory compliant home care tracking

provides for remote in-home documentation of care

provides the hospital’s outreach clients, such as physicians, their
office administrators, nursing homes, home health agencies, and
local businesses, with remote access to online, real-time, secure
patient data as needed and appropriate for each outreach client

available information includes insurance and billing information,
diagnosis and procedure coding, discharge summaries, pharmacy
profiles and other clinical and administrative information

electronic form templates replace paper-based records and care
forms

completed forms become a permanent part of the patient’s
electronic health record

electronic documentation of all aspects of physician/patient
encounter

documentation is integrated with clinical applications to allow
inclusion of diagnostic results, patient clinical data, patient
diagnosis, medications and orders

promotes compliance with regulatory standards while assisting in
optimizing reimbursement for services provided

Enterprise Applications. We provide software applications that support the products described above and are

useful to all areas of the hospital. These applications include: ad hoc reporting, automatic batch and real-time
system backups, an integrated fax system, archival data repository, document scanning and Microsoft Office
integration and an Application Portal. The Application Portal allows clients to access our applications remotely
via Microsoft Internet Explorer and the Internet without requiring the loading of any additional client software on
the accessing PC. User information and data accessed is secured with HIPAA compliant 128 bit cipher strength
Secure Socket Layer (SSL) encryption. Remote access using the Application Portal results in no discernible
difference to the user in software functionality.

Support and Maintenance Services

After a customer installs a CPSI system, we provide software application support, hardware maintenance,

continuing education and related services pursuant to a support agreement. The following describes services
provided to customers using CPSI systems.

Total System Support. We believe the quality of continuing customer support is one of the most critical
considerations in the selection of an information system provider. We provide hardware, technical and software
support for all aspects of our system which gives us the flexibility to take the necessary course of action to
resolve any issue. Unlike our competitors who use third-party services for hardware and software support, we
provide a single, convenient and efficient resource for all of our customers’ system support needs. In order to
minimize the impact of a system problem, we train our customer service personnel to be technically proficient,
courteous and prompt. Because a properly functioning information system is crucial to a hospital’s operations,

our support teams are available 24 hours per day to assist customers with any problem that may arise. Customers
can also use the Internet to directly access our support system. This allows customers to communicate
electronically with our support teams at any time. With over 600 employees who provide customer service and
support, we currently have close to a one-to-one support staff to customer ratio.

User Group. All of our customers have the opportunity to be members of our user group from which we solicit
feedback regarding our products. We host a national user group meeting annually. This group meets to discuss and
recommend product modifications and improvements which it then evaluates and prioritizes. Upon confirming that
the desired improvements are technically feasible, we agree to allocate a significant amount of programming time
each year to undertake the requested modification or improvement. The majority of our product enhancements
originate from suggestions from our customers that we receive through the user group structure.

Software Releases. We are committed to providing our customers with software and technology solutions
that will continue to meet their information system needs. To accomplish this purpose, we continually work to
enhance and improve our application programs. As part of this effort, for each customer covered under our
general support agreement, we provide software updates as they become available at no additional cost. We
design these enhancements to be seamlessly integrated into each customer’s existing CPSI system. The benefit of
these enhancements is that each customer, regardless of its original installation date, uses the most advanced
CPSI software available. Through this process, we can keep our customers up-to-date with the latest operational
innovations in the healthcare industry as well as with changing governmental regulatory requirements. Another
benefit of this “one system” concept is that our customer service teams can be more effective in responding to
customer needs because they maintain a complete understanding of and familiarity with the one system that all
customers use.

Purchasing a new information technology system requires the expenditure of a substantial amount of capital

and other resources, and many customers are concerned that these systems will become obsolete as technology
changes. Our periodic product updates eliminate our customers’ concerns about system obsolescence. We believe
providing this benefit is a strong incentive for potential customers to select our products over the products of our
competitors.

Hardware Replacement. As part of our general support agreements, we are also committed to promptly

replacing malfunctioning system hardware in order to minimize the effect of operational interruptions. By
offering all hardware used in our system, we believe we are better able to meet and address all of the information
technology needs of our customers.

Software as a Service. In some circumstances, we offer SaaS services to customers via remote access
telecommunications. As an application service provider, we store and maintain computer servers dedicated to
specific customers which contain all of such customers’ critical patient and administrative data. These customers
access this information remotely through direct telecommunications connections with these servers. Customers
may also elect to have their servers located on site at their hospitals.

Forms and Supplies. We offer our customers the forms that they need for their patient and financial records,

as well as their general office supplies. Furnishing these forms and supplies helps us to achieve our objective of
being a one-source solution for a hospital’s complete healthcare information system requirements.

Business Management, Consulting, and Managed Information Technology Services

We offer complementary services through TruBridge, our wholly-owned subsidiary, which can be grouped

into the following categories:

• Business Management Services

• Consulting Services

• Managed Information Technology Services

Business Management Services. Our business management services consist of the following service

offerings:

Electronic Billing

• We provide electronic billing for customers at prices competitive
with other electronic billing vendors. Once a customer processes
patient insurance claims using our system, we then perform the
electronic billing function with no other participation by hospital
staff. With this service, customers do not need to prepare billing
files or maintain interfaces with third-party software, thereby
saving the customer both time and money.

Insurance Services

•

In addition to electronic billing, we offer customers
complementary insurance services, including insurance follow-
up, claim eligibility checking, claim status checking, pharmacy
online adjudication, medical necessity database updates,
Medicare Connect access, review of health services transactions
and electronic remittances. Using these services allows customers
to improve their revenue cycle management by reducing the
incidents of invalid claims, monitoring the progress of valid
claims, and ensuring the timely and accurate application of
insurance payments.

Statement Processing

• Our customers may choose to have us prepare and distribute all

patient billing statements. We use our knowledge of a customer’s
collection system to produce statements without requiring any
action on the part of the hospital data processing personnel.
Because we can connect directly with a customer’s system, the
customer is not required to build and transfer files to us. All
system enhancements are incorporated into the statement process
without having to modify any third-party vendor interface.
Similar to electronic billing, this service saves the customer both
time and money.

• We offer customers the option of using us to perform their patient
billing functions and accounts receivable management. Using this
service allows customers to reduce costs by employing fewer full
time administrative employees.

Accounts Receivable
Management

Payroll Processing

• We offer customers the option of using us to perform their payroll

Contract Management

functions, including payroll processing, tax and deduction
management, quarterly and yearly reporting, and electronic pay
stubs.

• We offer customers the option of using us to perform audits of
payments from third-party insurers with which a customer
executes managed care contracts to ensure payments are made in
accordance with the agreed upon metrics.

Consulting Services. Our consulting services consist of the following service offerings:

Revenue Cycle
Consulting

• We offer customers revenue cycle consulting services, including

revenue cycle assessment, process redesign, interim management,
benchmarking, ICD-10 Readiness and custom contracted services.
With decades of experience in healthcare operations, we
understand what works in a rural and/or community healthcare
context and are able to develop achievable plans to help
customers meet their revenue cycle goals.

Clinical Consulting

• We offer customers clinical consulting services, including

Information
Technology (“IT”)
Consulting

computerized physician order entry adoption, meaningful use
achievement, point-of-care utilization, clinical application roll-
out, physician documentation, medical practice management,
medication reconciliation and custom contracted services. With
decades of experience in electronic health record technology, our
consultants are intimately familiar with what is required to meet
regulatory mandates and create useful clinical information
systems for caregivers of all kinds.

• We offer customers IT consulting services, including strategic
planning, IT infrastructure assessment, IT planning, design and
deployment, IT resource services, security risk assessment and
custom contract services. With a clear understanding of the IT
issues and challenges faced by rural and community healthcare
enterprises, our consultants can identify a path that will make best
use of a hospital’s existing infrastructure, while positioning the
hospital for the challenges yet to come.

Managed Information Technology (“IT”) Services. Our managed IT services consist of the following

service offerings:

Cloud Computing

Internet Service
Provider

Managed Network
Services

Server and Storage
Management

• We offer customers cloud computing services utilizing server and
storage resources maintained in our SOC 1 accredited data center.
Cloud computing utilizes virtual environments to meet customer
processing and data storage needs for live operations, disaster
recovery co-location, testing and training, and system backups.

• As part of our total information solution, we can provide Internet
connection services to our customers. We also can provide web
site design and hosting services.

• We offer comprehensive support for LAN, WLAN, WAN and

VPN infrastructures for those customers needing assistance with
their data networks. Security updates, hardware support, network
monitoring, wireless access management, VPN and private point-
to-point connectivity management and monitoring solutions can
be subscribed to based on the client’s unique needs.

• We offer complete management of CPSI installed server and
storage technology, including monitoring, administration and
change management solutions to enhance client availability
strategies for those important assets.

Desktop Support

• We offer timely support for desktop hardware, operating systems,

Communications
Solutions

Connectivity Solutions

select application software and peripheral devices. Desktop
support offerings can help expedite problem resolution and ensure
employees are not hindered by technological obstacles.

• We offer a robust set of fault tolerant communications hosting
solutions for web sites and electronic mail, smartphone email
integration and DNS services.

• We provide a variety of solutions to help ensure clients can stay
connected to the Internet in remote locations, including MPLS,
Metro-E, DSL, DS-1, DS-3 and other options.

Security Services

• We offer complete solutions for protecting the integrity of

Data Center Services

information systems and keeping system security compliant with
federal law, including HIPAA privacy and security requirements.
Solutions for malware (anti-virus protection), Internet content
filtering and firewall administration can all be provided by CPSI.

• We offer a SOC 1 accredited data center to house and manage
client servers and storage technologies. Solutions for managing
these environments and the provision of other data center
services, such as disaster recovery co-location and remote testing
services, are available.

The following table presents our revenues by major solutions and services as a percentage of total revenues:

Year ended December 31,

2012

2011

2010

Sales revenues:

System sales . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Support and maintenance . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Business management services . . . . . . . . . . . . . . . . . . . . . . .

39.6% 40.7% 40.0%
39.8% 38.9% 38.7%
20.6% 20.3% 21.4%

100.0% 100.0% 100.0%

System Implementation and Training

Conversion Services. When a customer purchases our system, we convert its existing data to the CPSI
system. Our knowledge of hospital data processing, in conjunction with extensive in-house technical expertise,
allows us to accomplish this task in a cost effective manner. When we install a new system, the data conversion
has already occurred so that the system is immediately operational. Our goal is for each customer to be
immediately productive in order not to waste time and money on the costly and inefficient task of maintaining
the same data on parallel systems. Our services also relieve the hospital staff of the time-consuming burden of
data conversion.

Training. In order to integrate the new system and to ensure its success, we spend approximately three
weeks providing individualized training on-site at each customer’s facility at the time of installation. We directly
train all hospital users, including staff members and healthcare providers, during all hospital shifts in the use of
hardware and software applications. In contrast, some of our competitors train only a hospital’s training staff at
an off-site location. We employ nurses, medical technicians, and providers in addition to our technical training
staff in order to help us communicate more effectively with our customers during the training process.

Technology

Operating Systems and Server Platform. Our system platform features a Linux operating system, an open

source SQL compliant database, Java, and a cross-platform user interface (UI). This platform allows CPSI to
provide its customers with an extensive range of capabilities to enhance IT operations and implement other new
complementary technologies such as rules-based customization and access from iOS, Android, Windows, Mac
and Linux-based devices. Additionally, with the release of version 18 of the operating system in 2011, the CPSI
system became iPad compatible. The SQL compliant database allows CPSI to efficiently mine the mass of
clinical data being captured by a hospital EHR system to meet both the hospital’s internal demands and
regulatory and interoperability requirements.

ClientWare® Networking. Our ClientWare® application integrates the Linux system with Microsoft

operating systems. This integration brings together the strengths of both operating environments. The processing
power of Linux combined with the communication capabilities of Microsoft Windows creates an information
system that allows the use of familiar “point and click” processing. This architecture also facilitates integration of
other Microsoft software and provides expanded opportunities for the inclusion of new technologies without
sacrificing system reliability or performance. Versions of ClientWare that feature Java programming offer easy
interface with and access to a wide range of devices and applications.

Wireless Technology. Traditional workstations were designed around access to electrical and network
outlets. We now use wireless networking technology to connect computers to the CPSI system. This allows
customers to use mobile computers and to place stationary computers in locations for optimal convenience and
ease of use. We incorporate wireless laptop and hand held computers into our system. Convenient to carry and
use, these mobile computers allow effective data collection and real-time access to patient information from
practically anywhere in the hospital. Information efficiently collected will then be more quickly accessible by
other caregivers throughout the hospital.

Point-of-Care Stations. We use “point-of-care stations” which allow nurses to enter information into the

system at a patient’s bedside. These stations consist of compact computers on individual data entry stations that
are lightweight, durable and easy to maneuver. We incorporate our wireless networking capabilities into these
stations in order to provide extended range and mobility.

Touch Sensitive Displays. Data entry is made easier through the use of touch sensitive displays. With this

technology, work areas are free of the traditional keyboard and mouse associated with most personal computers.
Touch screens are also more efficient for users who are not proficient with computers.

Biometric Recognition. As unique as each individual, a fingerprint cannot be duplicated, making it one of
the most secure methods of verifying a person’s identity. Because of the sensitivity of healthcare information and
federal security requirements, we have incorporated licensed fingerprint identification technology as an option
for our systems. When a user signs on to the system, he or she must scan his or her fingerprint as well as enter a
traditional password. The system rapidly responds with the confirmation or rejection of the user’s identity.

Product Development and Enhancement

We continually work to improve and enhance the CPSI system and to develop new products and services for

our system. The primary source of ideas for improvements to our products and services comes from our
customers, which submit suggestions to us through our national user group. We believe our interaction with
customers and their communication with each other is the most efficient way to learn about and respond to
changes in the healthcare operating environment. This approach to research and development allows us to
quickly adapt to technology advances and improve our products and services to better serve the needs of our
customers. Our management and customer support and service teams play a significant role in product
development by continually monitoring the needs and desires of our customers and our market. In addition to our
customer support and service teams a Product Development Services division was created in 2008. This division

is responsible for the development, quality assurance/testing, documentation, and distribution of all application
software. By consolidating all of our development efforts under a single division, we can ensure standardization
in our software development processes and effective utilization of our resources. We currently have 195
employees in our Product Development Services division, including 8 research and development employees
whose dedicated function is to develop new uses for and applications of technology available in the marketplace.
During the years ended December 31, 2012, 2011 and 2010, we expended approximately $2.8 million, $2.5
million and $2.4 million, respectively, on research and development activities.

Customers, Sales and Marketing

Target Market. The target market for our information system consists of small and midsize hospitals of 300

or fewer acute care beds, with a primary focus on hospitals with 100 or fewer acute care beds. In the United
States, there are approximately 4,200 community hospitals with 300 or fewer acute care beds, with
approximately 2,600 of these having 100 or fewer acute care beds. In addition, we market our products to small
specialty hospitals in the United States that focus on discrete medical areas such as surgery, rehabilitation and
psychiatry. As of February 11, 2013, we had installed our system in over 650 facilities in 45 states and the
District of Columbia. Approximately 94% of our existing customers are hospitals with 100 or fewer acute care
beds, while approximately 99% of our existing customers are hospitals with 200 or fewer acute care beds. Our
goal is to increase sales to hospitals with 100 to 300 acute care beds while continuing to increase our market
share and competitive position in the under 100 acute care bed market segment.

Sales Staff. Most of our new customers are referrals from our existing customers, thereby reducing the need

for a large sales force. Currently, we have 38 employees dedicated to direct sales, 19 of whom concentrate on
new prospects, and 19 of whom are responsible for the sale of additional products and services to existing
customers. We hire our sales representatives from our existing employees. Approximately two-thirds of our
current sales representatives have over 10 years of experience with the company, including experience in
installation, training and customer support. Our sales representatives have defined geographic territories in the
United States in which to target new customers. A significant portion of the compensation for all sales personnel
is commission based.

Marketing Strategy. Our primary marketing strategy is to generate referrals from our existing customers and

directly solicit potential users through presentations at industry seminars and trade shows. We also advertise in
various healthcare industry trade publications. For hospitals that we have targeted as potential customers, most of
our direct sales efforts involve site visits and meetings with hospital management. The typical sales cycle of a
healthcare information system usually takes six to eighteen months from the time of initial contact to the signing
of a contract. Therefore, we believe it is important for our sales staff to dedicate a substantial amount of time and
energy to building relationships with potential new customers. We do not conduct extensive marketing activities
and promotions because hospitals are easily identified, finite in number and generally send a request for proposal
to vendors when they contemplate the purchase of a hospital information system.

Competition

The market for our products and services is competitive, and we expect additional competition from
established and emerging companies in the future. Our market is characterized by rapidly changing technology,
evolving user needs and the frequent introduction of new products. We believe the principal competitive factors
that hospitals consider when choosing between us and our competitors are:

•

product features, functionality and performance;

level of customer service and satisfaction;

ease of integration and speed of implementation;

product price;

knowledge of the healthcare industry;

•

sales and marketing efforts; and

company reputation.

Our principal competitors are Medical Information Technology, Inc., or “Meditech,” Healthland, and
Healthcare Management Systems, Inc., or “HMS.” Meditech, Healthland and HMS compete with us directly in
our target market of small and midsize hospitals. These companies offer products and systems that are
comparable to our system and address the needs of hospitals in the markets we serve.

Our secondary competitors include McKesson Corporation, Quadramed Corp., Cerner Corporation, Quality
Systems, Inc. and Siemens Corporation. These companies are significantly larger than we are, and they typically
sell their products and services to larger hospitals outside of our target market. However, they will sometimes
compete directly with us. Our secondary competitors also include Prognosis Health Information Systems LLC
and Razor Insights, LLC, which are smaller than us.

We also face competition from providers of practice management systems, general decision support and
database systems and other segment-specific applications, as well as from healthcare technology consultants.
Any of these companies as well as other technology or healthcare companies could decide at any time to
specifically target hospitals within our target market.

A number of existing and potential competitors are more established than we are and have greater name
recognition and financial, technical and marketing resources than we have. Products of our competitors may have
better performance, lower prices and broader market acceptance than our products. We expect that competition
will continue to increase.

Health Information Security and Privacy Practices

The Health Insurance Portability and Accountability Act of 1996 (“HIPAA”) is a federal law that affects the

use, disclosure, transmission and storage of certain individually identifiable health information, referred to as
“protected health information,” and that was enacted for the purpose of, among other things, protecting the
privacy and security of protected health information. As directed by HIPAA, the Department of Health and
Human Services (“DHHS”) has promulgated standards and rules for certain electronic health transactions, code
sets, data security, unique identification numbers and privacy of protected health information. HIPAA and the
standards promulgated by DHHS apply to certain health plans, healthcare clearinghouses, and healthcare
providers (referred to as “covered entities”), which includes our hospital customers. The Health Information
Technology for Economic and Clinical Health Act and its implementing regulations published in January 2013
(“HITECH Act”) significantly expand HIPAA by extending privacy and security standards to “business
associates” of healthcare providers that are covered entities. Under the HITECH Act, business associates are
required to establish administrative, physical and technical safeguards and are subject to direct penalties for
violations. Our business management services activities performed through our wholly-owned subsidiary,
TruBridge, frequently entail us acting in the capacity of a business associate to the hospitals that we serve, and
therefore we are covered by the patient privacy and security standards of HIPAA and subject to oversight by
DHHS. We believe that we have taken all necessary steps to comply with HIPAA, as it applies to us as a business
associate, but it is important to note that DHHS could, at any time in the future, adopt new rules or modify
existing rules in a manner that could require us to change our systems or operations.

Internal Management Control System

We have developed and maintain an automated enterprise management system which permits us to manage
not only all of our internal management, accounting and personnel functions, but also all information relating to
each customer’s information system. Our system maintains detailed records of all information regarding each
customer’s system, including all system specifications, service history and customer communications, among
other things. This internal control system helps us to more effectively respond to customer support needs through
complete and current system information and through situation-based problem solving.

Intellectual Property

We regard some aspects of our internal operations, software and documentation as proprietary, and rely
primarily on a combination of contract and trade secret laws to protect our proprietary information. We believe,
because of the rapid pace of technological change in the computer software industry, trade secret and copyright
protection is less significant than factors such as the knowledge, ability and experience of our employees,
frequent software product enhancements and the timeliness and quality of our support services. We cannot
guarantee that these protections will be adequate or that our competitors will not independently develop
technologies that are substantially equivalent or superior to our technology.

We do not believe our software products or other CPSI proprietary rights infringe on the property rights of third
parties. However, we cannot guarantee that third parties will not assert infringement claims against us with
respect to current or future software products or that any such assertion may not require us to enter into royalty
arrangements or result in costly litigation.

Employees

As of February 28, 2013, we had 1,420 employees, almost all of whom are located at our offices in Mobile,
Fairhope and Lanett, Alabama and Monroe, Louisiana. Our employees can be grouped according to the following
general categories: 604 in software services and support, 427 in business management services, 100 in
information technology services and support, 195 in product development services, 50 in sales and marketing and
44 in administration. Our general practice is to recruit recent college graduates for entry-level positions and then
promote these individuals within the organization to fill vacancies in higher positions. We also hire nurses and
other medically-trained professionals in connection with our support services.

Since 1991, we have maintained a non-qualified discretionary profit-sharing plan under which all full-time
employees with three years of uninterrupted service are eligible to participate, other than executive officers and
commissioned salespeople. The plan is designed to provide each eligible employee with periodic cash bonuses
based on our profitability. Each eligible employee receives a pro rata share of the amount of cash distributed
under the profit-sharing plan based on the amount of his or her base salary compared to the sum of the salaries of
all participating employees. Our profit-sharing plan is not a qualified plan for tax purposes or a guaranteed
benefit. Contributions to the plan are made periodically at the sole discretion of the Board of Directors. During
2012, we distributed approximately $3.4 million under this profit-sharing plan. We plan to continue to make
distributions under this plan based on our profitability.

We are fortunate to have a high rate of employee retention, with our senior management having an average
tenure in excess of 18 years. Our performance depends in significant part on our ability to attract, train and retain
highly qualified personnel. None of our employees are represented by a labor union, and we believe our relations
with our employees are good.

Executive Officers

The executive officers of CPSI serve at the pleasure of the Board of Directors. Set forth below is a list of the

current executive officers of CPSI and a brief explanation of each individual’s principal employment during the
last five years.

J. Boyd Douglas – President and Chief Executive Officer. J. Boyd Douglas, age 46, has served as our
President and Chief Executive Officer since May 2006. He was elected as a director in March 2002. Mr. Douglas
began his career with us in August 1988 as a Financial Software Support Representative. From May 1990 until
November 1994, Mr. Douglas served as Manager of Electronic Billing, and from December 1994 until June
1999, he held the position of Director of Programming Services. From July 1999 until May 2006, Mr. Douglas
served as our Executive Vice President and Chief Operating Officer. Mr. Douglas’s wife’s sister’s husband,
Mr. Patrick A. Immel, is an executive officer of the Company. Mr. Immel is not a “family member” of
Mr. Douglas under NASDAQ Listing Rule 5605.

David A. Dye – Chief Financial Officer, Secretary and Treasurer. David A. Dye, age 43, has served as

our Chief Financial Officer, Secretary and Treasurer since July 1, 2010. Mr. Dye served as our President and
Chief Executive Officer from July 1999 to May 2006. He was elected as a director in March 2002 and has served
as our Chairman of the Board since May 2006. Mr. Dye began his career with CPSI in May 1990 as a Financial
Software Support Representative and served in various capacities until July 1999. Mr. Dye has served as a
director of Bulow Biotech Prosthetics, LLC, a company headquartered in Nashville, Tennessee that operates
prosthetic clinics in the Southeastern United States, since July 2006.

Victor S. Schneider – Executive Vice President–Corporate and Business Development. Victor S.
Schneider, age 54, has served as our Executive Vice President–Corporate and Business Development since
January 2013. Prior to his appointment as Executive Vice President – Corporate and Business Development,
Mr. Schneider served as our Senior Vice President – Corporate and Business Development since December 2005.
Mr. Schneider is responsible for revenue generation efforts, customer relations, strategic growth initiatives and
positioning, and market execution. Mr. Schneider began his career with us in June 1983 as Sales Manager. He
served in that capacity until January 1997 when he was promoted to Sales Director. He served as our Vice
President–Sales and Marketing from July 1999 until December 2005.

Robert D. Hinckle – Senior Vice President–Software Services. Robert D. Hinckle, age 43, served as our

Vice President–Software Services from October 2004 until January 2013 and has served as our Senior Vice
President – Software Services since January 2013. Mr. Hinckle is responsible for overseeing all aspects of the
installation and support of our software products. Since beginning his career with us in 1995 as a Financial
Software Support Representative, Mr. Hinckle has worked in various positions in our Software Services
Division, including Team Manager, Assistant Director and Director of that division.

Troy D. Rosser – Senior Vice President–Sales. Troy D. Rosser, age 48, has served as our Senior Vice
President–Sales since January 2012, having previously served as Vice President – Sales since October 2005.
Mr. Rosser is responsible for overseeing all of our sales and marketing efforts. Mr. Rosser began his career with
us in March 1989 as a Financial Software Support Representative. In 1992, Mr. Rosser was transferred to the
Sales and Marketing division where he has worked in various positions, including Sales Manager and, from
October 2000 until October 2005, Director of Sales.

Michael K. Muscat, Jr. – Senior Vice President–Product Development Services. Michael K. Muscat, Jr.,

age 39, has served as our Senior Vice President – Product Development Services since March 2008. Mr. Muscat
is responsible for overseeing all aspects of the development quality assurance/testing, documentation, and
distribution of all application software. Mr. Muscat began his career with us in July 1996 as a Software Support
Representative. Mr. Muscat then served as a Programmer and Manager of Outsourcing Services. From June 2002
to May 2006, Mr. Muscat served as the Director of Business Management Services and from May 2006 until
March 2008 as the Vice President of Business Management Services.

Robert D. Smith – Vice President–Product Development Services. Robert D. Smith, age 42, has served

as our Vice President – Product Development Services since March 2008. Mr. Smith is responsible for
overseeing all aspects of system programming and enhancements within our Product Development division.
Since Mr. Smith began his career with us in September 1993, he has served in the capacity of Technical Support
Representative, Programmer, and Programming Manager. From January 2001 to May 2006, Mr. Smith served as
the Director of Programming Services and from May 2006 to March 2008 as Vice President of Programming
Services.

James B. Britain – Vice President–Finance and Controller. James B. Britain, age 47, has served as our

Vice President – Finance and Controller since March 2011. Mr. Britain is our principal accounting officer.
Mr. Britain began his career with us in September 2007 as Controller and served in that capacity until March
2011. Prior to his appointment as Controller, Mr. Britain was Controller of Azalea Aviation, Inc., a fixed base
operator in Mobile, Alabama, from September 2006 until September 2007.

Lyle E. Hutchison – Vice President–Sales. Lyle E. Hutchison, age 47, has served as our Vice President –

Sales since October 2012. Mr. Hutchison is responsible for overseeing all of our sales efforts directed towards
new or prospective customers. Prior to his appointment as Vice President – Sales in October 2012, Mr. Hutchison
served as Senior Sales Director since May 2011. Mr. Hutchison began his career with us in August 1990 and has
held the positions of Sales Manager from August 2005 until June 2006, Sales Director from June 2006 until May
2011, and Senior Sales Director from May 2011 until October 2012.

Sean C. Nicholas – Vice President–Sales. Sean C. Nicholas, age 43, has served as our Vice President –
Sales since October 2012. Mr. Nicholas is responsible for overseeing all of our sales efforts directed towards our
established customers. Prior to his appointment as Vice President – Sales in October 2012, Mr. Nicholas served
as Senior Sales Director since May 2011. Mr. Nicholas began his career with us in July 1993 and has held the
positions of Sales Manager from January 1999 until October 2000, Marketing Director from October 2000 until
October 2003, Sales Director from October 2003 until May 2011, and Senior Sales Director from May 2011 until
October 2012.

J. Scott Littrell – Vice President–Information Technology Services. J. Scott Littrell, age 38, has served

as our Vice President – Information Technology Services since January 2013. Mr. Littrell is responsible for
overseeing all aspects of technical and hardware services. Mr. Littrell began his career with us in 2000 as a
Technical Support Representative. Since that time, Mr. Littrell has served as ImageLink Support Representative
from 2003 until 2004, R&D Analyst from 2004 until 2007, and most recently served as Director of Technical and
Hardware Services from 2007 until January 2013.

Stephanie P. Durkac – Vice President–Clinical Support. Stephanie P. Durkac, age 46, has served as our

Vice President – Clinical Support since January 2013. Ms. Durkac is responsible for overseeing the software
support services we provide to customers of our clinical applications. Prior to her appointment as Vice President
– Clinical Support in January 2013, Ms. Durkac served as Director of Software Services since November 2003.
Ms. Durkac began her career with us in 1994 and has held various positions within our Software Services
division, including Manager, Assistant Director, and Director.

Pamela S. Phillips – Vice President–Financial Support. Pamela S. Phillips, age 45, has served as our

Vice President – Financial Support since January 2013. Ms. Phillips is responsible for overseeing the software
support services we provide to customers of our financial applications. Prior to her appointment as Vice
President – Financial Support in January 2013, Ms. Phillips served as our Director of Financial Support from
November 2004 until January 2013. Ms. Phillips began her career with us in 1993 and has held various positions
within our Software Services division, including Software Implementation Team Manager, Education Manager,
and Director of Financial Support.

J. Lamar Cowart – Vice President–Implementation. J. Lamar Cowart, age 39, has served as our Vice
President – Implementation since January 2013. Mr. Cowart is responsible for overseeing the implementation
services we provide to those customers purchasing new applications. Mr. Cowart began his career with us in
1999 and has held various positions within our Software Services division, including Project Manager from 2003
until 2004, Director of Implementation Services from 2004 until 2011, and Senior Director of Implementation
Services from 2011 until January 2013.

In January 2013, the Company announced the formation of Trubridge, LLC (“TruBridge”), a wholly-owned
subsidiary of CPSI. The executive officers of TruBridge serve at the pleasure of the Board of Directors of CPSI.
Set forth below is a list of the current executive officers of TruBridge and a brief explanation of each individual’s
principal employment during the last five years.

Christopher L. Fowler – President–TruBridge. Christopher L. Fowler, age 37, has served as the President

of TruBridge since its formation in January 2013. Mr. Fowler is responsible for overseeing all aspects of the
business management, consulting and managed IT services we provide to our customers through

TruBridge. Prior to the formation of TruBridge, Mr. Fowler served as CPSI’s Vice President – Business
Management Services since March 2008. Mr. Fowler began his career with us in May 2000 as a Software
Support Representative and later as a manager of Financial Software Services. From August 2004 until March
2008, Mr. Fowler served as Assistant Director and Director of Business Management Services.

Patrick A. Immel – Senior Vice President of Professional Services–TruBridge. Patrick A. Immel, age
42, has served as the Senior Vice President of Professional Services of TruBridge since its formation in January
2013. Mr. Immel is responsible for overseeing the managed IT and consulting services we provide to our
customers through TruBridge. Prior to the formation of TrueBridge, Mr. Immel served as CPSI’s Vice President–
Information Technology Services since January 2000. Mr. Immel began his career with us in July 1993 as a
Financial Software Support Representative. Since that time, Mr. Immel has served as a programmer, Manager of
Technical Support and Director of Information Technology Services. Mr. Immel’s wife’s sister’s husband, Mr. J.
Boyd Douglas, is an executive officer of the Company. Mr. Douglas is not a “family member” of Mr. Immel
under NASDAQ Listing Rule 5605.

Gregory Leatherbury – Vice President of Business Services–TruBridge. Gregory Leatherbury, age 35,

has served as the Vice President of Business Services of TruBridge since its formation in January 2013.
Mr. Leatherbury is responsible for overseeing the business services we provide our customers through
TruBridge. Prior to the formation of TruBridge, Mr. Leatherbury served as CPSI’s Director of Revenue Cycle
Management since 2008. Mr. Leatherbury began his career with us in 2002 and has held various positions in both
the Software Services and Business Services divisions. Mr. Leatherbury’s uncle by marriage, Mr. Ernest F. Ladd,
III, is a director of the Company. Mr. Ladd is not a “family member” of Mr. Leatherbury under NASDAQ
Listing Rule 5605.

Rick Jones – Vice President of Sales–TruBridge. Rick Jones, age 43, has served as the Vice President of

Sales of TruBridge since its formation in January 2013. Mr. Jones is responsible for all sales and marketing
efforts related to TruBridge. Prior to the formation of TruBridge, Mr. Jones served as a Sales Director at CPSI
since 2006. Mr. Jones began his career with us in February 1994 and has held various sales and Software
Services positions within the Company.

Company Web Site

The Company maintains a web site at http://www.cpsinet.com. The Company makes available on its web
site, free of charge, its Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form
8-K, and all amendments to those reports, as soon as it is reasonably practicable after such material is
electronically filed with the Securities and Exchange Commission. The Company is not including the
information contained on or available through its web site as a part of, or incorporating such information into,
this Annual Report on Form 10-K.

ITEM 1A. RISK FACTORS

There is significant uncertainty in the healthcare industry in which we operate, both as a result of recently
enacted legislation and changing government regulation, which may have a material adverse impact on the
businesses of our hospital customers and ultimately on our business, financial condition and results of
operations.

The healthcare industry is subject to changing political, economic and regulatory influences that may affect

the procurement processes and operation of healthcare facilities, including our hospital customers. During the
past several years, the healthcare industry has been subject to an increase in governmental regulation of, among
other things, reimbursement rates and certain capital expenditures.

Recently enacted public laws reforming the U.S. healthcare system may have an impact on our business.
The Patient Protection and Affordable Care Act (H.R. 3590; Public Law 111-148) (“PPACA”) and The Health
Care and Education Reconciliation Act of 2010 (H.R. 4872) (the “Reconciliation Act”), which amends the
PPACA (collectively the “Health Reform Laws”), were signed into law in March 2010. The Health Reform Laws
contain various provisions which may impact us and our customers. Some of these provisions may have a
positive impact, by expanding the use of electronic health records in certain federal programs, for example, while
others, such as reductions in reimbursement for certain types of providers, may have a negative impact due to
fewer available resources. Increases in fraud and abuse penalties may also adversely affect participants in the
healthcare sector, including us.

Among other things, the Health Reform Laws require nearly all individuals to have health insurance, expand

Medicaid eligibility, mandate material changes to the delivery of healthcare services and reduce the
reimbursement paid for such services in order to generate savings in the Medicare program. The Health Reform
Laws also modify certain payment systems to encourage more cost-effective care and a reduction of
inefficiencies and waste, including through new tools to address fraud and abuse.

It is likely that the Health Reform Laws will affect hospitals differently depending upon the populations

they serve and their payor mix. Our target market of rural and community hospitals typically serve higher
uninsured populations than larger urban hospitals and rely more heavily on Medicare and Medicaid for
reimbursement. It remains to be seen whether the increase in the insured population for rural and community
hospitals will be sufficient to offset proposed cuts in Medicare and Medicaid reimbursements contained in the
Health Reform Laws.

The Health Reform Laws will ultimately lead to significant changes in the healthcare system. While it is too

early to fully understand and assess the impact of the Health Reform Laws on our hospital customers, it is
possible that the Health Reform Laws could have a material adverse effect on the business of our customers,
which in turn could have a material adverse effect on our operations and financial condition.

Various legislators have announced that they intend to examine further proposals to reform certain aspects

of the U.S. healthcare system. Healthcare providers may react to these proposals, and the uncertainty surrounding
such proposals, by curtailing or deferring investments, including those for our systems and related services. Cost-
containment measures instituted by healthcare providers as a result of regulatory reform or otherwise could result
in a reduction in the allocation of capital funds. Such a reduction could have an adverse effect on our ability to
sell our systems and related services. On the other hand, changes in the regulatory environment have increased
and may continue to increase the needs of healthcare organizations for cost-effective data management and
thereby enhance the overall market for healthcare management information systems. We cannot predict what
effect, if any, such additional proposals or healthcare reforms might have on our business, financial condition and
results of operations.

As existing regulations mature and become better defined, we anticipate that these regulations will continue
to directly affect certain of our products and services, but we cannot fully predict the effect at this time. We have

taken steps to modify our products, services and internal practices as necessary to facilitate our compliance with
the regulations, but there can be no assurance that we will be able to do so in a timely or complete manner.
Achieving compliance with these regulations could be costly and distract management’s attention and divert
other company resources, and any noncompliance by us could result in civil and criminal penalties.

The healthcare industry is heavily regulated at the local, state and national levels. Our failure to comply with
regulatory requirements could create liability for us, result in adverse publicity and negatively affect our
business.

The healthcare industry is heavily regulated and is constantly evolving due to the changing political,
legislative and regulatory landscapes. In some instances, the impact of these regulations on our business is direct
to the extent that we are subject to these laws and regulations ourselves. However, these regulations also impact
our business indirectly as, in a number of circumstances, our solutions, devices and services must be capable of
being used by our customers in a way that complies with those laws and regulations, even though we may not be
directly regulated by the specific healthcare laws and regulations. There is a significant number of wide-ranging
regulations, including regulations in the areas of healthcare fraud, e-prescribing, claims processing and
transmission, medical devices, the security and privacy of patient data and interoperability standards, that may be
directly or indirectly applicable to our operations and relationships or the business practices of our customers.
Specific areas that are subject to increased regulation include, but are not limited to, the following:

Healthcare Fraud. Federal and state governments continue to enhance regulation of and increase their

scrutiny over practices potentially involving healthcare fraud by healthcare providers whose services are
reimbursed by Medicare, Medicaid and other government healthcare programs. Our healthcare provider
customers are subject to laws and regulations regarding fraud and abuse that, among other things, prohibit the
direct or indirect payment or receipt of any remuneration for patient referrals, or arranging for or recommending
referrals or other business paid for in whole or in part by these federal or state healthcare programs. Federal
enforcement personnel have substantial funding, powers and remedies to pursue suspected or perceived fraud and
abuse. The effect of this government regulation on our customers is difficult to predict. Many of the regulations
applicable to our customers and that may be applicable to us, including those relating to marketing incentives
offered in connection with medical device sales, are vague or indefinite and have not been interpreted by the
courts. They may be interpreted or applied by a prosecutorial, regulatory or judicial authority in a manner that
could broaden their applicability to us or require our customers to make changes in their operations or the way in
which they deal with us. If such laws and regulations are determined to be applicable to us and if we fail to
comply with any applicable laws and regulations, we could be subject to civil and criminal penalties, sanctions or
other liability, including exclusion from government health programs, which could have a material adverse effect
on our business, results of operations and financial condition. Even an unsuccessful challenge by a regulatory or
prosecutorial authority of our activities could result in adverse publicity, could require a costly response from us
and could adversely affect our business, results of operations and financial condition.

E-Prescribing. The use of our solutions by physicians for electronic prescribing, electronic routing of

prescriptions to pharmacies and dispensing is governed by federal and state laws. States have differing
regulations that govern the electronic transmission of certain prescription orders and prescription format
requirements. Regulations implemented by the Centers for Medicare and Medicaid Services (“CMS”) related to
“EPrescribing and the Prescription Drug Program” set forth standards for the transmission of electronic
prescriptions. These standards are detailed and broad, and cover not only transactions between prescribers and
dispensers for prescriptions, but also electronic eligibility, benefits inquiries and drug formulary and benefit
coverage information. In general, regulations in this area can be burdensome and evolve regularly, meaning that
any potential benefits to our customers from utilizing such solutions and services may be reversed by a newly-
promulgated regulation that adversely affects our business model. Our efforts to provide solutions that enable our
customers to comply with these regulations could be time consuming and expensive.

Claims Transmission. Our system electronically transmits medical claims by physicians to patients’ payors
for immediate approval and reimbursement. In addition, we offer business management services that include the
manual and electronic processing and submission of medical claims by physicians to patients’ payors for
approval and reimbursement. Federal law provides that it is both a civil and a criminal violation for any person to
submit, or cause to be submitted, a claim to any payor, including, without limitation, Medicare, Medicaid and all
private health plans and managed care plans, seeking payment for any service or product that overbills or bills for
items that have not been provided to the patient. We have in place policies and procedures that we believe assure
that all claims that are transmitted by our system and through our services are accurate and complete, provided
that the information given to us by our customers is also accurate and complete. If, however, we do not follow
those procedures and policies, or they are not sufficient to prevent inaccurate claims from being submitted, we
could be subject to substantial liability including, but not limited to, civil and criminal liability. Additionally, any
such failure of our billing and collection services to comply with these laws and regulations could adversely
affect demand for our services and could force us to expend significant capital, research and development, and
other resources to address the failure.

In most cases where we are permitted to do so, we calculate charges for our billing and collection services
based on a percentage of the collections that our customers receive as a result of our services. To the extent that
violations or liability for violations of these laws and regulations require intent, it may be alleged that this
percentage calculation provides us or our employees with incentive to commit or overlook fraud or abuse in
connection with submission and payment of reimbursement claims. CMS has stated that it is concerned that
percentage-based billing services may encourage billing companies to commit or to overlook fraudulent or
abusive practices.

A portion of our business involves billing Medicare claims on behalf of its clients. In an effort to combat

fraudulent Medicare claims, the federal government offers rewards for reporting of Medicare fraud which could
encourage others to subject us to a charge of fraudulent claims, including charges that are ultimately provent to
be without merit.

As discussed below, the HIPAA security and privacy standards also affect our claims transmission services,

since those services must be structured and provided in a way that supports our customers’ HIPAA compliance
obligations.

Regulation of Medical Devices. The United States Food and Drug Administration (the “FDA”) has
determined that certain of our solutions, such as our ImageLink® product, are medical devices that are actively
regulated under the Federal Food, Drug and Cosmetic Act, as amended. If other of our solutions are deemed to be
actively regulated medical devices by the FDA, we could be subject to extensive requirements governing pre-
and post-marketing activities including pre-market notification clearance. Complying with these medical device
regulations is time consuming and expensive, and our marketing and other sales activities could be subject to
unanticipated and significant delays. Further, it is possible that the FDA may become more active in regulating
software and medical devices that are used in the healthcare industry. If we are unable to obtain the required
regulatory approvals for any such software or medical devices, our short to long term business plans for these
solutions or medical devices could be delayed or canceled and we could face FDA refusal to grant pre-market
clearance or approval of products; withdrawal of existing clearances and approvals; fines, injunctions, or civil
penalties; recalls or product corrections; production suspensions; and criminal prosecution. FDA regulation of
our products could increase our operating costs, delay or prevent the marketing of new or existing products and
adversely affect our revenue growth.

Security and Privacy of Patient Information. Federal, state and local laws regulate the confidentiality and
security of patient records and the circumstances under which those records may be released. These regulations
govern both the disclosure and use of confidential patient medical record information and require the users of
such information to implement specified security and privacy measures. United States regulations currently in
place governing electronic health data transmissions continue to evolve and are often unclear and difficult to
apply.

In the United States, HIPAA regulations require national standards for some types of electronic health

information transactions and the data elements used in those transactions, security standards to ensure the
integrity and confidentiality of health information, and standards to protect the privacy of individually
identifiable health information. Covered entities under HIPAA, which include healthcare organizations such as
our customers, and our claims processing, transmission and submission services, are required to comply with the
privacy standards, transaction regulations and security regulations. Moreover, HITECH and associated regulatory
requirements extend many of the HIPAA obligations, formerly imposed only upon covered entities, to business
associates as well. As a business associate of our customers who are covered entities, we were in most instances
already contractually required to ensure compliance with the HIPAA regulations as they pertain to handling of
covered customer data. However, the extension of these HIPAA obligations to business associates by law has
created additional liability risks related to the privacy and security of individually identifiable health information.

Evolving HIPAA and HITECH-related laws or regulations could restrict the ability of our customers to
obtain, use or disseminate patient information. This could adversely affect demand for our solutions and devices
if they are not re-designed in a timely manner in order to meet the requirements of any new interpretations or
regulations that seek to protect the privacy and security of patient data or enable our customers to execute new or
modified healthcare transactions. We may need to expend additional capital, software development and other
resources to modify our solutions to address these evolving data security and privacy issues. Furthermore, our
failure to maintain the confidentiality of sensitive personal information in accordance with the applicable
regulatory requirements could damage our reputation and expose us to breach of contract claims (although we
contractually limit liability, when possible and where permitted), fines and penalties.

Federal and state statutes and regulations have granted broad enforcement powers to regulatory agencies to

investigate and enforce compliance with these privacy and security laws and regulations. Federal and state
enforcement personnel have substantial funding, powers and remedies to pursue suspected or perceived
violations. If we fail to comply with any applicable laws or regulations, we could be subject to civil penalties,
sanctions or other liability. Enforcement investigations, even if meritless, could have a negative impact on our
reputation, cause us to lose existing customers or limit our ability to attract new customers.

Interoperability Standards. Our customers often require that our software solutions and services be
interoperable with other third party healthcare information technology. Market forces or governmental or
regulatory authorities could create interoperability standards that would apply to our software solutions or
services, and if our software solutions or services are not consistent with those standards, we could be forced to
incur substantial additional development costs to conform. The Certification Commission for Healthcare
Information Technology (CCHIT) has developed a comprehensive set of criteria for the functionality,
interoperability and security of various software modules in the healthcare information technology industry.
CCHIT, however, continues to modify and refine those standards. During 2010, both our hospital and medical
practice EHR solutions were certified by CCHIT as a complete EHR for purposes of achieving stage one of
meaningful use of EHR. Maintaining CCHIT certification is becoming a competitive requirement, resulting in
increased software development and administrative expense to conform to these standards.

ARRA Meaningful Use Program. Various federal and state government agencies are developing standards
that could become mandatory for systems purchased by entities that are funded by these agencies. For example,
the ARRA requires “meaningful use of certified electronic health record technology” by healthcare providers by
2015 in order to receive incentive payments. Regulations have been issued that identify standards and
implementation specifications and establish the certification standards for qualifying EHR technology.
Nevertheless, these standards and specifications are subject to interpretation by the entities designated to certify
such technology, such as CCHIT. While a combination of our solutions has been certified as meeting the initial
standards for certified health record technology, the regulatory standards to achieve certification will continue to
evolve over time. We may incur increased development costs and delays in delivering solutions if we need to
upgrade our software or healthcare devices to be in compliance with these varying and evolving standards. In

addition, delays in interpreting these standards may result in postponement or cancellation of our customers’
decisions to purchase our software solutions. If our software solutions are not compliant with these evolving
standards, our market position and sales could be impaired and we may have to invest significantly in changes to
our software solution, although we do not expect such costs to be significant in relation to the overall
development costs for our software solutions.

Standards for Submission of Healthcare Claims. CMS has mandated the use of new patient codes for

reporting medical diagnosis and inpatient procedures, referred to as the ICD-10 codes. CMS is requiring all
providers, payors, clearinghouses and billing services to utilize these ICD-10 codes when submitting claims for
payment. ICD-10 codes will affect diagnosis and inpatient procedure coding for everyone covered by HIPAA,
not just those who submit Medicare or Medicaid claims. Claims for services provided on or after October 1, 2013
must use ICD-10 codes for medical diagnosis and inpatient procedures or they will not be paid.

We do not anticipate significant remaining costs associated with implementing the use of the ICD-10 codes
within our products and services. However, if our products and services do not accommodate CMS mandates at
any future date, customers may cease to use those products and services that are not compliant and may choose
alternative vendors and products that are compliant. This could adversely impact future revenues.

Economic, market and other factors may cause a decline in spending for information technology and services
by our current and prospective customers which may result in less demand for our products, lower prices and,
consequently, lower revenues and a lower revenue growth rate.

The purchase of our information system involves a significant financial commitment by our customers. At

the same time, the healthcare industry faces significant financial pressures that could adversely affect overall
spending on healthcare information technology and services. For example, the recent economic recession and
continued decrease in availability of credit, combined with potential reductions in federal and state funding for
Medicare and Medicaid, has caused hospitals to reduce, eliminate or postpone information technology related
and other spending. To the extent spending for healthcare information technology and services declines or
increases slower than we anticipate, demand for our products and services, as well as the prices we charge, could
be adversely affected. Accordingly, we cannot assure you that we will be able to increase or maintain our
revenues or our growth rate.

There are a limited number of hospitals in our target market. Consolidation in the healthcare industry could
result in the loss of existing customers, a reduction in our potential customer base and downward pressure on
our products’ prices.

There are a finite number of hospitals with 300 or fewer acute care beds in our general target market.
Saturation of this market with our products or our competitors’ products could eventually limit our revenues and
growth. Furthermore, many healthcare providers have consolidated to create larger healthcare delivery
enterprises with greater market power. If this consolidation continues, we could lose existing customers and
could experience a decrease in the number of potential purchasers of our products and services. The loss of
existing and potential customers due to industry consolidation could cause our revenue growth rate to decline. In
addition, larger, consolidated enterprises could have greater bargaining power, which may lead to downward
pressure on the prices for our products and services.

Volatility in and disruption to the global capital and credit markets and tightened lending standards may
adversely affect our ability to access credit in the future, the cost of any credit obtained in the future, and the
financial soundness of our customers and our business.

While the Company does not currently have any debt, ongoing volatility and disruption in the global capital
and credit markets, tightened lending standards, reduced lending activity by financial institutions and decreased
liquidity may adversely affect the availability, terms and cost of credit should we seek it in the future. Although

we believe that our operating cash flow and financial assets will give us the ability to meet our financing needs
for the foreseeable future, there can be no assurance that the continued or increased volatility and disruption in
the global capital and credit markets will not impair our liquidity or increase the costs of any future borrowing.

Our business could also be negatively impacted to the extent that our hospital customers experience
disruptions resulting from tighter capital and credit markets, the recent economic recession or cuts in Medicare
and Medicaid funding. As a result, hospitals may modify, delay or cancel plans to purchase our software systems
or services. Additionally, if hospitals’ operating and financial performance deteriorates, or if they are unable to
make scheduled payments or obtain credit, they may not be able to pay, or may delay payment of, accounts
receivable owed to us. Any inability of customers to pay us for our products and services may adversely affect
our earnings and cash flow.

Tightened lending standards and the absence of third-party credit has resulted in many of our hospital

customers seeking financing arrangements from us to purchase our software systems and services. These
financing arrangements impact our short-term operating cash flow and cash available. Should the requests for
these financing arrangements continue or increase, our business could be negatively impacted by our inability to
finance these arrangements. In addition, the absence of credit could negatively impact our existing financing
receivables should our customers with financing arrangements be unable to meet their obligations.

Competition with companies that have greater financial, technical and marketing resources than we have
could result in a loss of customers and/or a lowering of prices for our products, causing a decrease in our
revenues and/or market share.

Our principal competitors are Meditech, Healthland and HMS. Meditech, Healthland and HMS compete

with us directly in our target market of rural and community hospitals with 300 or fewer acute care beds. These
companies offer products and services that are comparable to our system and are designed to address the needs of
rural and community hospitals.

Our secondary competitors include McKesson Corporation, Quadramed Corp., Cerner Corporation, Quality
Systems, Inc., Siemens Corporaiton, Prognosis Health Information Systems LLC, and Razor Insights, LLC. Most
of these companies are significantly larger than we are, and they typically sell their products and services to
larger hospitals outside of our target market. However, they sometimes compete directly with us. We also face
competition from providers of practice management systems, general decision support and database systems and
other segment-specific applications, as well as from healthcare technology consultants. Any of these companies,
as well as other technology or healthcare companies, could decide at any time to specifically target hospitals
within our target market.

A number of existing and potential competitors are more established than we are and have greater name

recognition and financial, technical and marketing resources. Products of our competitors may have better
performance, lower prices and broader market acceptance than our products. We expect increased competition
that could cause us to lose customers, lower our prices to remain competitive and, consequently, experience
lower revenues, revenue growth and profit margins. Additionally, the substantial amount of money contemplated
by the ARRA to be spent on healthcare information technology may further increase competition by attracting
new and financially stronger companies to this industry.

Our failure to develop new products or enhance current products in response to market demands could
adversely impact our competitive position and require substantial capital resources to correct.

The needs of hospitals in our target market are subject to rapid change due to government regulation, trends
in clinical care practices and technological advancements. As a result of these changes, our products may quickly
become obsolete or less competitive. New product introductions and enhancements by our competitors that more
effectively or timely respond to changing industry needs may weaken our competitive position.

We continually redesign and enhance our products to incorporate new technologies and adapt our products

to ever-changing hardware and software platforms. Often we face difficult choices regarding which new
technologies to adopt. If we fail to anticipate or respond adequately to technological advancements, or experience
significant delays in product development or introduction, our competitive position could be negatively affected.
Moreover, our failure to offer products acceptable to our target market could require us to make significant
capital investments and incur higher operating costs to redesign our products, which could negatively affect our
financial condition and operating results.

Our products assist clinical decision-making and related care by capturing, maintaining and reporting
relevant patient data. If our products fail to provide accurate and timely information, our customers could
assert claims against us that could result in substantial cost to us, harm our reputation in the industry and
cause demand for our products to decline.

We provide products that assist clinical decision-making and related care by capturing, maintaining and
reporting relevant patient data. Our products could fail or produce inaccurate results due to a variety of reasons,
including mechanical error, product flaws, faulty installation and/or human error during the initial data
conversion. If our products fail to provide accurate and timely information, customers and/or patients could sue
us to hold us responsible for losses they incur from these errors. These lawsuits, regardless of merit or outcome,
could result in substantial cost to us, divert management’s attention from operations and decrease market
acceptance of our products. We attempt to limit by contract our liability for damages arising from negligence,
errors or mistakes. Despite this precaution, such contract provisions may not be enforceable or may not otherwise
protect us from liability for damages. We maintain general liability insurance coverage, including coverage for
errors or omissions. However, this coverage may not be sufficient to cover one or more large claims against us or
otherwise continue to be available on terms acceptable to us. In addition, the insurer could disclaim coverage as
to any future claim.

Breaches of security and viruses in our systems could result in customer claims against us and harm to our
reputation causing us to incur expenses and/or lose customers.

In the course of our business operations, we compile and transmit confidential information, including patient
health information. We have included security features in our systems that are intended to protect the privacy and
integrity of this information. Despite the existence of these security features, our system may experience breakins
and similar disruptive problems that could jeopardize the security of information stored in and transmitted
through the computer networks of our customers. In addition, the other systems with which we may interface,
such as the Internet and related systems, may be vulnerable to security breaches, viruses, programming errors or
similar disruptive problems. Because of the sensitivity of medical information, customers could sue us for
breaches of security involving our system. Also, actual or perceived security breaches in our system could harm
the market perception of our products which could cause us to lose existing and prospective customers.
Additionally, the effect of security breaches and related issues could disrupt our ability to perform certain key
business functions and could potentially reduce demand for our products and services. Accordingly, we have
expended significant resources toward establishing and enhancing the security of our related infrastructures,
although no assurance can be given that these systems will be entirely free from potential breach. Maintaining
and enhancing our infrastructure security may require us to expend significant capital in the future.

New products that we introduce or enhancements to our existing products may contain undetected errors or
problems that could affect customer satisfaction and cause a decrease in revenues.

Highly complex software products such as ours sometimes contain undetected errors or failures when first
introduced or when updates and new versions are released. Tests of our products may not detect bugs or errors
because it is difficult to simulate our customers’ wide variety of computing environments. Despite extensive
testing, from time to time we have discovered defects or errors in our products. Defects or errors discovered in
our products could cause delays in product introductions and shipments, result in increased costs and diversion of

development resources, require design modifications, decrease market acceptance or customer satisfaction with
our products, cause a loss of revenue, result in legal actions by our customers and cause increased insurance
costs.

Our facilities are located in an area vulnerable to hurricanes and tropical storms, and the occurrence of a
severe hurricane, similar storm or other natural disaster could cause damage to our facilities and equipment,
which could require us to cease or limit our operations.

The vast majority of our facilities and employees are located 30 miles north of the coast of the Gulf of
Mexico. Our facilities are vulnerable to significant damage or destruction from hurricanes and tropical storms.
We are also vulnerable to damage from other types of disasters, including tornadoes, fires, floods and similar
events. If any disaster were to occur, our ability to conduct business at our facilities could be seriously impaired
or completely destroyed. This would have adverse consequences for our customers who depend on us for system
support or business management services. Also, the servers of customers who use our remote access services
could be damaged or destroyed in any such disaster. This would have potentially devastating consequences to
those customers. Although we have an emergency recovery plan, including back-up systems in remote locations,
there can be no assurance that this plan will effectively prevent the interruption of our business due to a natural
disaster. Furthermore, the insurance we maintain may not be adequate to cover our losses resulting from any
natural disaster or other business interruption.

Interruptions in our power supply and/or telecommunications capabilities could disrupt our operations, cause
us to lose revenues and/or increase our expenses.

We currently have backup generators to be used as alternative sources of power in the event of a loss of
power to our facilities. If these generators were to fail during any power outage, we would be temporarily unable
to continue operations at our facilities. This would have adverse consequences for our customers who depend on
us for system support, business management and information technology management and professional services.
Any such interruption in operations at our facilities could damage our reputation, harm our ability to retain
existing customers and obtain new customers, and could result in lost revenue and increased insurance and other
operating costs.

We also have customers for whom we store and maintain computer servers containing critical patient and
administrative data. Those customers access this data remotely through telecommunications lines. If our power
generators fail during any power outage or if our telecommunications lines are severed or impaired for any
reason, those customers would be unable to access their mission critical data causing an interruption in their
operations. In such event our remote access customers and/or their patients could seek to hold us responsible for
any losses. We would also potentially lose those customers, and our reputation could be harmed.

If we are unable to attract and retain qualified customer service and support personnel, our business and
operating results will suffer.

Our customer service and support is a key component of our business. Most of our hospital customers have
small information technology staffs, and they depend on us to service and support their systems. Future difficulty
in attracting, training and retaining capable customer service and support personnel could cause a decrease in the
overall quality of our customer service and support. That decrease would have a negative effect on customer
satisfaction which could cause us to lose existing customers and could have an adverse effect on our new
customer sales. The loss of customers due to inadequate customer service and support would negatively impact
our ability to continue to grow our business.

We do not have employment or non-competition agreements with our key personnel, and their departure could
harm our future success.

Our future success depends to a significant extent on the leadership and performance of our chief executive
officer and other executive officers. We do not have employment or non-competition agreements with any of our

executive officers. Therefore, they may terminate their employment with us at any time and may compete against
us. The loss of the services of any of our executive officers could have a material adverse effect on our business,
financial condition and results of operations.

Because we believe that proprietary rights are material to our success, misappropriation of these rights could
limit our ability to compete effectively and adversely affect our financial condition.

We are heavily dependent on the maintenance and protection of our intellectual property and we rely largely
on a combination of confidentiality provisions in our customer agreements, employee nondisclosure agreements,
trademark and trade secret laws and other measures to protect our intellectual property. Additionally, our
software is not patented or copyrighted. Although we attempt to control access to our intellectual property,
unauthorized persons may attempt to copy or otherwise use our intellectual property. There can be no assurance
that the legal protections and precautions we take will be adequate to prevent misappropriation of our technology
or that competitors will not independently develop technologies equivalent or superior to ours. Monitoring
unauthorized use of our intellectual property is difficult, and the steps we have taken may not prevent
unauthorized use. If our competitors gain access to our intellectual property, our competitive position in the
industry could be damaged. An inability to compete effectively could cause us to lose existing and potential
customers and experience lower revenues, revenue growth and profit margins. Third parties could obtain patents
that may require us to negotiate licenses to conduct our business, and the required licenses may not be available
on reasonable terms or at all. We also rely on nondisclosure agreements with certain employees, and we cannot
be certain that these agreements will not be breached or that we will have adequate remedies for any breach.

If we are deemed to infringe on the intellectual property rights of third parties, we could incur unanticipated
expense and be prevented from providing our products and services if we cannot obtain licenses to these rights
on commercially acceptable terms.

We do not believe that our operations or products infringe on the intellectual property rights of others.
However, there can be no assurance that others will not assert infringement or trade secret claims against us with
respect to our current or future products. Many participants in the technology industry have an increasing number
of patents and patent applications and have frequently demonstrated a readiness to take legal action based on
allegations of patent and other intellectual property infringement. Further, as the number and functionality of our
products increase, we believe we may become increasingly subject to the risk of infringement claims. If
infringement claims are brought against us, these assertions could distract management. We may have to spend a
significant amount of money and time to defend or settle those claims. In addition, claims against third parties
from which we purchase software could adversely affect our ability to access third party software for our
systems.

If we were found to infringe on the intellectual property rights of others, we could be forced to pay
significant license fees or damages for infringement. If we were unable to obtain licenses to these rights on
commercially acceptable terms, we would be required to discontinue the sale of our products that contain the
infringing technology. Our customers would also be required to discontinue the use of those products. We are
unable to insure against this risk on an economically feasible basis. Even if we were to prevail in an infringement
lawsuit, the accompanying publicity could adversely impact the demand for our system. Under some
circumstances, we agree to indemnify our customers for some types of infringement claims that may arise from
the use of our products.

We are subject to the development and maintenance of the Internet infrastructure, which is not within our
control, and which may diminish Internet usage and availability as well as access to our web site.

We deliver Internet-based services and, accordingly, we are dependent on the maintenance of the Internet by
third parties. The Internet infrastructure may be unable to support the demands placed on it and our performance
may decrease if the Internet continues to experience its historic trend of expanding usage. Internet related

problems may diminish Internet usage and availability of the Internet to us for transmittal of our Internet-based
services. In addition, difficulties, outages, and delays by Internet service providers, online service providers and
other web site operators may obstruct or diminish access to our web site by our customers resulting in a loss of
potential or existing users of our services.

We may be subject to liability in the event we provide inaccurate claims data to payors.

We offer electronic claims submission services as part of our business management services. While we have

implemented certain product features designed to maximize the accuracy and completeness of claims
submissions, these features may not be sufficient to prevent inaccurate claims data from being submitted to
payors. Should inaccurate claims data be submitted to payors, we may be subject to liability claims.

We are dependent on our license rights and products and other services from third parties, which may cause
us to discontinue, delay or reduce product shipments.

We depend upon licenses for some of the technology used in our products as well as other products and
services from third-party vendors. Most of these arrangements can be continued/renewed only by mutual consent
and may be terminated for any number of reasons. We may not be able to continue using the technology,
products or services made available to us under these arrangements on commercially reasonable terms or at all.
As a result, we may have to discontinue, delay or reduce product shipments or services provided until we can
obtain equivalent technology or services. Most of our third-party licenses are non-exclusive. Our competitors
may obtain the right to use any of the business elements covered by these arrangements and use these elements to
compete directly with us. In addition, if our vendors choose to discontinue providing their technology, products
or services in the future or are unsuccessful in their continued research and development efforts, we may not be
able to modify or adapt our own products.

We are subject to changes in and interpretations of financial accounting matters that govern the measurement
of our performance, one or more of which could adversely affect our business, financial condition, cash flows,
revenue and results of operations.

Based on our reading and interpretations of relevant guidance, principles or concepts issued by, among other

authorities, the American Institute of Certified Public Accountants, the Financial Accounting Standards Board
and the Securities and Exchange Commission, we believe our current sales and licensing contract terms and
business arrangements have been properly reported. However, there continue to be issued interpretations and
guidance for applying the relevant standards to a wide range of sales and licensing contract terms and business
arrangements that are prevalent in the software industry. Future interpretations or changes by the regulators of
existing accounting standards or changes in our business practices could result in changes in our revenue
recognition and/or other accounting policies and practices that could adversely affect our business, financial
condition, cash flows, revenue and results of operations.

The unpredictability of our quarterly operating results may cause us to fail to meet revenues or earnings
expectations which could cause the price of our common stock to fluctuate or decline.

There is no assurance that consistent quarterly growth in our business will occur. Our quarterly revenues may

fluctuate and may be difficult to forecast for a variety of reasons. For example, prospective customers often take
significant time evaluating our system and related services before making a purchase decision. Moreover, a
prospective customer who has placed an order for our system could decide to cancel that order or postpone
installation of the ordered system. If a prospective customer delays or cancels a scheduled system installation during
any quarter, we may not be able to schedule a substitute system installation during that quarter. The amount of
revenues that would have been generated from that installation will be postponed or lost. The possibility of delays
or cancellations of scheduled system installations could cause our quarterly revenues to fluctuate.

The following factors may also affect demand for our products and services and cause our quarterly

revenues to fluctuate:

•

changes in customer budgets and purchasing priorities;

the ability of our customers to obtain financing for the purchase of our products;

the financial stability of our customers;

the specific mix of software, hardware and services in orders from customers;

the timing of new product announcements and product introductions by us and our competitors;

• market acceptance of new products, product enhancements and services from us and our competitors;

•

product and price competition;

our success in expanding our sales and marketing programs;

the availability and cost of system components;

delay of revenue recognition to future quarters due to an increase in the sale of our remote access SaaS
services;

the length of sales cycles and installation processes;

changes in revenue recognition or other accounting guidelines employed by us and/or established by
the Financial Accounting Standards Board or other rulemaking bodies;

accounting policies concerning the timing of recognition of revenue;

personnel changes; and

general market and economic factors.

Variations in our quarterly revenues may adversely affect our operating results. In each fiscal quarter, our

expense levels, operating costs and hiring plans are based on projections of future revenues and are relatively
fixed. Because a significant percentage of our expenses are relatively fixed, a variation in the timing of systems
sales, implementations and installations can cause significant variations in operating results from quarter to
quarter. As a result, we believe that interim period-to-period comparisons of our results of operations are not
necessarily meaningful and should not be relied upon as indications of future performance. Further, our historical
operating results are not necessarily indicative of future performance for any particular period.

We currently recognize revenue pursuant to Financial Accounting Standards Board (“FASB”) Accounting

Standards Codification (“ASC”) Topic 985-605, Software, Revenue Recognition, or ASC 985-605. ASC 985-605
summarizes the FASB’s views in applying generally accepted accounting principles to revenue recognition in
financial statements. There can be no assurance that application and subsequent interpretations of this
pronouncement will not further modify our revenue recognition policies, or that such modifications would not
adversely affect our operating results reported in any particular quarter or year.

Due to all of the foregoing factors, it is possible that our operating results may be below the expectations of

securities analysts and investors. In such event, the price of our common stock would likely be adversely
affected.

Our common stock price has been volatile, which could result in substantial losses for investors purchasing
shares of our common stock and in litigation against us.

Volatility may be caused by a number of factors including but not limited to:

•

actual or anticipated quarterly variations in operating results;

•

rumors about our performance, software solutions, or merger and acquisition activity;

changes in expectations of future financial performance or changes in estimates of securities analysts;

governmental regulatory action;

healthcare reform measures;

customer relationship developments;

purchases or sales of Company stock;

changes occurring in the markets in general;

• macroeconomic conditions, both nationally and internationally; and

•

other factors, many of which are beyond our control.

Furthermore, the stock market in general, and the market for software, healthcare and high technology
companies in particular, has experienced significant volatility in recent years that often has been unrelated to the
operating performance of particular companies. These broad market and industry fluctuations may adversely
affect the trading price of our common stock, regardless of actual operating performance.

Moreover, in the past, securities class action litigation has often been brought against a company following
periods of volatility in the market price of its securities. We may in the future be the target of similar litigation.
Securities litigation could result in substantial costs and divert management’s attention and resources.

ITEM 1B. UNRESOLVED STAFF COMMENTS

None.

ITEM 2.

PROPERTIES

Our corporate campus is located on approximately 16.5 acres in Mobile, Alabama and includes
approximately 135,500 square feet of office space. Our main campus headquarters building consists of
approximately 66,000 square feet of office and warehouse space. We also have eleven additional smaller campus
buildings consisting of approximately 6,000 square feet of office space each. Each of these smaller buildings is
designed to accommodate a team of employees assigned to install and support a particular software application.
We also occupy an additional campus building consisting of approximately 3,500 square feet of office space
which houses our sales personnel. The Company also owns 11.3 acres of undeveloped real property adjacent to
our corporate campus.

Prior to December 13, 2011, we leased the 16.5 acres and all of our corporate campus buildings in Mobile,

Alabama from a related party, C.P. Investments, Inc., an Alabama corporation. Our leases with C.P. Investments,
Inc. were terminated on December 13, 2011 in conjunction with our purchase of the property from C.P.
Investments for $9.5 million. The 11.3 acres of undeveloped property is also directly owned by CPSI.

On January 1, 2007, we entered into a lease with Riverside Corporation to house a call center to support the
growth of our business management services (now offered by our subsidiary, TruBridge). This building consists
of approximately 10,000 square feet and is located in Lanett, Alabama.

On January 20, 2009, we entered into a lease agreement with Strauss Properties, LLC to house a call center
to further support the growth of our business management services (now offered by our subsidiary, TruBridge).
This lease consists of approximately 10,800 square feet of space and is located in Monroe, Louisiana.

On May 13, 2009, we entered into a lease agreement with USA Research and Technology Corporation for

temporary office space to conduct training for newly hired support staff. It is anticipated that the lease for this
space will be vacated sometime in 2013.

On September 14, 2009, we entered into a lease agreement with 3725 Airport Boulevard, LP to house the

majority of our employees providing business management services (now offered by our subsidiary, TruBridge).
This lease consists of approximately 32,240 square feet and is located in Mobile, Alabama, approximately 5
miles from our corporate campus location.

On February 1, 2010, we entered into a lease agreement with 3725 Airport Boulevard, LP to lease additional

space for our employees providing business management services (now offered by our subsidiary, TruBridge).
This lease consists of approximately 11,240 square feet and is located in Mobile, Alabama, approximately 5
miles from our corporate campus location.

On March 19, 2012, we entered into a lease agreement with Fairhope Group, LLC to lease additional space

for our software services employees. This lease consists of approximately 45,020 square feet and is located in
Fairhope, Alabama, approximately 30 miles from our corporate campus location.

We do not anticipate the need to lease additional office space in 2013, as we expect that our existing

facilities will be sufficient to meet our needs until the end of 2013 and beyond.

ITEM 3.

LEGAL PROCEEDINGS

From time to time, we are involved in routine litigation that arises in the ordinary course of business. We are

not currently involved in any litigation that we believe could reasonably be expected to have a material adverse
effect on our business, financial condition or results of operations.

ITEM 4. MINE SAFETY DISCLOSURES

Not applicable.

PART II

ITEM 5. MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER

MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES

Market for CPSI Common Stock

As of March 8, 2013, CPSI had 81 stockholders of record (which does not include the number of beneficial

owners whose shares are held in “street” names by broker-dealers and other nominees who are the record
holders) and 11,080,062 shares of common stock outstanding.

CPSI’s common stock is listed on the NASDAQ Global Select Market under the symbol “CPSI.” The
following table sets forth, for the calendar quarters indicated, the high and low sales prices per share for CPSI’s
common stock on the NASDAQ Global Select Market, and the cash dividends declared per share in each such
quarter:

2012
First Quarter . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Second Quarter
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Third Quarter . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Fourth Quarter . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2011
First Quarter . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Second Quarter
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Third Quarter . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Fourth Quarter . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

High

Low

Dividends
Declared
Per Share

$64.00
61.90
59.17
56.03

$64.39
66.00
79.06
74.62

$50.58
51.64
44.95
46.76

$43.32
51.68
56.78
41.80

$0.46
0.46
0.46
0.46(1)

$0.36
0.36
0.36
0.46

(1) Excluded from the quarterly dividend declared per share in the fourth quarter of 2012 is the December 2012
declaration of a special, one-time dividend of $1.00 per share in anticipation of increased federal income tax
rates on dividends beginning in 2013.

The last reported sales price of CPSI’s common stock as reported on the NASDAQ Global Select Market on

March 8, 2013 was $52.77.

Dividends

During 2012, we paid a quarterly dividend in the amount of $0.46 per share, compared to $0.36 per share

during 2011. Additionally, during 2012 our strong cash position allowed us to distribute the aforementioned
special, one-time dividend of $1.00 per share and also resulted in the announcement on January 31, 2013 of a
$0.05 increase in our quarterly dividend to $0.51 per share. We believe that paying dividends is an effective way
of providing an investment return to our stockholders and a beneficial use of our cash. However, the declaration
of dividends by CPSI is subject to the discretion of our Board of Directors. Our Board of Directors will take into
account such matters as general business conditions, our financial results and such other factors as our Board of
Directors may deem relevant.

ITEM 6.

SELECTED FINANCIAL DATA

INCOME DATA:
Total sales revenue . . . . . . . . . . . . . . .
Total costs of sales . . . . . . . . . . . . . . .

Gross profit . . . . . . . . . . . . . . . . . . . . .
Total operating expenses . . . . . . . . . . .

Operating income . . . . . . . . . . . . . . . .
Total other income . . . . . . . . . . . . . . .

Income before taxes . . . . . . . . . . . . . .
Income taxes . . . . . . . . . . . . . . . . . . . .

Net Income . . . . . . . . . . . . . . . . . . . . .

Net income per share—basic . . . . . . . .

Net income per share—diluted . . . . . .

Weighted average shares outstanding:
Basic . . . . . . . . . . . . . . . . . . . . . . . . . .
Diluted . . . . . . . . . . . . . . . . . . . . . . . . .

BALANCE SHEET DATA
Cash and cash equivalents . . . . . . . . . .
Working capital . . . . . . . . . . . . . . . . . .
Total assets . . . . . . . . . . . . . . . . . . . . .
Total current liabilities . . . . . . . . . . . .
Total stockholders’ equity . . . . . . . . . .

Year Ended December 31,

2012

2011

2010

2009

2008

(in thousands except for share and per share data)

183,309
102,648

173,476
94,065

153,247
88,863

127,742
74,483

119,664
66,443

80,661
39,384

41,277
721

41,998
12,025

29,973

2.71

79,411
38,116

41,295
667

41,962
16,129

25,833

2.34

64,384
35,287

29,097
674

29,771
11,033

18,738

1.71

53,259
29,890

23,369
728

24,097
8,914

15,183

1.39

53,221
29,510

23,711
940

24,651
9,213

15,438

1.42

11,066,456
11,066,456

11,033,804
11,033,804

10,962,874
10,962,874

10,953,747
10,955,167

10,849,060
10,867,669

2012

2011

2010

2009

2008

As of December 31,

8,912
32,486
77,839
18,461
57,202

6,664
37,498
75,645
16,671
57,384

2,940
35,135
62,735
14,485
46,464

4,387
34,426
54,450
11,247
42,691

11,744
33,223
52,867
11,852
40,559

ITEM 7. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND

RESULTS OF OPERATIONS

You should read the following discussion of our financial condition and results of operations in conjunction

with “Selected Financial Data” and our financial statements and the related notes included elsewhere in this
Annual Report. This discussion and analysis contains forward-looking statements that involve risks, uncertainties
and assumptions. Our actual results may differ materially from those anticipated in these forward-looking
statements as a result of many factors, including but not limited to those set forth under “Risk Factors” and
elsewhere in this Annual Report.

Background

CPSI was founded in 1979 and specializes in delivering comprehensive healthcare information systems and
related services to rural and community hospitals. Our systems and services are designed to support the primary
functional areas of a hospital and to enhance access to necessary financial and clinical information. Our
comprehensive system enables healthcare providers to improve clinical, financial and administrative processes
and outcomes. Our products and services provide solutions in key areas, including patient management, financial
management, patient care and clinical, enterprise and office automation. In addition to servicing small to
medium-sized hospitals, we provide information technology services to other related entities in the healthcare
industry, such as nursing homes, home health agencies and physician clinics.

We sell a fully integrated, enterprise-wide financial and clinical hospital information system comprised of
all necessary software, hardware, peripherals, forms and office supplies, together with comprehensive customer
service and support. We also offer business management services, including electronic billing submissions,
patient statement processing and accounts receivable management, as part of our overall information system
solution.

Our system currently is installed and operating in over 650 hospitals in 45 states and the District of
Columbia. Our customers consist of rural and community hospitals with 300 or fewer acute care beds, with
hospitals having 100 or fewer acute care beds comprising approximately 94% of our customers.

Management Overview

We primarily seek revenue growth through sales of healthcare information technology systems and related

services to existing and new customers within our historic target market. Our strategy has produced consistent
revenue growth over the long term, as reflected in five-and ten-year compounded annual growth rates in revenues
of approximately 10.8% and 9.5%, respectively. Selling new and additional products and services to our existing
customer base is an important part of CPSI’s future revenue growth. We believe that as our customer base grows,
the demand for additional products and services, including business management services, will also continue to
grow, supporting further increases in recurring revenues. We also expect to drive revenue growth from new
product development that we may generate from our research and development activities.

In January 2013, we announced the formation of TruBridge, LLC (“TruBridge”), a wholly-owned subsidiary

of CPSI. Initially, TruBridge will provide the business management, consulting and managed information
technology services that have historically been provided by CPSI with the expectation of expanding both our
service offerings and our footprint in this particular marketplace in the future. We expect this strategic initiative
to allow us to more fully take advantage of the market opportunities in providing such services by facilitating the
expansion of our target market to include the entire rural and community hospital market, no longer limiting the
market for our services to hospitals where CPSI already serves as the primary information technology vendor.

In addition to revenue growth, our business model is focused on earnings growth. Once a hospital has
installed our system, we continue to provide support and maintenance services to our customers on an ongoing

basis. These services are typically provided by the same personnel who perform our system installations but at a
reduced cost to us, and therefore at an increased gross margin. We also look to increase margins through cost
containment measures where appropriate.

As a result of the recent economic recession, continued economic uncertainty and tightened lending
standards, hospitals have experienced reduced availability of third party credit and an overall reduction in their
investment portfolios. In addition, healthcare organizations with a large dependency on Medicare and Medicaid
populations, such as community based hospitals, have been impacted by the challenging financial condition of
the federal government and many state governments and government programs. Accordingly, we recognize that
prospective hospital customers often do not have the necessary capital to make investments in information
technology. Additionally, in response to these challenges, hospitals have become more selective regarding where
they invest capital, resulting in a focus on strategic spending that generates a return on their investment. Despite
the current economic environment, we believe healthcare information technology is often viewed as more
strategic to hospitals than other possible purchases because the technology offers the possibility of a quick return
on investment. Information technology also plays an important role in healthcare by improving safety and
efficiency and reducing cost. Additionally, we believe most hospitals recognize that they must invest in
healthcare information technology to meet current and future regulatory, compliance and government
reimbursement requirements.

We have experienced an increase in customers seeking financing arrangements from us over the past five

years for system installations as a result of ongoing economic conditions and tightened lending standards,
resulting in the majority of our new system installation customers seeking financing arrangements during 2012.
Historically, we have made financing arrangements available to customers on a case-by-case basis depending
upon various aspects of the proposed contract and customer attributes. These financing arrangements include
short-term payment plans, longer-term lease financing through us or third-party financing companies, and
Software as a Service (SaaS) arrangements. We intend to continue to work with prospective customers to provide
for financing arrangements to purchase our systems so long as such arrangements do not adversely affect our
financial position or liquidity. We believe that meeting the financial needs of community-based hospitals while
allowing for the profitable expansion of our footprint in this market will remain both an opportunity and a
challenge for us in the foreseeable future.

Despite the ongoing challenging economic conditions generally, including continued tightened lending
standards, we have not experienced a decline in demand for our products and services and our collections of
receivables remains consistent with historical trends.

American Recovery and Reinvestment Act of 2009

While the ongoing challenging economic conditions and tightened lending standards have impacted and
could continue to impact the community hospitals that comprise our target market, we believe that the American
Recovery and Reinvestment Act of 2009 (the “ARRA”) has increased and will continue to increase demand for
healthcare information technology and will have a positive impact on our business prospects through 2015. The
ARRA includes more than $19 billion in funding to aid healthcare organizations in modernizing their operations
through the acquisition and wide-spread use of healthcare information technology. Included in the funding is
approximately $17.2 billion in incentives through Medicare and Medicaid reimbursement systems to encourage
and assist healthcare providers in adopting and using electronic health records (“EHRs”). These incentive
payments began in 2011, but if an eligible healthcare provider does not begin to demonstrate meaningful use of
EHRs by October 1, 2015, then reimbursement under Medicare will begin to be reduced. Our hospital customers
began receiving these incentive payments under the ARRA in 2011. As of March 8, 2013, approximately 273 of
our hospital customers had received payments for EHR adoption totaling more than $277 million.

We have been focused on ensuring that we take the necessary steps to meet the needs of rural and

community hospitals to help them gain access to the incentives made available under the ARRA. Primary among
those steps was ensuring that our technology meets the ARRA’s EHR certification requirements. During 2010,

both our hospital and medical practice EHR solutions were certified as a complete EHR by CCHIT®. Receiving
this certification for both our hospital and medical practice EHR products ensures that both hospitals and
providers using our EHR systems can attain “meaningful use” of EHRs and qualify for certain EHR incentives.
According to data reported by the Office of the National Coordinator for Health IT, along with the Center for
Medicare and Medicaid Services, as of October 2012 CPSI is second among all vendors in terms of successful
hospital attestations for complete EHR systems. As a result of our obtaining this certification and our track record
with our hospital customers successfully achieving meaningful use, the ARRA has had and should continue to
have a positive impact on our business and the businesses of the community hospitals that comprise our target
market.

Health Care Reform

In March 2010, President Obama signed into law the Patient Protection and Affordable Care Act and the
Health Care and Education Reconciliation Act of 2010, collectively referred to as the “Health Reform Laws.”
This sweeping legislation implements changes to the healthcare and health insurance industries from 2010
through 2015, with the ultimate goal of requiring substantially all U.S. citizens and legal residents to have
qualifying health insurance coverage by 2014 and providing the means by which it will be made available to
them. We anticipate that the Health Reform Laws will have little direct impact on our internal operation but may
have a significant impact on the businesses of our hospital customers once fully in effect. We have not been able
to determine at this point whether the impact will be positive, negative or neutral; however, it is likely that the
Health Reform Laws will affect hospitals differently depending upon the populations they service. Rural and
community hospitals typically service higher uninsured populations than larger urban hospitals and rely more
heavily on Medicare and Medicaid for reimbursement. It remains to be seen whether the increase in the insured
populations for rural and community hospitals, as well as the increase in Medicare and Medicaid reimbursements
under ARRA for hospitals that implement EHR technology, will be enough to offset proposed cuts in Medicare
and Medicaid reimbursements contained in the Health Reform Laws.

We believe healthcare initiatives will continue during the foreseeable future. If adopted, some aspects of
previously proposed reforms, such as further reductions in Medicare and Medicaid payments, could adversely
affect the businesses of our customers and thereby harm our business.

Deficit Reduction/Sequestration

President Obama signed legislation on August 2, 2011, the Budget Control Act of 2011, to increase the U.S.

debt ceiling. This legislation mandates significant cuts in federal spending over the next decade, as the special
bipartisan Congressional committee appointed under the legislation failed to take any action on deficit reduction.
Although Medicaid is specifically exempted from the federal spending cuts mandated by the legislation, it calls
for a reduction of up to 2% in federal Medicare spending, all of which will be achieved by reduced
reimbursements to healthcare providers. With the passage of the American Taxpayer Relief Act of 2012, the
reduced reimbursements provided for under the Budget Control Act took effect starting in March 2013. As our
hospital customers rely heavily on reimbursements from Medicare to fund their operations, the anticipated
reduction in reimbursement rates, although capped at 2%, could negatively affect the businesses of our customers
and our business.

2012 Financial Overview

Our gross revenues increased 5.7%, while our net income increased 16.0%. The disproportionate increase in
net income versus gross revenues is due to a 25% decrease in income tax expense as, during 2012, we recognized
significant provision-to-return adjustments related to prior years’ Domestic Production Activities Deduction
(“DPAD”) amounts. Despite the increase in net income, cash flow from operations decreased 4.0% due primarily
to significant increases in our financing receivables. We continued to experience increased levels of customers
seeking financing arrangements for system installations during the year due to continued challenging economic
conditions and unavailability of third-party credit. Additionally, as our new system installation customer base

expects significant future cash inflows in the form of EHR incentive payments, we have experienced a significant
demand for financing arrangements allowing new system installation customers to minimize the near-term
impact on their current cash resources. As a result, we have experienced a significant increase in financing
arrangements that allow customers to utilize anticipated cash inflows under the EHR incentive programs in
satisfaction of their principal obligation in purchasing our EHR solution. These customers have opted for
payment terms that result in the full satisfaction of principal within a timeframe consistent with that of our
historical financing arrangements. We will continue to grant financing arrangements to customers on a case-by-
case basis depending upon various aspects of the proposed contract and customer attributes.

Despite the decrease in cash flow from operations during the year, we paid a special, one-time dividend of
approximately $11.1 million ($1.00 per share) during December 2012 in anticipation of a significant increase in
tax rates on dividends beginning in 2013. This dividend, which was in addition to our standard quarterly
dividend, was partially funded by the liquidation of $7.0 million of our investment portfolio. We have maintained
a strong cash position that we believe is sufficient to meet our operating requirements. We believe that a strong
cash position enables us to compete better in the marketplace and maintain the quality of our customer service
and product offerings.

At the beginning of 2012, we began including language in certain of our customer license agreements that
more evenly matches customers’ anticipated cash inflows under the EHR incentive program with the necessary
cash outflows for purchasing our EHR solution (“Extended Meaningful Use Installment Plans”). Under these
arrangements, customers are required to remit to us incentive payments (not to exceed the remaining balance
under the arrangement) received for adoption of qualifying EHRs upon receipt of such funds, with only nominal
payments required until the customer’s receipt of such incentive payments. If no such incentive payments are
received by the customer or if such payments are not sufficient to pay the remaining balance under the
arrangement, payments continue at contracted nominal amounts until the balance of the contract price is paid in
full. EHR incentive payments aside, these nominal payment amounts would result in the overall duration of the
payment periods significantly exceeding that of our historical financing arrangements. As a result, revenue from
these arrangements is recognized as the amounts become due. As of December 31, 2012, we have accumulated
unrecognized revenue of $7.1 million to be recognized as the amounts become due under these contracts. Of the
customers contributing to the $7.1 million in accumulated unrecognized revenue as of December 31, 2012, more
than half have attested to stage one of meaningful use as of March 8, 2013, with each of those customers attesting
to stage one having already received related Medicaid incentive payments. Medicare payments, which are
typically significantly larger than the related Medicaid payments, are still pending for most of these customers.
Our experience suggests an average time from successful attestation in stage one to receipt of funds from
Medicare under the EHR incentive program of approximately six weeks. Overall with respect to these contracts,
we typically experience a timeframe of 6 to 12 months from the date of installation to receipt of funds under the
EHR incentive program. The final new system installation under an Extended Meaningful Use Installment Plan
was performed during the fourth quarter of 2012, and the Company does not expect to offer such payment terms
going forward. As a result, aside from the anticipated recognition of the $7.1 million of accumulated
unrecognized revenue as of December 31, 2012, we do not expect Extended Meaningful Use Installment Plans to
have a significant impact on our future financial statements. Although we do not expect to offer Extended
Meaningful Use Installment Plans going forward, we expect the trend towards increased financing arrangements
to continue for the next few years. However, the overall payment period durations of future financing
arrangements are expected to be consistent with that of our historical financing arrangements, resulting in
revenue from future financing arrangements being recognized upon installation of our EHR solution.

Revenues

The Company allocates revenue to its multiple element arrangements, including software and software-
related services based on a hierarchy of evidence to support selling prices in accordance with generally accepted
accounting principles. Revenue from general support agreements for post-contract support services (support and
maintenance) and information technology management and consulting services are recognized by the Company
ratably over the term of the agreement.

System Sales. Revenues from system sales are derived from the sale of information systems (including
software, conversion and installation services, hardware and peripherals) to new customers and from the sale of
new or additional products to existing customers. We do not record revenue upon the execution of a sales
contract. Revenue from the sale of the software perpetual license and the system installation and training is
recognized on a module-by-module basis after the installation and training have been completed and the system
is functioning as designed for each individual module. Revenue from the sale of hardware is recognized upon
shipment of the hardware to the customer.

Support and Maintenance. We also derive revenues from the provision of system support services, including

software application support, hardware maintenance, continuing education and related services, and sales of
forms and supplies. Support services are provided pursuant to a support agreement under which we provide
comprehensive system support and related services in exchange for a monthly fee based on the services provided.
The initial term of these contracts ranges from one to seven years, with a typical duration of five years. Upon
expiration of the initial term, these contracts renew automatically on a year-to-year basis thereafter until
terminated. Revenues from support services are recognized in the month when these services are performed.

We provide our products to some customers utilizing the “Software as a Service” model, or “SaaS.” We
provide SaaS services on a remote access basis by storing and maintaining servers at our headquarters which
contain customers’ patient and administrative data. These customers then access this data remotely in exchange
for a monthly fee. In addition, as part of our total information solution, we serve as an Internet service provider,
or “ISP,” for some of our customers for a monthly fee. We also provide web site design, hosting services, and
other information technology management and professional services if needed. Revenues from our SaaS and ISP
services are recognized in the month when these services are performed.

Business Management Services. Our business management services include electronic billing, statement
processing, payroll processing and business office management (primarily accounts receivable management and
private pay services). Most of these business management services are sold pursuant to one-year customer
agreements, with automatic one year renewals until terminated. Revenues from business management services
are recognized when these services are performed.

Reference is made to Note 2 to the financial statements for additional discussion of our revenue recognition

policies.

Costs of Sales

System Sales. The principal costs associated with the design, development, sale and installation of our

systems are employee salaries, benefits, travel expenses and certain other overhead expenses. These costs are
expensed as incurred. For the sale of equipment, we incur costs to acquire these products from the respective
distributors or manufacturers. The costs related to the acquisition of equipment are capitalized into inventory and
expensed upon the sale of the equipment utilizing the average cost method.

Support and Maintenance. The principal costs associated with our system support and maintenance services

are employee salaries, benefits and certain other overhead expenses. These costs are expensed as incurred.

Our employees that perform system installations also provide support and maintenance services. We
allocate their time equally between the two functions to provide them with an equal amount of time at home
providing support services versus travelling away from home performing system installations. As such, salary
related expenses are allocated between cost of system sales and cost of support and maintenance services based
upon an estimate of the percentage of time employees spend performing each function. We had 652 software
installation and support employees as of December 31, 2012 compared to 572 as of December 31, 2011.

Supplies and forms represent an additional cost associated with our support and maintenance services. These

costs are expensed as incurred.

Business Management Services. The principal cost related to our statement processing services is postage.
The principal costs related to our electronic billing, payroll processing and business office management services
are employee related expenses, such as salaries and benefits, and long distance telecommunication fees.

Results of Operations

The following table sets forth certain items included in our results of operations for each of the three years
in the period ended December 31, 2012, expressed as a percentage of our total revenues for these periods (dollar
amounts in thousands):

INCOME DATA:
Sales revenues:

System sales . . . . . . . . . . . . . . . .
Support and maintenance . . . . . .
Business management

Year ended December 31,

2012

2011

2010

Amount % Revenues

$ 72,553
73,026

39.6% $ 70,644
67,557
39.8%

40.7% $ 61,253
59,259
38.9%

40.0%
38.7%

services . . . . . . . . . . . . . . . . . .

37,730

20.6%

35,275

20.3%

32,735

21.4%

183,309

100.0% 173,476

100.0% 153,247

100.0%

Total sales revenues . . . . . . . . . . . . . .
Costs of sales:

System sales . . . . . . . . . . . . . . . .
Support and maintenance . . . . . .
Business management

49,019
31,119

services . . . . . . . . . . . . . . . . . .

22,510

Total costs of sales . . . . . . . . . . . . . . .

102,648

Gross profit
Operating expenses:

. . . . . . . . . . . . . . . . . . . . .

Sales and marketing . . . . . . . . . .
General and administrative . . . . .

Total operating expenses . . . . . . . . . . .

Operating income . . . . . . . . . . . . . . . .
Other income:

Interest income . . . . . . . . . . . . . .

Total other income . . . . . . . . . . . . . . .

80,661

14,290
25,094

39,384

41,277

721

Income before taxes . . . . . . . . . . . . . .
Income taxes . . . . . . . . . . . . . . . . . . . .

41,998
12,025

26.7%
17.0%

12.3%

56.0%

44.0%

7.8%
13.7%

21.5%

22.5%

0.4%

22.9%
6.6%

47,603
27,239

19,223

94,065

79,411

13,413
24,703

38,116

41,295

667

41,962
16,129

27.4%
15.7%

11.1%

54.2%

45.8%

7.8%
14.2%

22.0%

23.8%

0.4%

24.2%
9.3%

46,801
23,923

18,139

88,863

64,384

11,605
23,682

35,287

29,097

674

29,771
11,033

30.6%
15.6%

11.8%

58.0%

42.0%

7.7%
15.5%

23.0%

19.0%

0.4%

19.4%
7.2%

12.2%

Net income . . . . . . . . . . . . . . . . . . . . .

$ 29,973

16.3% $ 25,833

14.9% $ 18,738

2012 Compared to 2011

Revenues. Total revenues increased by 5.7%, or $9.8 million. This was largely attributable to an increase in
support and maintenance revenues and business management services revenues due to a larger customer base and
increased applications within that customer base requiring support and maintenance services, as well as increased
demand and market acceptance of our IT managed services.

System sales revenues increased by 2.7%, or $1.9 million. We completed financial and patient software

system installations at 34 new hospital clients in 2012 (10 of which were under Extended Meaningful Use
Installment Plans), compared to 17 new hospital clients in 2011 (none of which were under Extended Meaningful
Use Installment Plans). System sales to existing customers accounted for 64.1% of our revenues during 2012

compared to 75.4% in 2011. During 2012, the Company installed systems under Extended Meaningful Use
Installment Plans for which a substantial majority of the consideration will not be received or revenue recognized
until the customers successfully achieve “meaningful use” designation and receive related stage one ARRA
incentive payments, resulting in net unrecognized revenue of $7.1 million accumulated during 2012 to be
recognized in future periods as the amounts become due and payable. The Company recognized $3.6 million of
revenue during 2012 for previously installed Software as a Service (“SaaS”) arrangements that were converted to
perpetual license arrangements.

Support and maintenance revenues increased by 8.1%, or $5.5 million. This increase was attributable to an

increase in recurring revenues as a result of a larger customer base, an increase in support service fees for add-on
business sold to existing customers, increases in support rates from contractually agreed upon Consumer Price
Index (“CPI”) rate increases and the addition of IT managed services to our suite of service offerings.
Specifically, from 2011 to 2012 support service fees increased by 7.9%, or $4.7 million, and SaaS, hosting and
other fees decreased by 27.0%, or $1.9 million. IT managed services, which was a new service offering
beginning in the third quarter of 2011, resulted in revenues of $3.3 million in 2012 compared to $0.7 million in
2011.

Business management services revenues increased by 7.0%, or $2.5 million. We experienced this increase in

business management services revenues primarily as a result in customer demand for accounts receivable
management, revenue cycle management, private pay and claims eligibility services.

Costs of Sales. Total costs of sales increased by 9.1%, or $8.6 million. As a percentage of revenues, costs of

sales increased slightly from 54.2% to 56.0%.

Costs of systems sales increased 3.0%, or $1.4 million. This increase is mostly attributable to increases in

travel costs and payroll and related expenses. Travel costs increased 21.6%, or $2.3 million, as a result of the
increased activity in new system installations. Payroll and related expenses increased 4.0%, or $1.0 million, due
to moderate increases in the related headcount necessary to successfully accomplish the increased installation
workload. These increases were partially offset by a 19.4%, or $1.7 million, decrease in cost of equipment due
largely to a 27% decrease in equipment sales. During 2011, we experienced an unusually high number of
equipment sales to existing customers and related cost of equipment due to the Company’s migration to a new
operating platform, which required many customers to upgrade existing hardware to support the new platform.
The gross margin on system sales remained relatively flat, decreasing slightly from 32.6% in 2011 to 32.4% in
2012. This is despite the prevalence of Extended Meaningful Use Installment Plans in the Company’s 2012 new
system implementations, which comprised nearly one third of all new system installations for 2012. Under these
arrangements, the Company recognizes all non-equipment expenses as the installations occur but will not
recognize the related revenue until the customers successfully achieve “meaningful use” designation and receive
related ARRA incentive payments. Excluding the effects of the unrecognized revenue noted above and the
deferral of the related cost of equipment, the adjusted gross margin on system sales (as hereinafter defined in the
“Non-GAAP Financial Measures” section below) increased to 37.8% in 2012. The table below summarizes the
major components of costs of system sales as a percentage of system sales revenues:

Payroll and related expenses . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Travel expenses . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Cost of equipment

Year Ended December 31,

2012

34.5%
17.7%
9.7%

2011

34.1%
14.9%
12.4%

If the Company had recognized the $7.1 million of unrecognized revenue accumulated during 2012 from

Extended Meaningful Use Installment Plans, payroll and related expenses, travel expenses, and adjusted cost of
equipment (as hereinafter defined in the “Non-GAAP Financial Measures” section below) would represent
31.4%, 16.1%, and 9.5%, respectively, of adjusted system sales (as hereinafter defined in the Non-GAAP

Financial Measures” section below) for 2012. Please see the tables set forth below under the caption “Non-
GAAP Financial Measures” for a reconciliation of each of these non-GAAP financial measures to the
comparable financial measure determined in accordance with GAAP.

Cost of support and maintenance increased 14.3%, or $3.9 million, due entirely to an increase in payroll and

related costs of 16.3%, or $3.9 million. The increase in payroll and related costs was driven by the addition of
personnel to provide IT managed services, which was a new service offering beginning in the third quarter of
2011. The gross margin on support and maintenance decreased from 59.7% in 2011 to 57.4% in 2012, as our IT
managed services offering has yet to achieve the economies of scale that currently benefit the remainder of our
support and maintenance services mix.

Our costs associated with business management services increased 17.1%, or $3.3 million, due primarily to
an increase in payroll and related costs. The gross margin on business management services decreased to 40.3%
in 2012 from 45.5% in 2011 due to the disproportionate increase in payroll and related costs versus revenues.
Payroll and related expenses increased 22.6%, or $2.5 million, as a result of adding more employees in order to
support and develop our growing customer base. Similarly, temporary labor expenses increased 26.8%, or $0.2
million.

Sales and Marketing Expenses. Sales and marketing expenses increased 6.5%, or $0.9 million. The increase
was attributable to increased sales commission expense and increased salaries as a result of additional personnel.

General and Administrative Expenses. General and administrative expenses increased 1.6%, or $0.4 million.

Group health insurance expense increased 16.4%, or $1.1 million, due to the combined factors of increased
overall headcount and continuing increases in healthcare costs. Expenses resulting from our annual national user
group conference and various regional or application-specific user group meetings hosted during 2012 increased
$0.8 million due to an increase in the number of such meetings and more costly host locations in 2012 than in
2011. Depreciation expense increased $0.7 million as a result of our acquisition of our corporate campus in
Mobile, Alabama during December 2011. These increases were mostly offset by a $1.5 million decrease in rent
expense related to the aforementioned campus acquisition during December 2011 and a $0.9 million decrease in
bad debt expense. Bad debt expense in 2011 was significantly higher than historical trends as several customers
declared bankruptcy during the second quarter of 2011 and we increased reserves for specific customers with
which we had experienced collection problems.

As a result of the foregoing factors, income before taxes remained unchanged at $42.0 million during both

2012 and 2011.

Income Taxes. Our effective income tax rate for the years ended December 31, 2012 and 2011was 28.6%
and 38.4%, respectively. The significant decrease in our effective income tax rate was primarily due to favorable
provision-to-return adjustments related to differences between the DPAD reported on the 2011 federal income
tax returns and amounts previously estimated, as well as the estimated additional net federal tax benefit to be
realized by the Company upon amending federal income tax returns for all open years for revised DPAD
amounts. The federal research and development tax credit expired effective December 31, 2011, but was
retroactively extended for amounts incurred from January 1, 2012 through December 31, 2013, when the
American Taxpayer Relief Act of 2012 (“ATRA”) was signed into law in January 2013. As the ATRA was
signed into law during the first quarter of 2013, no tax benefit from these potential credits has been recorded for
2012. However, our effective tax rate for the first quarter of 2013 will include a tax benefit from federal research
and development tax credits attributable to the entire 2012 fiscal year and the first quarter of 2013. Excluding the
impact of the 2012 federal research and development tax credits to be recorded during 2013, we anticipate our
effective income tax rate to be 36.0% for the year ended December 31, 2013.

2011 Compared to 2010

Revenues. Total revenues increased by 13.2%, or $20.2 million. This was largely attributable to an increase

in system sales of clinical applications to existing customers attempting to attain “meaningful use” of EHRs
under the ARRA, as well as an increase in support fees for these added clinical applications.

System sales revenues increased by 15.3%, or $9.4 million. We completed financial and patient software
system installations at 17 new hospital clients in 2011, compared to installations at 44 new hospital clients in
2010. System sales to existing customers in 2011 was 75.4% of total revenues as compared to 64.0% for 2010.
We encountered many hospitals deferring IT system purchases in 2011 until they had further information
regarding reimbursement of these expenditures under the ARRA. This deferral resulted in fewer system
installations in 2011. Despite the reduction of new system installations, we were still able to increase revenues
due to high levels of clinical application installations by our existing customers in order to meet the meaningful
use provisions of the ARRA.

Support and maintenance revenues increased by 14.0%, or $8.3 million. The increase in revenues was
primarily attributable to an increase in customers adding clinical systems which require additional support and
maintenance services. We had 657 customers at December 31, 2011, compared to 670 at December 31, 2010, due
to the loss in 2011 of a hospital syndicate with multiple facilities. SaaS revenues increased by 177.4%, or
$1.4 million, while ISP services revenues did not change significantly from 2010. We had 17 customers with
SaaS agreements at December 31, 2011 compared to 12 at December 31, 2010. We had 4 customers buy out their
SaaS agreements during 2011, which contributed $1.3 million to system sales revenue in 2011.

Business management service revenues increased by 7.8%, or $2.5 million. This increase was due to the
following: a 15.7%, or $1.3 million, increase in private pay receivable management services, a 5.1%, or $0.5
million, increase in electronic billing and statement outsourcing services, and a 27.3%, or $0.7 million, increase
in eligibility and medical necessity checking services and connection fees. We were providing our full suite of
business management services to 33 customers at December 31, 2011, compared to 30 customers at
December 31, 2010.

Costs of Sales. Total costs of sales increased by 5.9%, or $5.2 million. As a percentage of revenues, cost of

sales decreased to 54.2% from 58.0%.

Cost of system sales increased by 1.7%, or $0.8 million. The gross margin on system sales increased to

32.6% from 23.6%. As a percentage of system sales, payroll and related expenses remained relatively stable at
34.1% compared to 34.9% in 2010; travel expense decreased to 15.2% from 16.5%; cost of software increased to
4.5% compared to 4.2%; and cost of equipment decreased to 12.4% compared to 19.2% in 2010, as add-on sales
generally require less equipment investment. Year-over-year, payroll and related costs increased 13.1%, or $2.8
million, cost of equipment decreased 25.5%, or $3.0 million, cost of software increased 23.1%, or $0.6 million,
and travel and related costs increased 6.4%, or $0.6 million.

Cost of support and maintenance increased 13.9%, or $3.3 million. The gross margin on support and

maintenance revenues remained stable at 59.7% compared to 59.6% for 2010. Year-over-year, the increase in the
cost of support and maintenance was due to an increase in payroll and related costs of 16.4%, or $3.4 million, as
the result of additional personnel.

Our costs associated with business management services increased 6.0%, or $1.1 million. The gross margin
on business management services increased to 45.5% compared to 44.6% for 2010 due to economies of scale of
our existing business management staff across a larger customer base. Payroll and related expenses increased
$1.6 million due to additional employees, which was offset by a $0.8 million decrease in temporary labor
expense. Occupancy costs increased $0.3 million due to a full year of rent expense in the new facility to house
our business management service personnel that opened in June 2010.

Sales and Marketing Expenses. Sales and marketing expenses increased 15.6%, or $1.8 million. The
increase was attributable to increased sales commission expense and increased salaries as a result of additional
personnel. Advertising expenses increased approximately $0.3 million as the result of a corporate logo change
and related expenses.

General and Administrative Expenses. General and administrative expenses increased 4.3%, or $1.0 million.

Bad debt expense increased $0.4 million, as the Company changed its calculation of allowance for bad debt in
order to better reflect historical experience. Depreciation expense increased 48.1%, or $0.6 million, as the result
of a full year of depreciation of our new business management services facility and the depreciation of our
corporate headquarters facility, which we purchased on December 13, 2011. Group health insurance expense
decreased slightly by $0.2 million during 2011 as the result of positive claims experience. Expenses related to
our national customer user group decreased by $0.5 million due to our hosting of this group’s annual convention
in Mobile, Alabama in 2011 rather than in Chicago, Illinois in 2010.

As a result of the foregoing factors, income before taxes increased by 40.9%, or $12.2 million.

Income Taxes. Our effective income tax rate for the years ended December 31, 2011 and 2010 was 38.4%

and 37.1%, respectively. We utilized research and development tax credits to lower our effective tax rate in 2011
and 2010.

Liquidity and Capital Resources

As of December 31, 2012, we had $8.9 million in cash and cash equivalents and $10.7 million in
investments. Management believes that cash and investments plus cash generated from our normal operating
activities should be adequate to fund our business through the remainder of 2013. Our principal source of
liquidity has been cash provided by operating activities. Cash provided by operating activities has been used
primarily to fund the growth in our business and return cash to our shareholders in the form of dividends.
Because of our cash position, our Board of Directors decided to begin paying a quarterly dividend in 2003. We
declared and paid dividends in the aggregate amount of $31.4 million in 2012 (including a special, one-time
dividend of approximately $11.1 million during December 2012 in anticipation of a significant increase in tax
rates on dividends beginning in 2013), $15.9 million in 2011 and $15.8 million in 2010. We believe that paying
dividends is an effective way of providing an investment return to our stockholders and a beneficial use of our
cash. However, the declaration of dividends by CPSI is subject to the discretion of our Board of Directors. Our
Board of Directors will continue to take into account such matters as general business conditions, our financial
results and such other factors as our Board of Directors may deem relevant.

Net cash provided by operating activities totaled $32.2 million, $33.5 million and $19.6 million for 2012,

2011 and 2010, respectively. The slight decrease in net cash provided by operating activities in 2012 is despite a
16.0% increase in net income from 2011 to 2012, due primarily to significant increases in our financing
receivables. We continued to experience increased levels of customers seeking financing arrangements for
system installations during the year due to continued challenging economic conditions, unavailability of third-
party credit, and the increasing preference by our new system installation customers to minimize the near-term
impact that purchasing our system will have on their current cash resources. We expect this trend of increased
levels of customers seeking financing arrangements for system installations to continue during the next twelve
months, resulting in further increases in our financing receivables. The expected increase in financing
receivables, although offset by periodic collections of previously outstanding amounts, could negatively impact
our net cash provided by operating activities.

During 2012, investing activities provided net cash of $1.5 million, compared to net cash used in investing
activities of $14.0 million and $5.3 million for 2011 and 2010, respectively. In 2012, we purchased $4.4 million
of property and equipment, a significant decrease from the $10.8 million in such capital expenditures in 2011. Of
the $10.8 million in capital expenditures in 2011, $9.5 million related to the purchase of our corporate

headquarters which we had previously been leasing. We experienced a return to more historical levels of capital
expenditures in 2012. Purchases of investments decreased from $3.2 million in 2011 to $1.2 million in 2012 as
the cash outflows necessary to install systems under Extended Meaningful Use Installment Plans reduced the
excess cash available for investment. Additionally, we liquidated $7.0 million of our investment portfolio in
December 2012 to partially fund the aforementioned one-time, special dividend of $11.1 million. For 2013, we
anticipate the need for approximately $2.2 million in capital expenditures.

Net cash used in financing activities totaled $31.4 million, $15.8 million and $15.8 million for 2012, 2011
and 2010, respectively. We declared and paid dividends in the aggregate amount of $31.4 million (including the
aforementioned one-time, special dividend of $11.1 million), $15.9 million and $15.8 million during 2012, 2011
and 2010, respectively.

Our days sales outstanding, which represents the average collection time for accounts receivable, for the

years 2012, 2011 and 2010 were 39, 45, and 60 days, respectively.

We currently do not have a bank line of credit or other credit facility in place. Because we have no debt, we

are not subject to contractual restrictions or other influences on our operations, such as payment demands and
restrictions on the use of operating funds that are typically associated with debt. If we borrow money in the
future, we will likely be subject to operating and financial covenants that could limit our ability to operate as
profitably as we have in the past. Defaults under applicable loan agreements could result in the demand by
lenders for immediate payment of substantial funds and substantial restrictions on expenditures, among other
things. Due to the recent economic recession and ongoing tightened lending standards, additional capital, if
needed, may not be available on terms favorable to the Company, or at all.

Non-GAAP Financial Measures

We have included in the discussion under the caption “2012 Compared to 2011” above financial measures

that were not prepared in accordance with GAAP. Any analysis of non-GAAP financial measures should be
made only in conjunction with results presented in accordance with GAAP. Below, we define each of these non-
GAAP financial measures, provide a reconciliation of each non-GAAP financial measure to the most directly
comparable financial measure calculated in accordance with GAAP, and discuss the reasons that we believe this
information is useful to management and may be useful to investors.

We use the non-GAAP financial measures “adjusted gross margin on system sales,” “adjusted cost of
equipment,” and “adjusted system sales.” Management believes these non-GAAP financial measures provide our
Board of Directors, investors, potential investors, securities analysts and others with useful information to
evaluate our performance because they exclude the impact of unrecognized revenue, recognized revenue and
related deferral of cost of equipment resulting from our use of Extended Meaningful Use Installment Plans.
Extended Meaningful Use Installment Plans were new to the Company in 2012, resulting in the Company not
having sufficient experience with comparable arrangements to establish evidence of a standard business practice
of historically collecting under the original payment terms of such contracts without making concessions. As a
result, the provisions of the Software topic and Revenue Recognition subtopic of the Financial Accounting
Standards Board Accounting Standards Codification result in a conclusion that the fee is not fixed or
determinable and, as a result, the revenue is to be recognized as the amounts become due. Because the timing of
our recognition of revenue under Extended Meaningful Use Installment Plans is not related to any remaining
obligation on the part of the Company, the Company and our Board of Directors use these non-GAAP financial
measures to evaluate our performance relative to other periods. We believe that the most directly comparable
GAAP measures to adjusted gross margin on system sales, adjusted cost of equipment, and adjusted system sales

are gross margin on system sales, cost of equipment, and system sales, respectively. Set forth below are
reconciliations of adjusted gross margin on system sales, adjusted cost of equipment, and adjusted system sales to
the comparable financial measures calculated in accordance with GAAP (dollar amounts in thousands):

Adjusted Gross Margin on System Sales

Year ended December 31,

2012

2011

Gross margin on system sales . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

$23,534

$23,041

Add: Unrecognized revenue accumulated related to Extended Meaningful Use

Installment Plans . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

12,581

Less: Revenue recognized related to Extended Meaningful Use Installment

Plans . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

(5,524)

Less: Deferred cost of equipment related to Extended Meaningful Use

Installment Plans . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

(983)

Add: Amortization of deferred cost of equipment related to Extended

Meaningful Use Installment Plans . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

462

—

Adjusted gross margin on system sales . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

$30,070

$23,041

Adjusted Cost of Equipment

Cost of equipment

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

$7,055

Add: Deferred cost of equipment related to Extended Meaningful Use

Installment Plans . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

983

Less: Amortization of deferred cost of equipment related to Extended

Meaningful Use Installment Plans . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

(462)

2012

2011

$8,763

—

Adjusted cost of equipment . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

$7,576

$8,763

Year ended December 31,

Adjusted System Sales

Year ended December 31,

2012

2011

System sales . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

$72,553

$70,644

Add: Unrecognized revenue accumulated related to Extended Meaningful Use

Installment Plans . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

12,581

Less: Revenue recognized related to Extended Meaningful Use Installment

Plans . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

(5,524)

—

Adjusted system sales . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

$79,610

$70,644

Related Party Transactions

On December 13, 2011, we purchased our corporate campus headquarters, including 16.5 acres of land on
which the headquarters is located, in Mobile, Alabama from a related party, C.P. Investments, Inc., an Alabama
corporation, for $9.5 million. The stockholders of C.P. Investment include, among others, Michael K. Muscat,
Jr., who is one of our executive officers, and his siblings, Ellen M. Harvey and Susan M. Slaton. Prior to the
purchase, we leased the facilities from C.P. Investments, Inc. In 2011, we made total lease payments in the
amount of $1,900,810 to C.P. Investments, Inc. These lease agreements were all cancelled simultaneously with
the purchase. The purchase price for the corporate campus headquarters and 16.5 acres of land was determined
following receipt of three separate independent third-party appraisals of the property.

Contractual Obligations

Our real estate leases are the only material contractual obligations requiring payments in the future. Our

payments under these leases subsequent to December 31, 2012, are set forth below:

Payment due by period

Total

Less than 1 Year

1-3 Years

3-5 Years

More than 5
Years

Operating lease obligations . . . . . . . . . . . . .

$4,572,205

$639,032

$1,162,672

$622,401

$2,148,100

The table above excludes any amounts related to the $744,705 of unrecognized tax benefit as the Company

cannot make a reasonably reliable estimate of the periods of cash settlements with the respective taxing
authorities. See Note 5 to the financial statements for additional information.

Off-Balance Sheet Arrangements

We had no off-balance sheet arrangements as of December 31, 2012. As of December 31, 2011, our only

off-balance sheet arrangement, as defined by Item 303(a)(4) of SEC Regulation S-K, consisted of our guarantee
of certain lease obligations of Solis Healthcare, LP (“Solis Healthcare”) to Winthrop Resources Corporation
(“Winthrop”) under a lease agreement. Solis Healthcare purchased a software system from the Company and
then entered into a sale-leaseback transaction with Winthrop in the first quarter of 2008. We provided this
guarantee in order to facilitate Solis Healthcare in leasing the new system. During May 2012, all amounts
outstanding under the lease were paid in full, resulting in the termination of our obligations under the guarantee.

The Company also has other lease rights and obligations that it accounts for as operating leases that may be
reclassified as balance sheet arrangements under accounting pronouncements currently being considered by the
FASB.

Critical Accounting Policies

General. Our discussion and analysis of our financial condition and results of operations are based on our
financial statements, which have been prepared in accordance with accounting principles generally accepted in
the United States of America. We are required to make some estimates and judgments that affect the preparation
of these financial statements. We base our estimates on historical experience and on various other assumptions
that we believe to be reasonable under the circumstances, but actual results may differ from these estimates under
different assumptions or conditions.

Revenue Recognition. We generate revenue from the following sources:

• The sale of information systems, which includes software licenses, conversion and installation services,

hardware and peripherals;

• The provision of system support services, which includes software application support, hardware
maintenance, continuing education, Software as a Service (or “SaaS”) products, Internet service
provider (“ISP”) products, consulting and managed information technology services, forms and
supplies; and

• The provision of business management services, which includes electronic billing, statement

processing, payroll processing, accounts receivable management, contract management and insurance
services.

We recognize revenue in accordance with the accounting principles required by the Software topic and

Revenue Recognition subtopic of the Financial Accounting Standards Board (“FASB”) Accounting Standards
Codification (the “Codification”) and those prescribed by the SEC, as well as the accounting principles relevant

to multiple-element arrangements in the Revenue Recognition topic and Multiple-Element Arrangments subtopic
of the Codification. These standards require that four basic criteria must be met before revenues can be
recognized: (1) persuasive evidence that an arrangement exists; (2) delivery has occurred or services have been
rendered; (3) the fee is fixed and determinable; and (4) collectability is reasonably assured. The recognition of
revenue pursuant to these criteria involves estimates and judgments regarding:

1) The allocation of total arrangement consideration to the various elements of our multiple-element
arrangements, including, for certain elements, estimates and judgments regarding vendor-specific
objective evidence (“VSOE”) of fair value, which we base on either the price charged when the same
element is sold separately or the price established by management having the relevant authority to do
so, for an element not yet sold separately. VSOE calculations are updated and reviewed regularly
depending on the nature of the product or service. We base VSOE for the related undelivered elements
on either renewals or stand-alone sales as appropriate.

2) Our determination that total fees for our products and services are fixed or determinable, which we

base on signed contracts and orders.

3) Our assessment that collection of amounts due is reasonably assured, which we base on our standard

payment terms and collection history.

Risks associated with these estimates and judgments and the effects thereof include: (1) if VSOE of fair

value of any undelivered element does not exist, all revenue is deferred until VSOE of fair value of the
undelivered element is established or the element has been delivered and (2) if the fees are not fixed or
determinable, or if collection is not reasonably assured, then the revenue recognized in various periods will be
less than amounts that would have been otherwise recognizable using the residual method provided under the
Codification. See Note 2 to the financial statements for further discussion of our revenue recognition policies.

Although we believe that our approach to estimates and judgments regarding revenue recognition is
reasonable, actual results could differ and we may be exposed to increases or decreases in revenue that could be
material.

Allowance for Doubtful Accounts. Trade accounts receivable are stated at the amount the Company expects
to collect and do not bear interest. The collectability of trade receivable balances is regularly evaluated based on
a combination of factors such as customer credit-worthiness, past transaction history with the customer, current
economic industry trends and changes in customer payment patterns, resulting in the establishment of general
reserves. Additionally, if it is determined that a customer will be unable to fully meet its financial obligation,
such as in the case of a bankruptcy filing or other material events impacting its business, a specific reserve for
bad debt is recorded to reduce the related receivable to the amount expected to be recovered.

Although we believe that our approach to estimates and judgments regarding our allowance for doubtful
accounts is reasonable, actual results could differ and we may be exposed to increases or decreases in required
reserves that could be material.

Allowance for Credit Losses. The Company leases its information and patient care systems to certain
healthcare providers under sales-type leases. The Company establishes an allowance for credit losses for these
financing receivables based on the historical level of customer defaults under such financing arrangements.
Additionally, if it is determined that a customer will be unable to meet its financial obligation, such as in the case
of a bankruptcy filing or other material event impacting its business, a specific reserve is recorded to reduce the
related receivable to the amount expected to be recovered. Reference is made to Note 8 to the financial
statements for further information about our financing receivables.

Although we believe that that our approach to estimates and judgments regarding our allowance for credit

losses is reasonable, actual results could differ and we may be exposed to increases or decreases in required
reserves that could be material.

Estimates. The Company uses estimates to record certain transactions and liabilities. These estimates are

generally based on management’s best judgment, past experience, and utilization of third party services such as
actuarial and other expert services. Because these estimates are subjective and variable, actual results could differ
significantly from these estimates. Significant estimates included in our financial statements include those for
self-insurance reserves under our health insurance plan, reserves for uncertain tax positions, bad debt and credit
allowances, legal liability exposure or lack thereof, and accrued expenses.

Backlog

Backlog consists of revenues we reasonably expect to recognize over the next twelve months under existing

contracts. The revenues to be recognized may relate to a combination of one-time fees for system sales, and
recurring fees for support, business management, SaaS and ISP services. As of December 31, 2012, we had a
twelve-month backlog of approximately $42 million in connection with non-recurring system purchases and
approximately $107 million in connection with recurring payments under support, business management and
SaaS contracts. The backlog amounts exclude amounts to be recognized in subsequent periods related to
Extended Meaningful Use Installment Plans. Our backlog increase is the result of new contracts signed in 2012
to be installed in 2013, as well as an increase in our customer base for recurring business.

Quantitative and Qualitative Disclosures about Market and Interest Rate Risk

Our exposure to market risk relates primarily to the potential change in the value of our investment portfolio

as a result of fluctuations in interest rates. The primary purpose of our investment activities is to preserve
principal while maximizing the income we receive from our investments without significantly increasing risk of
loss. As of December 31, 2012, our investment portfolio consisted of a variety of financial instruments,
including, but not limited to, money market securities and high quality government and corporate obligations. It
is our intent to ensure the safety and preservation of our invested principal funds by limiting default risk, market
risk, and reinvestment risk. We do not hold financial instruments for trading or other speculative purposes. The
securities in our investment portfolio are classified as available-for-sale and, consequently, are recorded on our
balance sheet as a current asset at fair market value with their unrealized gain or loss reflected as a component of
accumulated other comprehensive income (loss) in stockholders’ equity.

Investments in both fixed rate and floating rate interest earning instruments carry a degree of interest rate

risk. Fixed rate securities may have their fair market value adversely impacted due to a rise in interest rates,
while floating rate securities may produce less income than expected if interest rates fall. Due in part to these
factors, our future investment income may fall short of expectation due to changes in interest rates or we may
suffer losses in principal if forced to sell securities which have declined in market value due to changes in
interest rates.

We believe that the market risk arising from our holdings of these financial instruments is minimal. Due to

the conservative allocation of our investment portfolio, we do not believe that an immediate 10% increase in
interest rates would have a material effect on the market value of our portfolio. Since we have the ability to
liquidate this portfolio, we do not expect our operating results or cash flows to be materially affected to any
significant degree by a sudden change in market interest rates on our investment portfolio. We do not utilize
derivative financial instruments to manage the interest rate risks associated with our investments.

The table that follows presents fair values of principal amounts and weighted average interest rates for our

investment portfolio as of December 31, 2012 and 2011.

Aggregate Fair Value

Weighted Average
Interest Rate

2012

2011

2012

2011

Cash and Cash Equivalents:

Cash and cash equivalents . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

$8,912,457

$6,664,482

0.00% 0.00%

Short-Term Investments:(1)

Accrued income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Money market funds . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Obligations of the U.S. Treasury, U.S government corporations
and agencies . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Corporate debt securities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

57,507
391,913

$ 102,510
1,474,680

0.00% 0.00%
0.14% 0.19%

1,448,433
2,579,992

3,865,906
4,302,715

0.45% 0.77%
3.83% 4.33%

Total short-term investments . . . . . . . . . . . . . . . . . . . . . . .

$4,477,845

$9,745,811

Long-Term Investments:(2)

Obligations of the U.S. Treasury, U.S government corporations
and agencies . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Mortgage backed securities . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Corporate debt securities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

$ 933,346
95,604
5,167,814

$2,089,984
102,832
4,548,061

1.10% 1.74%
1.75% 2.00%
2.68% 3.36%

Total long-term investments . . . . . . . . . . . . . . . . . . . . . . . .

$6,196,764

$6,740,877

(1) Reflects instruments with a contractual maturity of less than one year.
(2) Reflects instruments with a contractual maturity of one year or more.

Recent Accounting Pronouncements

Reference is made to Note 2 to the financial statements for a discussion of accounting pronouncements that

have been recently issued which we have not yet adopted.

ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

The information required by this item is contained in Item 7 herein under the heading “Quantitative and

Qualitative Disclosures about Market and Interest Rate Risk.”

ITEM 8.

FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

Index to Financial Statements

Page

Management’s Report on Internal Control Over Financial Reporting . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Report of Grant Thornton LLP, Independent Registered Public Accounting Firm, on Financial

Statements . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Report of Grant Thornton LLP, Independent Registered Public Accounting Firm, on Internal Control Over
Financial Reporting . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Balance Sheets — December 31, 2012 and 2011 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Statements of Income — Years ended December 31, 2012, 2011 and 2010 . . . . . . . . . . . . . . . . . . . . . . . . . .

Statements of Comprehensive Income — Years ended December 31, 2012, 2011, and 2010 . . . . . . . . . . . .

Statements of Stockholders’ Equity — Years ended December 31, 2012, 2011 and 2010 . . . . . . . . . . . . . . .

Statements of Cash Flows — Years ended December 31, 2012, 2011 and 2010 . . . . . . . . . . . . . . . . . . . . . .

Notes to Financial Statements . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Index to Financial Statement Schedules

Schedule II — Valuation and Qualifying Accounts

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

All other schedules to the financial statements required by Article 9 of Regulation S-X are not applicable

and therefore have been omitted.

MANAGEMENT’S REPORT ON INTERNAL CONTROL OVER FINANCIAL REPORTING

Management is responsible for establishing and maintaining adequate internal control over financial

reporting as defined in Rule 13a-15(f) under the Securities Exchange Act of 1934. Computer Programs and
Systems, Inc.’s (“CPSI”) internal control over financial reporting is designed to provide reasonable assurance
regarding the reliability of financial reporting and the preparation of financial statements for external purposes in
accordance with generally accepted accounting principles. CPSI’s internal control over financial reporting
includes those policies and procedures that:

(i) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the

transactions and dispositions of the assets of CPSI;

(ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of

financial statements in accordance with generally accepted accounting principles, and that receipts and
expenditures of CPSI are being made only in accordance with authorizations of management and directors
of CPSI; and

(iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition,

use or disposition of CPSI’s assets that could have a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect
misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that
controls may become inadequate because of changes in conditions, or that the degree of compliance with the
policies or procedures may deteriorate.

Management assessed the effectiveness of CPSI’s internal control over financial reporting as of
December 31, 2012. In making this assessment, management used the criteria set forth by the Committee of
Sponsoring Organizations of the Treadway Commission (COSO) in Internal Control-Integrated Framework.

Based on our assessment and those criteria, management believes that CPSI maintained effective internal

control over financial reporting as of December 31, 2012.

The independent registered public accounting firm, Grant Thornton LLP, has audited the financial

statements as of and for the year ended December 31, 2012, and has also issued its report on the effectiveness of
the Company’s internal control over financial reporting included in this report on page 57.

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

To the Board of Directors and Stockholders
Computer Programs and Systems, Inc.:

We have audited the accompanying balance sheets of Computer Programs and Systems, Inc. (a Delaware
corporation) as of December 31, 2012 and 2011, and the related statements of income, comprehensive income,
changes in stockholders’ equity, and cash flows for each of the three years in the period ended December 31,
2012. Our audits of the basic financial statements included an audit of the financial statement schedule listed in
the index appearing under Item 8. These financial statements and financial statement schedule are the
responsibility of the Company’s management. Our responsibility is to express an opinion on these financial
statements and financial statement schedule based on our audits.

We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board
(United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about
whether the financial statements are free of material misstatement. An audit includes examining, on a test basis,
evidence supporting the amounts and disclosures in the financial statements. An audit also includes assessing the
accounting principles used and significant estimates made by management, as well as evaluating the overall
financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.

In our opinion, the financial statements referred to above present fairly, in all material respects, the financial
position of Computer Programs and Systems, Inc. as of December 31, 2012 and 2011, and the results of its
operations and its cash flows for each of the three years in the period ended December 31, 2012 in conformity
with accounting principles generally accepted in the United States of America. Also in our opinion, the related
financial statement schedule, when considered in relation to the basic financial statements taken as a whole,
presents fairly, in all material respects, the information set forth therein.

We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board
(United States), the Company’s internal control over financial reporting as of December 31, 2012, based on
criteria established in Internal Control—Integrated Framework issued by the Committee of Sponsoring
Organizations of the Treadway Commission (COSO), and our report dated March 11, 2013 expressed an
unqualified opinion.

/s/ GRANT THORNTON LLP

Atlanta, Georgia
March 11, 2013

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

To the Board of Directors and Stockholders of
Computer Programs and Systems Inc.:

We have audited the internal control over financial reporting of Computer Programs and Systems, Inc. (a
Delaware corporation) as of December 31, 2012, based on criteria established in Internal Control—Integrated
Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). The
Company’s management is responsible for maintaining effective internal control over financial reporting and for
its assessment of the effectiveness of internal control over financial reporting, included in the accompanying
Management’s Report on Internal Control Over Financial Reporting. Our responsibility is to express an opinion
on the Company’s internal control over financial reporting based on our audit.

We conducted our audit in accordance with the standards of the Public Company Accounting Oversight Board
(United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about
whether effective internal control over financial reporting was maintained in all material respects. Our audit
included obtaining an understanding of internal control over financial reporting, assessing the risk that a material
weakness exists, testing and evaluating the design and operating effectiveness of internal control based on the
assessed risk, and performing such other procedures as we considered necessary in the circumstances. We believe
that our audit provides a reasonable basis for our opinion.

A company’s internal control over financial reporting is a process designed to provide reasonable assurance
regarding the reliability of financial reporting and the preparation of financial statements for external purposes in
accordance with generally accepted accounting principles. A company’s internal control over financial reporting
includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail,
accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable
assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance
with generally accepted accounting principles, and that receipts and expenditures of the company are being made
only in accordance with authorizations of management and directors of the company; and (3) provide reasonable
assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of the
company’s assets that could have a material effect on the financial statements.

In our opinion, the Company maintained, in all material respects, effective internal control over financial
reporting as of December 31, 2012, based on criteria established in Internal Control—Integrated Framework
issued by COSO.

We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board
(United States), the financial statements of the Company as of and for the year ended December 31, 2012, and
our report dated March 11, 2013 expressed an unqualified opinion on those financial statements.

/s/ GRANT THORNTON LLP

Atlanta, Georgia
March 11, 2013

COMPUTER PROGRAMS AND SYSTEMS, INC.

Balance Sheets

Assets

Current assets:

Cash and cash equivalents . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Investments . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Accounts receivable, net of allowance for doubtful accounts of

$1,124,000 and $1,276,000, respectively . . . . . . . . . . . . . . . . . . . . . . .
Financing receivables, current portion, net . . . . . . . . . . . . . . . . . . . . . . . .
Inventories . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Deferred tax assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Prepaid income taxes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Prepaid expenses and other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Total current assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Property and equipment . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Land . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Buildings and improvements . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Maintenance equipment . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Computer equipment . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Leasehold improvements . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Office furniture and equipment . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Automobiles . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Less accumulated depreciation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

December 31,
2012

December 31,
2011

$ 8,912,457
10,674,609

$ 6,664,482
16,486,688

19,704,767
4,618,131
1,682,008
2,463,567
1,809,220
1,081,421

21,521,260
3,780,621
1,838,937
2,543,624
834,750
498,172

50,946,180

54,168,534

2,848,276
9,067,504
2,588,452
5,795,707
3,067,756
2,845,548
314,905

2,848,276
8,779,673
4,638,219
9,391,704
1,937,524
2,959,534
190,542

26,528,148
(7,498,174)

30,745,472
(13,326,241)

Property and equipment, net
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Financing receivables . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

19,029,974
7,862,833

17,419,231
4,056,748

Total assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

$77,838,987

$ 75,644,513

Liabilities and Stockholders’ Equity

Current liabilities:

Accounts payable . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Deferred revenue . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Accrued vacation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Other accrued liabilities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

$ 2,980,174
7,452,612
3,506,106
4,521,773

$ 2,469,157
5,589,792
3,211,693
5,399,996

Total current liabilities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Deferred tax liabilities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Stockholders’ equity:

Common stock, $0.001 par value; 30,000,000 shares authorized;

18,460,665
2,176,130

16,670,638
1,589,838

11,077,672 and 11,063,220 shares issued and outstanding . . . . . . . . . .
Additional paid-in capital
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Accumulated other comprehensive income . . . . . . . . . . . . . . . . . . . . . . . .
Retained earnings . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

11,078
32,848,101
27,693
24,315,320

11,063
31,582,108
7,380
25,783,486

Total stockholders’ equity . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

57,202,192

57,384,037

Total liabilities and stockholders’ equity . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

$77,838,987

$ 75,644,513

The accompanying notes are an integral part of these financial statements.

COMPUTER PROGRAMS AND SYSTEMS, INC.

Statements of Income

Year ended December 31,

2012

2011

2010

Sales revenues:

System sales . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Support and maintenance . . . . . . . . . . . . . . . . . . . . . . . . . . .
Business management services . . . . . . . . . . . . . . . . . . . . . . .

$ 72,553,036
73,026,491
37,729,876

$ 70,643,877
67,557,386
35,275,081

$ 61,252,949
59,259,133
32,735,162

Total sales revenues . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

183,309,403

173,476,344

153,247,244

Costs of sales:

49,018,946
31,119,718
22,509,770

47,602,817
27,238,779
19,223,543

46,800,755
23,923,099
18,139,259

Total costs of sales . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

102,648,434

94,065,139

88,863,113

Gross profit . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

80,660,969

79,411,205

64,384,131

Operating expenses:

Sales and marketing . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
General and administrative . . . . . . . . . . . . . . . . . . . . . . . . . .

14,290,061
25,093,527

13,413,587
24,702,679

11,605,123
23,681,584

Total operating expenses . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

39,383,588

38,116,266

35,286,707

Operating income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

41,277,381

41,294,939

29,097,424

Other income:

Interest income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Income before taxes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Income taxes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

720,573
41,997,954
12,024,482

667,564
41,962,503
16,129,113

673,224
29,770,648
11,032,795

Net income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

$ 29,973,472

$ 25,833,390

$ 18,737,853

Net income per share - basic . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Net income per share - diluted . . . . . . . . . . . . . . . . . . . . . . . . . . .

2.71

2.34

1.71

Weighted average shares outstanding

Basic . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Diluted . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

11,066,456
11,066,456

11,033,804
11,033,804

10,962,874
10,962,874

The accompanying notes are an integral part of these financial statements.

COMPUTER PROGRAMS AND SYSTEMS, INC.

Statements of Comprehensive Income

Net income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Other comprehensive income (loss), net of tax

Unrealized gain (loss) on investments available for sale, net of

Year Ended December 31,

2012

2011

2010

$29,973,472

$25,833,390

$18,737,853

tax . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

20,313

(51,523)

(41,200)

Total other comprehensive income (loss), net of tax . . . . . . . . . . . . .
Comprehensive income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

20,313
$29,993,785

(51,523)
$25,781,867

(41,200)
$18,696,653

The accompanying notes are an integral part of these financial statements.

COMPUTER PROGRAMS AND SYSTEMS, INC.

Statements of Stockholders’ Equity

Common
Shares

Common
Stock

Additional
Paid-in
Capital

Balance at December 31, 2009 . . . 10,972,757 $10,973 $29,679,385
Net income . . . . . . . . . . . . . . . . . .
Forefeiture of common stock . . . .
Unrealized loss on investments

—
(9,883)

—
(10)

—
10

Accumulated
Other
Comprehensive
Income(Loss)

$100,103

—
—

Retained
Earnings

Total
Stockholders’
Equity

$ 12,900,810 $ 42,691,271
18,737,853

18,737,853
—

—

held for sale, net of tax . . . . . . .
Stock-based compensation . . . . . .
Dividends . . . . . . . . . . . . . . . . . . .
Income tax benefit from restricted
stock dividends . . . . . . . . . . . . .

—
—
—

—

—
—
—

—

—
855,819
—

(41,200)
—
—

—
—

(15,793,655)

(41,200)
855,819
(15,793,655)

13,935

—

13,935

Balance at December 31, 2010 . . . 10,962,874 $10,963 $30,549,149

$ 58,903

$ 15,845,008 $ 46,464,023

Net income . . . . . . . . . . . . . . . . . .
Unrealized loss on investments

held for sale,net of tax . . . . . . .
Issuance of restricted stock . . . . .
Stock-based compensation . . . . . .
Dividends . . . . . . . . . . . . . . . . . . .
Income tax benefit from restricted
stock dividends . . . . . . . . . . . . .
Income tax benefit from restricted
stock . . . . . . . . . . . . . . . . . . . . .

—

—
100,346
—
—

—

—
100
—
—

—

25,833,390

—
(100)
928,224
—

(51,523)
—
—
—

—
—
—

(15,894,912)

(51,523)
—
928,224
(15,894,912)

42,266

62,569

—

42,266

62,569

Balance at December 31, 2011 . . . 11,063,220 $11,063 $31,582,108

7,380

$ 25,783,486 $ 57,384,037

Net income . . . . . . . . . . . . . . . . . .
Unrealized gain on investments

Deficient tax benefit from

restricted stock . . . . . . . . . . . . .

—

—
14,452
—
—

—

—
15
—
—

—

29,973,472

—
(15)
1,264,779
—

20,313
—
—
—

—
—
—

(31,441,638)

20,313
—

1,264,779
(31,441,638)

98,163

(96,934)

—

98,163

(96,934)

Balance at December 31, 2012 . . . 11,077,672 $11,078 $32,848,101

$ 27,693

$ 24,315,320 $ 57,202,192

The accompanying notes are an integral part of these financial statements.

COMPUTER PROGRAMS AND SYSTEMS, INC.

Statements of Cash Flows

Operating Activities
Net income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Adjustments to net income:

Provision for bad debt . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Deferred taxes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Stock based compensation . . . . . . . . . . . . . . . . . . . . . . . . . . .
Deficient (excess) tax benefit from restricted stock . . . . . . . .
Income tax benefit from restricted stock dividends . . . . . . . .
Depreciation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Changes in operating assets and liabilities:

Accounts receivable . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Financing receivables . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Inventories . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Prepaid expenses and other . . . . . . . . . . . . . . . . . . . . . . . . . . .
Accounts payable . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Deferred revenue . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Other liabilities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Prepaid income taxes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Year ended December 31,

2012

2011

2010

$ 29,973,472

$ 25,833,390

$ 18,737,853

515,138
654,093
1,264,779
96,934
(98,163)
3,164,184

1,516,349
(4,858,589)
(255,037)
(583,249)
511,017
1,862,820
(583,810)
(973,241)

1,436,549
(452,891)
928,224
(62,569)
(42,266)
2,500,324

3,014,205
(790,376)
(445,974)
64,038
(148,220)
1,120,285
1,213,121
(627,665)

1,077,250
572,890
855,819
—
(13,935)
1,853,724

(6,843,741)
(251,022)
(508,044)
143,271
405,292
886,637
1,946,176
779,510

Net cash provided by operating activities . . . . . . . . . . . . . . . . . . . .

32,206,697

33,540,175

19,641,680

Investing Activities
Purchases of property and equipment . . . . . . . . . . . . . . . . . . . . . . .
Purchases of investments . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Sale of investments . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

(4,362,961)
(1,155,352)
7,000,000

(10,846,717)
(3,178,738)

(5,092,047)
(216,837)

—

Net cash provided by (used in) investing activities . . . . . . . . . . . .

1,481,687

(14,025,455)

(5,308,884)

Financing Activities
Dividends paid . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Excess (deficient) tax benefit from restricted stock . . . . . . . . . . . .
Income tax benefit from restricted stock dividends . . . . . . . . . . . .

(31,441,638)
(96,934)
98,163

(15,894,912)
62,569
42,266

(15,793,655)

—
13,935

Net cash used in financing activities . . . . . . . . . . . . . . . . . . . . . . . .

(31,440,409)

(15,790,077)

(15,779,720)

Increase (Decrease) in cash and cash equivalents . . . . . . . . . . . . . .
Cash and cash equivalents at beginning of year . . . . . . . . . . . . . . .

2,247,975
6,664,482

3,724,643
2,939,839

(1,446,924)
4,386,763

Cash and cash equivalents at end of year . . . . . . . . . . . . . . . . . . . .

$ 8,912,457

$ 6,664,482

$ 2,939,839

Supplemental disclosure of cash flow information
Cash paid for interest
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Cash paid for income taxes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Reclassification of inventory to property and equipment . . . . . . . .
Write-off of fully depreciated assets . . . . . . . . . . . . . . . . . . . . . . . .

$
$ 12,330,270
$
411,966
$ 8,687,631

— $

—

$ 17,146,023
$
389,780
$

$ 9,513,193
428,970
$
—
— $

The accompanying notes are an integral part of these financial statements.

COMPUTER PROGRAMS AND SYSTEMS, INC.
NOTES TO FINANCIAL STATEMENTS
DECEMBER 31, 2011

1. NATURE OF OPERATIONS

Computer Programs and Systems, Inc. (“CPSI” or the “Company”) is a healthcare information technology

solutions provider which was formed and commenced operations in 1979. The Company provides, on an
integrated basis, enterprise-wide clinical management, access management, patient financial management, health
information management, strategic decision support, resource planning management and enterprise application
integration solutions to healthcare organizations throughout the United States. Additionally, CPSI provides other
information technology solutions, including business management services, remote hosting, networking
technologies and other related services. The Company operates in a single segment reporting to the chief
executive officer, based on the criteria of the Segment Reporting topic of the Financial Accounting Standards
Board (“FASB”) Accounting Standards Codification (the “Codification”).

In January 2013, the Company announced the formation of TruBridge, LLC (“TruBridge”), a wholly-owned

subsidiary of CPSI. TruBridge will provide business management, consulting and managed information
technology (“IT”) services specifically targeted at rural and community healthcare organizations.

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Cash and Cash Equivalents

Cash and cash equivalents can include time deposits and certificates of deposit with original maturities of

three months or less that are highly liquid and readily convertible to a known amount of cash. These investments
are stated at cost, which approximates market value, due to their short duration or liquid nature.

Investments

The Company accounts for investments in accordance with FASB Codification topic, Investments – Debt

and Equity Securities. Accordingly, investments are classified as available-for-sale securities and are reported at
fair value, with unrealized gains and losses excluded from earnings and reported in a separate component of
stockholders’ equity. The Company’s management determines the appropriate classifications of investments in
fixed maturity securities at the time of acquisition and re-evaluates the classifications at each balance sheet date.
An average cost method is used for purposes of determining the cost of investments sold.

Investments are comprised of the following at December 31, 2012:

Short term investments (cash and accrued

income) . . . . . . . . . . . . . . . . . . . . . . . . . . .

449,420

$ —

449,420

Amortized
Cost

Unrealized
Gains

Unrealized
Losses

Fair
Value

Obligations of U.S. Treasury, U.S.

government corporations and agencies . . .
Mortgaged-backed securities . . . . . . . . . . . . .
Corporate bonds . . . . . . . . . . . . . . . . . . . . . .

2,381,313
93,458
7,705,914

1,031
2,146
53,236

565
—
11,344

2,381,779
95,604
7,747,806

$10,630,105

$56,413

$11,909

$10,674,609

Shown below are the amortized cost and estimated fair value of securities with fixed maturities at

December 31, 2012, by contract maturity date. Actual maturities may differ from contractual maturities because
issuers of certain securities retain early call or prepayment rights.

Due in 2013 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Due in 2014 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Due in 2015 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Due in 2016 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Due thereafter . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Amortized
Cost

$ 4,464,345
3,594,812
2,477,490
—
93,458

Fair
Value

$ 4,477,844
3,612,009
2,489,152

—
95,604

$10,630,105

$10,674,609

Investments were comprised of the following at December 31, 2011:

Short term investments (cash and accrued

income) . . . . . . . . . . . . . . . . . . . . . . . . . . .

$ 1,577,190

$ —

$ 1,577,190

Amortized
Cost

Unrealized
Gains

Unrealized
Losses

Fair
Value

Obligations of U.S. Treasury, U.S.

government corporations and agencies . . .
Mortgaged-backed securities . . . . . . . . . . . . .
Corporate bonds . . . . . . . . . . . . . . . . . . . . . .

5,944,885
100,620
8,851,895

11,369
2,212
32,971

364
—
34,090

5,955,890
102,832
8,850,776

$16,474,590

$46,552

$34,454

$16,486,688

The following table shows the Company’s investments’ gross unrealized losses and fair value, aggregated
by investment category and length of time that individual securities have been in a continuous loss position, at
December 31, 2012 and 2011, respectively:

Obligations of U.S. Treasury, U.S.
government corporations and
agencies . . . . . . . . . . . . . . . . . . . . . .
Corporate bonds . . . . . . . . . . . . . . . . . .

At December 31, 2012

Less than 12 Months

12 Months or More

Total

Fair
Value

Unrealized
Losses

Fair
Value

Unrealized
Losses

Fair
Value

Unrealized
Losses

$1,649,980
243,612

565
9,800

$ — $ — $1,649,980
912,360
1,544
668,748

$
565
11,344

$1,893,592

$10,365

$668,748

$1,544

$2,562,340

$11,909

At December 31, 2011

Less than 12 Months

12 Months or More

Total

Fair
Value

Unrealized
Losses

Fair
Value

Unrealized
Losses

Fair
Value

Unrealized
Losses

$ 364,385
2,522,030

364
24,113

$ — $ — $ 364,385
3,030,618
9,977

508,588

364
34,090

$2,886,415

$24,477

$508,588

$9,977

$3,395,003

$34,454

Our investment portfolio, including those securities in unrealized loss positions at December 31, 2012, is
comprised almost entirely of investment-grade corporate and government debt securities. The Company does not

intend to sell the investments that are in an unrealized loss position, and it is not likely that the Company will be
required to sell any investments before recovery of their amortized cost basis. As a result, the Company has
determined that the unrealized losses are deemed to be temporary impairments as of December 31, 2012. The
Company believes that the unrealized losses generally are caused by liquidity discounts and increases in risk
premiums required by market participants rather than an adverse change in cash flows or a fundamental
weakness in the credit quality of the issuer or underlying assets.

Income Taxes

We account for income taxes in accordance with FASB Codification topic – Income Taxes. Under this topic,

deferred income taxes are determined utilizing the asset and liability approach. This method gives consideration
to the future tax consequences associated with differences between financial accounting and tax bases of assets
and liabilities. The effect on the deferred tax assets and liabilities of a change in tax rates is recognized in income
in the period that includes the enactment date. We recognize interest and penalties accrued related to
unrecognized tax benefits in the statements of income under general and administrative expenses.

We also make a provision for uncertain income tax positions in accordance with the Income Taxes

Codification topic. These provisions require that a tax position taken in a tax return be recognized in the financial
statements when it is more likely than not (i.e. a likelihood of more than fifty percent) that the position would be
sustained upon examination by tax authorities. A recognized tax position is then measured at the largest amount
of benefit that is greater than fifty percent likely of being realized upon settlement. The topic also requires that
changes in judgment that result in subsequent recognition, derecognition, or change in a measurement date of a
tax position taken in a prior annual period (including any related interest and penalties) be recognized as a
discrete item in the interim period in which the change occurs.

Accounts Receivable and Allowance for Doubtful Accounts

Trade accounts receivable are stated at the amount the Company expects to collect and do not bear interest.
The Company establishes a general allowance for doubtful accounts based on collections history. In the case of a
bankruptcy filing or other similar event indicating the collectability of specific customer accounts is no longer
probable, a specific reserve for bad debt is recorded to reduce the related receivable to the amount expected to be
recovered.

Financing Receivables

Financing receivables are initially recorded at the present value of the related minimum lease payments,
computed at the interest rate implicit in the lease, and are presented net of unearned income. Unearned income is
amortized over the lease term to produce a constant periodic rate of return on the net investment in the lease (the
interest method). An allowance for credit losses has been established based on the historical level of customer
defaults under such arrangements. In the case of a bankruptcy filing or other similar event indicating the
collectability of specific customer accounts is no longer probable, a specific reserve is recorded to reduce the
related receivable to the amount expected to be recovered. Customer payments are considered past due if a
scheduled payment is not received within contractually agreed upon terms, with amounts reclassified to accounts
receivable when they become due. As a result, we evaluate the credit quality of our financing receivables on an
ongoing basis utilizing an aging of receivables and write-offs, customer collection experience, the customer’s
financial condition and known risk characteristics impacting the respective customer base, as well as existing
economic conditions, to determine if any further allowance is necessary. Amounts are specifically charged off
once all available means of collection have been exhausted.

Inventories

Inventories are stated at lower of cost or market using the average cost method. The Company’s inventories

are composed of computer equipment, forms and supplies. For cash flow presentation, inventory used by the
Company and capitalized as property and equipment is shown as a change in inventory.

Property and Equipment

Property and equipment is recorded at cost, less accumulated depreciation. Additions and improvements to
property and equipment that materially increase productive capacity or extend the life of an asset are capitalized.
Maintenance, repairs and minor renewals are expensed as incurred. Upon retirement or other disposition of such
assets, the related costs and accumulated depreciation are removed from the respective accounts and any
resulting gain or loss is included in the results of operations.

Depreciation expense is computed using the straight-line method over the asset’s useful life, which is

generally 5 years for computer equipment, furniture, and fixtures and 30 years for buildings. Leasehold
improvements are depreciated over the shorter of the asset’s useful life or the remaining lease term. The
Company reviews for the possible impairment of long-lived assets whenever events or changes in circumstances
indicate that the carrying amount of an asset may not be recoverable. Depreciation expense is reported in the
statement of income as a component of support and maintenance costs and operating expenses.

Deferred Revenue

Deferred revenue represents amounts received from customers under licensing agreements and

implementation fees for which the revenue earnings process has not been completed.

Revenue Recognition

The Company recognizes revenue in accordance with accounting principles generally accepted in the United

States of America, principally those required by the Software topic and Revenue Recognition subtopic of the
Codification and those prescribed by the SEC.

The Company’s revenue is generated from three sources:

•

System Sales - the sale of information systems, which includes software licenses, conversion and
installation services, hardware and peripherals;

Support and Maintenance - the provision of system support services, which includes software
application support, hardware maintenance, continuing education, “Software as a Service” (or “SaaS”)
products, Internet service provider (“ISP”) products, consulting and managed information technology
services, forms and supplies; and

• Business Management Services - the provision of business management services, which includes

electronic billing, statement processing, payroll processing, accounts receivable management, contract
management and insurance services.

System Sales, Software Application Support, and Hardware Maintenance

The Company enters into contractual obligations to sell hardware, perpetual software licenses, installation

and training services, and support and maintenance services. On average, the Company is able to complete a
system installation in three to four weeks. The methods employed by the Company to recognize revenue, which
are discussed by element below, achieve results materially consistent with the provisions of Accounting
Standards Update (“ASU”) 2009-13, Multiple-Deliverable Revenue Arrangements, due to the relatively short
period during which there are multiple undelivered elements, the relatively small amount of non-software related
elements in the system sale arrangements, and the limited number of contracts in-process at the end of each
reporting period. The Company recognizes revenue on the elements noted above as follows:

•

Software application support and hardware maintenance – We have established vendor-specific
objective evidence (“VSOE”) of the fair value of our software application support and hardware
maintenance services by reference to the price our customers are required to pay for the services when
sold separately via renewals. Support and maintenance revenue is recognized on a straight-line basis
over the term of the maintenance contracts, which is generally three to five years.

• Hardware – We recognize revenue for hardware upon shipment. The selling price of hardware is based

on management’s best estimate of selling price, which consists of cost plus a targeted margin.

•

Software licenses and installation and training – The selling price of software licenses and installation
and training is based on management’s best estimate of selling price. In determining management’s
best estimate of selling price, we consider the following: (1) competitor pricing, (2) supply and demand
of installation staff, (3) overall economic conditions, and (4) our pricing practices as it relates to
discounts. With the exception of those arrangements with extended payment terms that are not
comparable to our historical arrangements (see Note 8), the method of recognizing revenue for the
perpetual license of the associated modules included in the arrangement and the related installation and
training services over the term the services are performed is on a module by module basis as the
respective installation and training for each specific module is completed as this is representative of the
pattern of provision of these services.

SaaS, ISP, and Other Professional IT Services

The Company accounts for SaaS contracts in accordance with the requirements of the Hosting Arrangement

section under the Software topic and Revenue Recognition subtopic of the Codification. The Codification states
that the software elements of SaaS products should not be accounted for as a hosting arrangement “if the
customer has the contractual right to take possession of the software at any time during the hosting period
without significant penalty and it is feasible for the customer to either run the software on its own hardware or
contract with another party unrelated to the vendor to host the software.” Each SaaS contract includes a system
purchase and buyout clause, and this clause specifies the total amount of the system buyout. In addition, a clause
is included which states that should the system be bought out by the customer, the customer would be required to
enter into a general support agreement (for post-contract support services) for the remainder of the original SaaS
term. Accordingly, the Company has concluded that SaaS customers do not have the right to take possession of
the system without significant penalty (i.e., the purchase price of the system), and thus SaaS revenue of the
Company falls within the scope of the Hosting Arrangement section of the Codification. In accordance with SEC
regulations, revenue for SaaS arrangements is recognized when the services are performed.

The Company will occasionally provide ISP and other professional IT services. We consider these services
to be non-software elements. The selling price of these services is based on third-party evidence of selling price
of similar services. Revenue from this element is recognized as the services are performed.

Business Management Services

Business management services consist of electronic billing services, statement processing services, accounts

receivable management services, payroll processing, contract management and insurance services. While
business management service arrangements are contracts separate from the system sale and support and
maintenance contracts, these contracts are sometimes executed within a short time frame of each other. The
selling price of these services is based on VSOE of fair value by reference to the rate our customers renew as
well as the rate the services are sold to customers when the business management services agreement is not
executed within a short time frame. Because the pricing is transaction based (per unit pricing), customers are
billed and revenue recognized as services are performed based on transaction levels.

Stock-Based Compensation

The Company accounts for stock-based compensation according to the provisions of FASB Codification
topic, Compensation – Stock Compensation, which establishes accounting for stock-based awards exchanged for
employee services. Accordingly, stock-based compensation cost is measured at grant date based on the fair value
of the award, and is recognized as an expense on a straight-line basis over the employee’s or non-employee
director’s requisite service period.

Research and Development Costs

Research and development costs are expensed as incurred. Research and development costs totaled

approximately $2,757,000, $2,452,000 and $2,328,000 for the years ended December 31, 2012, 2011 and 2010,
respectively. Research and development costs are included in cost of support and maintenance in the
accompanying statements of income.

Advertising

Advertising costs are expensed as incurred. Advertising expense was approximately $132,000, $283,000

and $57,000 for the years ended December 31, 2012, 2011 and 2010, respectively, and are recorded in sales and
marketing expenses in the accompanying statements of income.

Shipping and Handling Costs

Shipping and handling costs are expensed as incurred and included in general and administrative expenses.

Shipping and handling costs totaled approximately $617,000, $720,000 and $1,042,000 for the years ended
December 31, 2012, 2011 and 2010, respectively.

Use of Estimates

The preparation of financial statements in conformity with accounting principles generally accepted in the

United States of America requires that management make estimates and assumptions that affect the reported
amounts of assets and liabilities, the disclosures of contingent assets and liabilities at the date of the financial
statements and the reported revenues and expenses during the reporting periods. Actual results could differ from
those estimates.

Accounting Standards Adopted by CPSI in 2012

Effective January 1, 2012, the Company retrospectively adopted ASU 2011-05, Presentation of

Comprehensive Income, as amended by ASU 2011-12, Deferral of the Effective Date for Amendments to the
Presentation of Reclassifications of Items Out of Accumulated Other Comprehensive Income in Accounting
Standards Update No. 2011-05. This update requires entities to present comprehensive income either in a single
continuous financial statement or in two separate but consecutive statements. Entities no longer have the option
to present components of other comprehensive income as part of the statement of changes in stockholders’
equity. The Company’s adoption of this update did not have a material impact on our financial statements and
resulted in the accompanying Statements of Comprehensive Income.

Recently Issued Accounting Pronouncements Not Yet Adopted

In February 2013, the FASB issued ASU 2013-02, Reporting of Amounts Reclassified Out of Accumulated

Other Comprehensive Income, to improve the transparency of reporting reclassifications out of accumulated
other comprehensive income (“OCI”) by requiring entities to present in one place information about significant
amounts reclassified and, in some cases, to provide cross-reference to related footnote disclosures. The
amendments do not change the current requirements for reporting net income or OCI in the financial statements,
nor do they require new information to be disclosed. The new guidance requires an entity to present, either on the
face of the statement where net income is presented or as a separate disclosure in the notes, the effect on the
respective line items of net income for items required to be reclassified out of accumulated OCI to net income in
their entirety in the same reporting period. For other amounts that are not required to be reclassified in their
entirety to net income in the same reporting period, an entity is required to cross-reference to other required
disclosures that provide additional details about those amounts. These provisions are effective for fiscal and
interim periods beginning after December 15, 2012 (January 1, 2013 for us). The adoption of these provisions
will not have a material impact on our financial statements.

3. DETAILS OF BALANCE SHEET AMOUNTS

Other accrued liabilities are comprised of the following at December 31, 2012 and 2011:

Salaries and benefits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Commissions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Self-insurance reserves . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Unrecognized tax benefit
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

$2,155,435
716,087
633,700
744,705
271,846

$3,257,663
503,172
793,378
731,346
114,437

2012

2011

$4,521,773

$5,399,996

4. NET INCOME PER SHARE

The Company presents both basic and diluted earnings per share (“EPS”) amounts. Basic EPS is calculated

by dividing net income by the weighted average number of common shares outstanding during the period
presented. Diluted EPS amounts are based upon the weighted average number of common and common
equivalent shares outstanding during the period presented. There were no dilutive shares outstanding for the
years ended December 31, 2012, 2011 and 2010.

5. INCOME TAXES

The Company accounts for income taxes in accordance with the FASB’s Codification topic, Income Taxes.

These provisions require a company to determine whether it is more likely than not that a tax position will be
sustained upon examination based on the technical merits of the position. If the more-likely-than-not threshold is
met, a company must measure the tax position to determine the amount to recognize in the financial statements.

We applied these provisions to all tax positions for which the statute of limitations remained open. A

reconciliation of the beginning and ending amount of unrecognized tax benefits is as follows:

Beginning balance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Additions based on tax positions related to the current year
. . . . . . . . . . . . . .
Additions for tax positions of prior years . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Reductions for tax positions of prior years . . . . . . . . . . . . . . . . . . . . . . . . . . . .

$731,346
—
13,359
—

$697,723
70,935
—
(37,312)

Ending balance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

$744,705

$731,346

2012

2011

The total amount of unrecognized tax benefits, if recognized, that would affect the effective tax rate is

$744,705.

The Company classifies interest and penalties arising from the underpayment of income taxes in the
statements of income under general and administrative expenses. As of December 31, 2012, we had recorded no
accrued interest or penalties related to uncertain tax positions, as such potential amounts are considered
immaterial. The federal returns for the tax years 2004, 2005, and 2006 are currently under examination by the
Internal Revenue Service, primarily in relation to research credits claimed on those returns by the Company. The
federal returns for tax years 2007 through 2011 remain open to examination, and the tax years 2006 through 2011
remain open to other taxing jurisdictions to which the Company is subject.

It is reasonably possible that the amount of unrecognized tax benefits, inclusive of related interest, will

change in the next twelve months. At December 31, 2012, there is no estimated increase or decrease in the
amount of unrecognized tax benefits.

Deferred income taxes arise from the temporary differences in the recognition of income and expenses for

tax purposes. A valuation allowance is established when the Company believes that it is more likely than not that
some portion of its deferred tax assets will not be realized. Deferred tax assets and liabilities are comprised of the
following at December 31, 2012 and 2011:

2012

2011

Deferred tax assets:

Accounts receivable . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Accrued vacation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Stock-based compensation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Accrued liabilities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

$ 696,672
1,367,381
351,850
432,707

$ 672,056
1,252,560
334,383
629,906

Total deferred tax assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

$2,848,610

$2,888,905

Deferred tax liabilities:

Other comprehensive income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Depreciation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

16,974
2,544,199

4,718
1,930,401

Total deferred tax liabilities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

$2,561,173

$1,935,119

Significant components of the income tax provision for the years ended December 31, 2012, 2011 and 2010

are as follows:

Current provision:

2012

2011

2010

Federal . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
State . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

$ 9,997,468
1,372,921

$13,602,045
2,979,959

$ 8,478,494
1,981,411

Deferred provision:

Federal . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
State . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

587,008
67,085

(406,441)
(46,450)

514,132
58,758

Total income tax provision . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

$12,024,482

$16,129,113

$11,032,795

The difference between income taxes at the U.S. federal statutory income tax rate of 35% and those reported

in the statements of income for the years ended December 31, 2012, 2011 and 2010 are as follows:

Income taxes at U. S. Federal statutory rate . . . . . . . . . . . . . . . . . . . .
Provision-to-return adjustments . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
State income tax, net of federal tax effect . . . . . . . . . . . . . . . . . . . . . .
Impact of tax credits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

$14,699,284
(3,085,812)
1,558,169
(1,236,701)
89,542

$14,686,876
—
1,890,523
(708,448)
260,162

$10,419,727

—

1,346,675
(590,928)
(142,679)

Total income tax provision . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

$12,024,482

$16,129,113

$11,032,795

2012

2011

2010

The provision-to-return adjustments presented above for the year ended December 31, 2012 are primarily
related to differences between the Domestic Production Activities Deduction (“DPAD”) reported on the 2011
federal income tax return and amounts previously estimated, as well as the estimated additional net federal tax
benefit to be realized by the Company upon amending federal income tax returns for all open years for revised
DPAD amounts.

During January of 2013, the American Taxpayer Relief Act of 2012 was signed into law. This law

retroactively extended the federal research credits for amounts incurred from January 1, 2012 through
December 31, 2013. As a result of the retroactive extension, our effective tax rate for the first quarter of fiscal
2013 will include a tax benefit from research credits attributable to the entire 2012 fiscal year and the first quarter
of 2013.

6. STOCK-BASED COMPENSATION AND EMPLOYEE INCENTIVE PROGRAMS

Stock-based compensation cost is measured at the grant date based on the fair value of the award, and is

recognized as an expense over the employee’s or non-employee director’s requisite service period.

The following table shows total stock-based compensation expense for the years ended December 31, 2012,

2011 and 2010, included in the Statements of Income:

2012

2011

2010

Costs of sales . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Operating expenses . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

$ 459,996
804,783

$348,274
579,950

$299,988
555,831

Pre-tax stock-based compensation expense . . . . . . . . . . . . . . .
Less: income tax effect . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

1,264,779
493,264

Net stock-based compensation expense . . . . . . . . . . . . . . . . . .

771,515

928,224
362,007

566,217

855,819
333,770

522,049

Basic and diluted per share impact . . . . . . . . . . . . . . . . . . . . . .

0.07

0.05

Cash flows resulting from deficient or excess tax benefits are required to be classified as a part of cash flows

from financing activities. Deficient tax benefits are realized tax benefits from tax deductions for the vested
portion of restricted share awards that are less than the deferred tax asset attributable to stock compensation costs
for such restricted share awards. Conversely, excess tax benefits are realized tax benefits from tax deductions for
the vested portion of restricted share awards that are in excess of the deferred tax asset attributable to stock
compensation costs for such restricted share awards. As a result, a deficient tax benefit of $96,934 has been
classified as a financing cash outflow for the year ended December 31, 2012, and excess tax benefits of $62,569
and $0 have been classified as financing cash inflows for the years ended December 31, 2011 and 2010,
respectively. In addition to tax benefits related to the vested portion of restricted share awards, the Company also
pays dividends on unvested restricted stock which resulted in excess tax benefits of $98,163, $42,266 and
$13,935 for the years ended December 31, 2012, 2011 and 2010, respectively, which are classified as cash
inflows from financing activities.

2005 Restricted Stock Plan

On January 27, 2006, the Compensation Committee of the Board of Directors approved the grant of 116,498

shares of restricted stock, effective January 30, 2006, to certain executive officers of the Company under the
Company’s 2005 Restricted Stock Plan. The grant date fair value was $42.91 per share. The restricted stock
vested in five equal annual installments commencing on the first anniversary date of grant.

On May 17, 2006, the Compensation Committee of the Board of Directors approved the grant of 17,810
shares of restricted stock, effective May 17, 2006, to the then Chief Operating Officer of the Company. The grant
date fair value was $42.11 per share. The restricted stock vested in five equal annual installments commencing
on January 30, 2007, and each January 30 thereafter.

On January 23, 2008, the Compensation Committee of the Board of Directors approved the grant of 16,471
shares of restricted stock to the Company’s then Vice President – Finance and Chief Financial Officer. The grant
date fair value was $21.25 per share. The restricted stock was scheduled to vest in five equal annual installments
commencing on January 30, 2009, and each January 30 thereafter. On June 30, 2010, 9,883 shares of unvested
restricted stock were forfeited, cancelled and returned to the authorized and unissued shares of the Company as a
result of the termination of employment of this individual on such date.

On April 18, 2011, the Compensation Committee of the Board of Directors approved the grant of a total of
100,346 shares of restricted stock, effective April 18, 2011, to certain executive officers of the Company. Under
the terms of the restricted stock award agreements with the executive officers, the shares of restricted stock are

scheduled to vest in five equal annual installments commencing on April 18, 2012 and each April 18 thereafter,
assuming that the recipient of the award continues to serve as an executive officer of the Company on each applicable
vesting date. Compensation expense for this grant will be recognized on a straight-line basis over five years.

On October 31, 2012, the Compensation Committee of the Board of Directors approved the grant of a total
of 12,292 shares of restricted stock, effective October 31, 2012, to two executive officers of the Company. The
grant date fair value was $48.81 per share. Under the terms of the restricted stock award agreements with the
executive officers, the shares of restricted stock are scheduled to vest in five equal annual installments
commencing on October 31, 2013 and each October 31 thereafter, assuming that the recipient of the award
continues to serve as an executive officer of the Company on each applicable vesting date. Compensation
expense for this grant will be recognized on a straight-line basis over five years.

Of the 300,000 shares of the Company’s common stock initially reserved for issuance under the 2005

Restricted Stock Plan, 79,085 remain available for future issuances as of December 31, 2012.

2012 Restricted Stock Plan for Non-Employee Directors

On June 18, 2012, the Compensation Committee of the Board of Directors approved the grant of a total of

2,160 shares of restricted stock, effective June 18, 2012, to the five non-employee directors of the Company
under the Company’s 2012 Restricted Stock Plan for Non-Employee Directors. The grant date fair value was
$55.55 per share. Under the terms of the restricted stock award agreements with the non-employee directors, the
shares of restricted stock are scheduled to vest on the third anniversary of the date of grant, assuming that the
recipient of the grant continues to serve as a director of the Company on the vesting date. Compensation expense
for this grant will be recognized on a straight-line basis over three years.

Of the 100,000 shares of the Company’s common stock initially reserved for issuance under the 2012

Restricted Stock Plan for Non-Employee Directors, 97,840 remain available for future issuances as of
December 31, 2012.

A summary of activity under the 2005 Restricted Stock Plan and the 2012 Restricted Stock Plan for Non-

Employee Directors (the “Plans”) during the years ended December 31, 2012, 2011 and 2010 is as follows:

Nonvested stock outstanding at January 1, 2010 . . . . . . . . . . . . . . . . . . . .
Granted . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Vested . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Forfeited . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Nonvested stock outstanding at December 31, 2010 . . . . . . . . . . . . . . . . .

52,920
—
23,166
9,883

19,871

Granted . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Vested . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Forfeited . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

100,346
19,871
—

Weigted-Average
Grant-Date
Fair Value

$37.41
—
39.71
21.25

$42.77

60.79
42.77
—

Nonvested stock outstanding at December 31, 2011 . . . . . . . . . . . . . . . . .

100,346

$60.79

Nonvested stock outstanding at December 31, 2012 . . . . . . . . . . . . . . . . .

14,452
20,069
—

94,729

49.82
60.79
—

$59.12

As of December 31, 2012, there was $4,701,275 of total unrecognized compensation cost related to non-
vested share-based compensation arrangements granted under the Plans. As of December 31, 2012, this cost is
expected to be recognized over a weighted-average period of 3.5 years.

2012 Incentive Program

On January 23, 2012, the Board of Directors, upon the recommendation of the Compensation Committee,

adopted a short-term incentive program for 2012 for certain executive officers of the Company (the “2012
Incentive Program”). Under the 2012 Incentive Program, each individual serving as an executive officer of the
Company at that time, other than executive officers earning any commission-based compensation, was granted a
short-term incentive cash bonus opportunity based on the achievement of a specified level of financial
performance, specifically the Company’s earnings before interest, income taxes, depreciation and amortization
(“EBITDA”) in 2012 (“2012 EBITDA”) compared to the Company’s EBITDA in 2011 (“2011 EBITDA”).

Participants in the 2012 Incentive Program would receive 100% of their target award if the Company’s 2012

EBITDA is 105% of 2011 EBITDA, 75% of the target award if the Company achieves a minimum threshold
level of performance (2012 EBITDA reaching 95% of 2011 EBITDA), and a maximum of 150% of the target
award for a maximum level of performance (2012 EBITDA equaling or exceeding 130% of 2011 EBITDA). No
payments are to be made for performance below the specified threshold amount. Payouts between the threshold
and maximum are calculated by the Compensation Committee using the interpolation process described in the
2012 Incentive Program. The Compensation Committee may make adjustments to the terms and conditions of,
and the criteria included in, awards under the 2012 Incentive Program in recognition of unusual or nonrecurring
events affecting a participant or the Company, or the financial statements of the Company, or in certain other
instances specified in the 2012 Incentive Program.

Awards earned under the 2012 Incentive Program are to be paid solely in cash. In addition, awards pursuant
to the 2012 Incentive Program are subject to recovery or adjustments by the Company in certain circumstances in
which the operating results on which payment was based are restated or otherwise adjusted or in the event that a
participant’s conduct is not in good faith and materially disrupts, damages, impairs or interferes with the business
of the Company.

7. CONCENTRATION OF CREDIT RISK

Financial instruments, which potentially subject the Company to concentration of credit risk, consist
principally of temporary cash investments and trade receivables. The Company places its temporary cash
investments with credit-worthy, high-quality financial institutions.

The Company’s customer base is concentrated in the healthcare industry. Customers are located throughout
the United States. The Company requires no collateral or other security to support customer accounts receivable.
An allowance for doubtful accounts has been established for potential credit losses based on historical collection
experience.

The Company maintains its cash and cash equivalents in bank deposit accounts, which, at times, may exceed
federally insured limits. The Company has not experienced any losses in such accounts and does not believe it is
exposed to any significant credit risk on cash and cash equivalents.

8. FINANCING RECEIVABLES

The Company leases its information and patient care systems to certain healthcare providers under sales-

type leases expiring in various years through 2017. These receivables typically have terms from two to five
years, bear interest at various rates, and are usually collateralized by a security interest in the underlying assets.
Since the Company has a history of successfully collecting amounts due under the original payment terms of
these extended payment arrangements without making any concessions to its customers, the Company satisfies
the requirement for revenue recognition. The Company’s history with these types of extended payment term
arrangements supports management’s assertion that revenues are fixed and determinable and probable of
collection.

The components of these lease receivables were as follows on December 31:

Total minimum lease payments receivable . . . . . . . . . . . . . . . . . . . . . . .
Less allowance for losses . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Less unearned income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

$13,665,300
(662,315)
(970,508)

$ 8,254,652
(447,321)
(692,027)

Lease receivables . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Less current portion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

12,032,477
(4,169,644)

7,115,304
(3,058,556)

Amounts due after one year . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

$ 7,862,833

$ 4,056,748

2012

2011

Future minimum lease payments to be received subsequent to December 31, 2012 are as follows:

2013 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2014 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2015 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2016 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2017 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Thereafter

$ 5,387,029
3,343,238
4,422,141
483,980
28,912
—

Total minimum lease payments to be received . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Less unearned income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

13,665,300
(970,508)

Net leases receivable . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

$12,694,792

The Company has also sold information and patient care systems to certain healthcare providers under
extended payment terms. These receivables, included in the current portion of financing receivables, typically
have terms from 3 to 12 months. Total amounts receivable under these arrangements at December 31, 2012 and
2011 were $448,487 and $722,065, respectively.

Credit Quality of Financing Receivables and Allowance for Credit Losses

The following table is a roll-forward of the allowance for financing credit losses for the years ended

December 31, 2011 and 2012:

December 31, 2011 . . . . . . . . . . . . . . . . . . . . . . . . . . .
December 31, 2012 . . . . . . . . . . . . . . . . . . . . . . . . . . .

$233,396
$447,321

$499,485
$214,994

$(285,560)
$

—

$—
$—

Begining
Balance

Provision

Charge-offs Recoveries

Ending
Balance

$447,321
$662,315

The Company’s financing receivables are comprised of a single portfolio segment as the balances are all
derived from sales-type leasing arrangements within our target market of rural and community hospitals. The
Company evaluates the credit quality of its financing receivables based on a combination of factors, including,
but not limited to, customer collection experience, economic conditions, the customer’s financial condition, and
known risk characteristics impacting the respective customer base of rural and community hospitals, the most
notable of which relate to enacted and potential changes in Medicare and Medicaid reimbursement rates as rural
and community hospitals typically generate a significant portion of their revenues and related cash flows from
beneficiaries of these programs. In addition to specific account identification, the Company utilizes historical
collection experience to establish the allowance for credit losses. Financing receivables are written off only after
the Company has exhausted all collection efforts. The Company has been successful collecting its financing
receivables and considers the credit quality of such arrangements to be good, especially as the underlying assets
act as collateral for the receivables.

Customer payments are considered past due if a scheduled payment is not received within contractually
agreed upon terms. To facilitate customer collection and credit monitoring efforts, financing receivable amounts
are invoiced and reclassified to trade accounts receivable when they become due, with all invoiced amounts
placed on nonaccrual status. As a result, all past due amounts related to the Company’s financing receivables are
included in trade accounts receivable in the accompanying balance sheets. The following is an analysis of the age
of financing receivables amounts that have been reclassified to trade accounts receivable and are past due as of
December 31, 2012 and 2011:

1 to 90 Days
Past Due

91 to 180 Days
Past Due

181 + Days
Past Due

Total
Past Due

December 31, 2012 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
December 31, 2011 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

$1,108,108
$ 813,351

$297,812
$271,994

$301,896
$ 48,652

$1,707,816
$1,133,997

From time to time, the Company may agree to alternative payment terms outside of the terms of the original

financing receivable agreement due to customer difficulties in achieving the original terms. In general, such
alternative payment arrangements do not result in a re-aging of the related receivables. Rather, payments
pursuant to any alternative payment arrangements are applied to the already outstanding invoices beginning with
the oldest outstanding invoices as the payments are received.

Because amounts are reclassified to trade accounts receivable when they become due, there are no past due

amounts included within the financing receivables or the financing receivables, current portion, net amounts in
the accompanying balance sheets.

The Company utilizes an aging of trade accounts receivable as the primary credit quality indicator for its
financing receivables, which is facilitated by the reclassification of customer payment amounts to trade accounts
receivable when they become due. The table below categorizes customer financing receivable balances, none of
which are considered past due, based on the age of the oldest payment outstanding that has been reclassified to
trade accounts receivable:

December 31,
2012

December 31,
2011

Customer balances with amounts reclassified to trade accounts

receivable that are:

1 to 90 Days Past Due . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
91 to 180 Days Past Due . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
181 + Days Past Due . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

$ 7,337,602
1,028,235
252,770

$3,380,285
834,474
1,138,582

Total customer balances with past due amounts reclassified to trade

accounts receivable . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

$ 8,618,607

$5,353,341

Total customer balances with no past due amounts reclassified to trade

accounts receivable . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

4,076,185

2,209,284

Total financing receivables with contractual maturities of one year or

less . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Less allowance for losses . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

448,487
(662,315)

722,065
(447,321)

Total financing receivables . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

$12,480,964

$7,837,369

Extended Meaningful Use Installment Plans

During 2012, the Company entered into multiple customer license agreements with payment terms requiring

the customer to remit to the Company incentive payments (not to exceed the remaining balance of the contract
price) received under the American Recovery and Reinvestment Act of 2009 (“ARRA”) for adoption of
qualifying electronic health records (“EHRs”), with only nominal payment amounts required until the customer’s
receipt of such incentive payments. If no such incentive payments are received by the customer or if such

payments are not sufficient to pay the remaining balance under the arrangement, payments continue at contracted
nominal amounts until the balance of the contract price is paid full. Because of the significant difference in the
underlying economics of these arrangements compared to our historical financing receivables, management has
determined that these arrangements are not comparable to historical arrangements. In accordance with the
Software topic and Revenue Recognition subtopic of the Codification, the Company recognizes revenue related to
these arrangements as the amounts become due. Anticipated future cash flows from these arrangements are
excluded from the Company’s financing receivables and deferred revenue in the accompanying balance sheets.
Direct, incremental costs in the amount of $520,572, included as a component of prepaid expenses and other in
the accompanying balance sheets, have been capitalized as of December 31, 2012 related to these arrangements.
There were no such capitalized direct, incremental costs as of December 31, 2011, as these arrangements were
new to the Company beginning in the first quarter of 2012.

9. BENEFIT PLANS

In January 1994, the Company adopted the CPSI 401(k) Retirement Plan that covers all eligible employees
of the Company who have completed one year of service. The plan allows eligible employees to contribute up to
60% of their pre-tax earnings up to the statutory limit prescribed by the Internal Revenue Service. The Company
matches a discretionary amount determined by the Board of Directors. The Company contributed approximately
$1,749,000, $1,495,000, and $1,256,000 to the plan for the years ended December 31, 2012, 2011 and 2010,
respectively.

The Company provides certain health and medical benefits to eligible employees, their spouses and
dependents pursuant to a benefit plan funded by the Company. Each participating employee contributes to the
Company’s costs associated with such benefit plan. The Company’s obligation to fund this benefit plan and pay
for these benefits is limited through the Company’s purchase of an insurance policy from a third-party insurer.
The amount established as a reserve is intended to recognize the Company’s estimated obligations with respect to
its payment of claims and claims incurred but not yet reported under the benefit plan. Management believes that
the recorded liability for medical self-insurance at December 31, 2012 and 2011 is adequate to cover the losses
and claims incurred, but these reserves are based on estimates and the amount ultimately paid may be more or
less than such estimates.

10. OPERATING LEASES

Prior to the Company’s purchase of the property on December 13, 2011, the Company leased certain real

property, most of which was partially owned by an executive officer of the Company. The lease agreements had
terms of ten years and were set to expire on or before December 2015. These related party leases were cancelled
in December 2011 in conjunction with the Company’s purchase of these properties from the related party entity
for $9.5 million. For the years ended December 31, 2011 and 2010, total rent expense paid to the related party
entity was $1,901,810 and $1,697,478, respectively. The Company also leased during 2012 office space in
Mobile, Fairhope and Lanette, Alabama, and Monroe, Louisiana. These leases have terms expiring from 2013
through 2024 but do contain optional extension terms.

The future minimum lease payments payable under operating leases subsequent to December 31, 2012 are

as follows:

2013 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2014 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2015 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2016 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2017 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Thereafter

$ 639,032
703,679
458,993
285,877
336,524
2,148,100

$4,572,205

Total rent expense for the years ended December 31, 2012, 2011, and 2010 was $934,206, $2,437,422, and

$2,160,698, respectively.

11. COMMITMENTS AND CONTINGENCIES

From time to time, the Company is involved in routine litigation that arises in the ordinary course of
business. Management does not expect this to have a material adverse effect on the Company’s financial
statements.

12. FAIR VALUE

FASB Codification topic, Fair Value Measurements and Disclosures, establishes a framework for

measuring fair value and expands financial statement disclosures about fair value measurements. Fair value is the
price that would be received to sell an asset or paid to transfer a liability (an exit price) in the principal or most
advantageous market for the asset or liability in an orderly transaction between market participants at the
measurement date. The Codification does not require any new fair value measurements, but rather applies to all
other accounting pronouncements that require or permit fair value measurements. The Codification requires that
assets and liabilities carried at fair value be classified and disclosed in one of the following three categories:

Level 1: Quoted market prices in active markets for identical assets or liabilities.

Level 2: Observable market-based inputs or unobservable inputs that are corroborated by market data.

Level 3: Unobservable inputs that are not corroborated by market data.

The fair values of the Company’s available-for-sale securities are based on matrix pricing for the periods
ended December 31, 2012 and 2011, which uses observable market based inputs (such as benchmark yields) in
addition to quoted prices in active markets to derive fair values. As a result, these inputs are classified as Level 2
within the fair value hierarchy. We generally apply fair value techniques on a non-recurring basis associated with
(1) valuing potential impairment loss related to financing receivables accounted for pursuant to Codification
topic, Leases, and (2) valuing potential impairment loss related to long-lived assets accounted for pursuant to
Codification topic, Property, Plant and Equipment, when events or circumstances indicate a possible impairment.

The following table summarizes the carrying amounts and fair values of certain assets and liabilities at

December 31, 2012 and December 31, 2011:

Fair Value at December 31, 2012 Using

Carrying
Amount at
12/31/2012

Quoted Prices in
Active Markets for
Identical Assets
(Level 1)

Significant Other
Observable Inputs
(Level 2)

Significant
Unobservable Inputs
(Level 3)

Description
Available-for-sale securities

Short-term investments (cash and

accrued income) . . . . . . . . . . . . . .
Mortgage backed securities . . . . . . .
Obligations of U.S. Treasury, U.S.
government corporations and
agencies . . . . . . . . . . . . . . . . . . . .
Corporate bonds . . . . . . . . . . . . . . . .

449,420
95,604

2,381,779
7,747,806

Total available-for-sale securites . . . . . . .

$10,674,609

$ —
—

—
—

$ —

449,420
95,604

2,381,779
7,747,806

$10,674,609

$ —
—

—
—

$ —

Fair Value at December 31, 2012 Using

Carrying
Amount at
12/31/2012

Quoted Prices in
Active Markets for
Identical Assets
(Level 1)

Significant Other
Observable Inputs
(Level 2)

Significant
Unobservable Inputs
(Level 3)

Description
Available-for-sale securities

Short-term investments (cash and

$ 1,577,190
102,832

5,955,890
8,850,776

Total available-for-sale securites . . . . . . .

$16,486,688

$—
—

—
—

$—

$ 1,577,190
102,832

5,955,890
8,850,776

$16,486,688

$—
—

—
—

$—

Accrued income in the above table represents earnings due and payable to our investment portfolio at any

point in time but not yet received.

The carrying amount of other financial instruments reported in the balance sheet for current assets and

current liabilities approximates their fair values because of the short-term nature of these instruments.

13. SUBSEQUENT EVENTS

Declaration of Dividends

On January 31, 2013, the Company announced a dividend for the first quarter of 2013 in the amount of
$0.51 per share. The dividend was paid on February 22, 2013 to stockholders of record as of the close of business
on February 7, 2013.

Issuance of Restricted Stock

On March 4, 2013, the Compensation Committee of the Board of Directors approved the grant of a total of

2,390 shares of restricted stock, effective March 4, 2013, to the five non-employee directors of the Company
under the Company’s 2012 Restricted Stock Plan for Non-Employee Directors. The grant date fair value was
$52.32 per share. Under the terms of the restricted stock award agreements with the non-employee directors, the
shares of restricted stock are scheduled to vest on the third anniversary of the date of grant, assuming that the
recipient of the grant continues to serve as a director of the Company on the vesting date. Compensation expense
for this grant will be recognized on a straight-line basis over three years.

Adoption of 2013 Incentive Program

On March 4, 2013, the Board of Directors, upon the recommendation of the Compensation Committee,
adopted a short-term incentive program for 2013 for the executive officers of the Company, other than executive
officers earning any commission-based compensation (the “2013 Incentive Program). Under the 2013 Incentive
Program, certain executive officers of the Company were granted a short-term incentive cash bonus opportunity
based on achievements of a specified level of financial performance, specifically the Company’s earnings before
interest, income taxes, depreciation and amortization (“EBITDA”) in 2013 (“2013 EBITDA”) compared to the
Company’s EBITDA in 2012 (“2012 EBITDA”).

Participants in the 2013 Incentive Program will receive 100% of their target award amount if the Company’s

2013 EBITDA is 105% of 2012 EBITDA, 75% of the target award amount if the Company achieves a minimum

threshold level of performance (2013 EBITDA reaching 95% of 2012 EBITDA), and a maximum of 150% of the
target award amount for a maximum level of performance (2013 EBITDA equaling or exceeding 130% of 2012
EBITDA). No payments are to be made for performance below the specified threshold amount. Payouts between
the threshold and maximum are calculated by the Compensation Committee using the interpolation process
described in the 2013 Incentive Program. The Compensation Committee may make adjustments to the terms and
conditions of, and the criteria included in, awards under the 2013 Incentive Program in recognition of unusual or
nonrecurring events affecting a participant or the Company, or the financial statements of the Company, or in
certain other instances specified in the 2013 Incentive Program.

Awards earned under the 2013 Incentive Program are to be paid solely in cash. In addition, awards pursuant
to the 2013 Incentive Program are subject to recovery or adjustments by the Company in certain circumstances in
which the operating results on which payment was based are restated or otherwise adjusted or in the event that a
participant’s conduct is not in good faith and materially disrupts, damages, impairs or interferes with the business
of the Company.

14. QUARTERLY FINANCIAL STATEMENTS (UNAUDITED)

The following table presents a summary of our results of operations for our eight most recent quarters ended

December 31, 2012. The information for each of these quarters is unaudited and has been prepared on a basis
consistent with the audited financial statements. This information includes all adjustments, consisting only of
normal recurring adjustments, we consider necessary for fair presentation of this information when read in
conjunction with the audited financial statements and related notes. Our operating results have varied on a
quarterly basis and may fluctuate significantly in the future.

Year Ended December 31, 2012

Sales revenues . . . . . . . . . . . . . . . . . . . . . . . . . . .
Gross profit . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Operating income . . . . . . . . . . . . . . . . . . . . . . . .
Net income . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Net income per share

Basic . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Diluted . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Weighted average shares outstanding

Basic . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Diluted . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Year Ended December 31, 2011

Basic . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Diluted . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Weighted average shares outstanding

1st Quarter

2nd Quarter

3rd Quarter

4th Quarter

(In thousands except for share and per share data)

44,489
19,267
8,999
5,649

0.51
0.51

11,063,220
11,063,220

40,380
17,136
8,491
5,373

0.49
0.49

45,731
20,139
9,925
8,261

0.75
0.75

11,063,529
11,063,529

48,839
24,157
11,518
7,916

0.72
0.72

45,174
20,015
9,991
6,925

0.63
0.63

11,065,380
11,065,380

42,045
19,477
9,638
5,989

0.54
0.54

47,915
21,240
12,362
9,139

0.83
0.83

11,073,575
11,073,575

42,212
18,642
10,527
6,555

0.59
0.59

Basic . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Diluted . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

10,962,874
10,962,874

11,044,474
11,044,474

11,063,220
11,063,220

SCHEDULE II
COMPUTER PROGRAMS AND SYSTEMS, INC.
VALUATION AND QUALIFYING ACCOUNTS

Description

Allowance for doubtful accounts deducted from

accounts receivable in the balance sheet . . . . . .

Balance at
beginning of
period

(1) Additions
charged to cost
and expenses

(2)
Deductions

Balance at end
of period

2010
2011
2012

$ 759,000
$ 969,000
$1,276,000

$849,000
$937,000
$300,144

$639,000
$630,000
$452,144

$ 969,000
$1,276,000
$1,124,000

(1) Adjustments to allowance for change in estimates.
(2) Uncollectible accounts written off, net of recoveries.

Description

Allowance for credit losses deducted from

financing receivables in the balance sheet . . . . .

Balance at
beginning of
period

(1) Additions
charged to cost
and expenses

(2)
Deductions

Balance at end
of period

2010
2011
2012

$ —
$233,396
$447,321

$233,396
$499,485
$214,994

$ —
$285,560
$ —

$233,396
$447,321
$662,315

(1) Adjustments to allowance for change in estimates.
(2) Uncollectible accounts written off, net of recoveries.

ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND

FINANCIAL DISCLOSURE

None.

ITEM 9A. CONTROLS AND PROCEDURES.

Evaluation of Disclosure Controls and Procedures

We maintain disclosure controls and procedures that are designed to provide reasonable assurance that the
information required to be disclosed by us in reports that we file or submit under the Securities Exchange Act of
1934, as amended (the “Exchange Act”), is recorded, processed, summarized and reported within the time
periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to
our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate to allow
timely decisions regarding required disclosure. Because of the inherent limitations to the effectiveness of any
system of disclosure controls and procedures, no evaluation of disclosure controls and procedures can provide
absolute assurance that all control issues and instances of fraud, if any, with a company have been prevented or
detected on a timely basis. Even disclosure controls and procedures determined to be effective can only provide
reasonable assurance that their objectives are achieved.

As of the end of the period covered by this report, we carried out an evaluation, under the supervision and

with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, of
the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Exchange
Act Rule 13a-15(e)) pursuant to Rule 13a-15 of the Exchange Act. Based upon that evaluation, our Chief
Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures are effective
at the reasonable assurance level.

Changes in Internal Control over Financial Reporting

There were no changes in the Company’s internal control over financial reporting (as defined in Exchange

Act Rule 13a-15(f)) during the quarter ended December 31, 2012 that have materially affected, or are reasonably
likely to materially affect, the Company’s internal control over financial reporting.

Management’s Annual Report on Internal Control Over Financial Reporting

This report is included in Item 8 on page 55 and is incorporated herein by reference.

Report of Independent Registered Public Accounting Firm on Internal Control Over Financial Reporting

This report is included in Item 8 on page 57 and is incorporated herein by reference.

ITEM 9B. OTHER INFORMATION.

None.

PART III

ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE

We have adopted a Code of Business Conduct and Ethics applicable to all of our directors, officers
(including our Chief Executive Officer and senior financial officers) and employees. We have also adopted a
separate code of ethics with additional guidelines and responsibilities applicable to our Chief Executive Officer
and senior financial officers, known as the Code of Ethics for CEO and Senior Financial Officers. Copies of the
Code of Business Conduct and Ethics and the Code of Ethics for CEO and Senior Financial Officers are available
on CPSI’s web site at www.cpsinet.com in the “Investors” section under “Governance.”

Other information required by this Item regarding executive officers is included in Part I of this Form 10-K

under the caption “Executive Officers” in accordance with Instruction 3 of the Instructions to Paragraph (b) of
Item 401 of Regulation S-K.

Other information required by this Item is incorporated by reference pursuant to General Instruction G(3) of
Form 10-K from CPSI’s definitive Proxy Statement for the 2013 Annual Meeting of Stockholders to be filed with
the Securities and Exchange Commission pursuant to Regulation 14A.

ITEM 11. EXECUTIVE COMPENSATION

The information required by this Item is incorporated by reference pursuant to General Instruction G(3) of

Form 10-K from CPSI’s definitive Proxy Statement for the 2013 Annual Meeting of Stockholders to be filed with
the Securities and Exchange Commission pursuant to Regulation 14A.

ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT

AND RELATED STOCKHOLDER MATTERS

The information required by this Item is incorporated by reference pursuant to General Instruction G(3) of

Form 10-K from CPSI’s definitive Proxy Statement for the 2013 Annual Meeting of Stockholders to be filed with
the Securities and Exchange Commission pursuant to Regulation 14A.

ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR

INDEPENDENCE

The information required by this Item is incorporated by reference pursuant to General Instruction G(3) of

Form 10-K from CPSI’s definitive Proxy Statement for the 2013 Annual Meeting of Stockholders to be filed with
the Securities and Exchange Commission pursuant to Regulation 14A.

ITEM 14. PRINCIPAL ACCOUNTANT FEES AND SERVICES

The information required by this Item is incorporated by reference pursuant to General Instruction G(3) of

Form 10-K from CPSI’s definitive Proxy Statement for the 2013 Annual Meeting of Stockholders to be filed with
the Securities and Exchange Commission pursuant to Regulation 14A.

PART IV

ITEM 15. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES

(a)(1) and (2) and (c) – Financial Statements and Financial Statement Schedules.

Financial Statements: The Financial Statements and related Financial Statements Schedule of CPSI
are included herein in Part II, Item 8.

(a)(3) and (b) – Exhibits.

The exhibits listed on the Exhibit Index beginning on page 84 of this Form 10-K are filed herewith
or are incorporated herein by reference.

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant
has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized, on this the
11th day of March, 2013.

COMPUTER PROGRAMS AND SYSTEMS, INC.

By: /s/ J. Boyd Douglas

J. Boyd Douglas
President and Chief Executive Officer

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by

the following persons on behalf of the registrant and in the capacities and on the dates indicated.

Name

/s/ David A. Dye

David A. Dye

/s/ J. Boyd Douglas

J. Boyd Douglas

/s/ James B. Britain

James B. Britain

/s/ Ernest F. Ladd, III

Ernest F. Ladd, III

/s/ W. Austin Mulherin, III

W. Austin Mulherin, III

/s/ William R. Seifert, II

William R. Seifert, II

/s/ John C. Johnson

John C. Johnson

/s/ Charles P. Huffman

Charles P. Huffman

Title

Date

Chairman of the Board and Director,
Chief Financial Officer
(principal financial officer)

March 11, 2013

President, Chief Executive Officer and
Director (principal executive officer)

March 11, 2013

Vice President – Finance and Controller
(principal accounting officer)

March 11, 2013

Director

Officers

J. Boyd Douglas, Jr.
President and
Chief Executive Officer

David A. Dye
Chief Financial Officer

Directors and officers

Board of Directors

David A. Dye
Chairman and Chief
Financial Officer
Computer Programs and Systems, Inc.

Charles P. Huffman
Retired Executive Vice President and
Chief Financial Officer
EnergySouth, Inc.

W. Austin Mulherin, III
Attorney
Frazer, Greene, Upchurch &
Baker, LLC

John C. Johnson
Real Estate Appraiser
Courtney & Morris
Appraisals, Inc.

J. Boyd Douglas, Jr.
President and
Chief Executive Officer
Computer Programs and Systems, Inc.

Ernest F. Ladd, III
Retired Executive Vice President and
Chief Financial Officer
Dravo Corporation

William R. Seifert, II
Retired Executive Vice President
Regions Bank
Chairman
South Alabama Advisory Board of
Regions Bank

Stock Performance Graph
The following graph sets forth the cumulative total return (assuming reinvestment of dividends) to our stockholders during the period
beginning December 31, 2007, and ending on December 31, 2012, compared to an overall stock market index (NASDAQ Composite Index),
and the NASDAQ Computer and Data Processing Group.

$300

$275

$250

$225

$200

$175

$150

$125

$100

$75

$50

$25

12/07

12/08

12/09

12/10

12/11

12/12

Computer programs and Systems, Inc.

S&p 500

naSDaQ Computer and Data processing

Computer programs and Systems, Inc.
S&p 500
naSDaQ Computer & Data processing

12/07
100.00
100.00
100.00

$
$
$

12/08
125.26
63.00
57.50

$
$
$

12/09
$ 224.29
79.67
$
90.39
$

1210

$ 236.02
91.67
$
98.29
$

12/11
$ 264.02
93.61
$
95.15
$

12/12
271.89
108.59
106.83

$
$
$

Corporate Data

Independent Registered Public Accounting Firm
Grant Thornton LLP
1100 Peachtree Street, Suite 1200
Atlanta, GA 30309

Transfer Agent
American Stock Transfer & Trust Company, LLC
6201 15th Avenue
Brooklyn, NY 11219
Toll free: (800) 937-5449
Local & international: (718) 921-8124
Email: info@amstock.com
Web site: www.amstock.com

Legal Counsel
Maynard, Cooper & Gale, P.C.
1901 Sixth Avenue North, Suite 2400
Regions/Harbert Plaza
Birmingham, AL 35203-2618

Corporate Headquarters
Computer Programs and Systems, Inc.
6600 Wall Street
Mobile, AL 36695
(251) 639-8100
www.cpsinet.com

Common Stock
Computer Programs and Systems, Inc.’s common stock
is traded on The NASDAQ Stock Market’s Global Select
Market under the symbol “CPSI.”

6600 Wall Street | Mobile, Alabama 36695